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Abstract 
Ferritins are ubiquitous proteins that serve the dual-function of iron reservoir and 
sequestering the Fe(II) toxicity. The function of ferritins totally depends on the 
characteristic spherical structure with a di-iron centre performing the iron oxidation 
and a hallow cavity enclosing the iron minerals in a bioavailable form. I have 
characterised the structure, assembly and function of a new member of ferritin 
superfamily that is natively enclosed within an encapsulin shell. Encapsulin proteins 
are structurally-related to a virus capsid and form 60-meric or 180-meric icosahedrons. 
I show that this encapsulin associated ferritin-like protein (EncFtn) possesses two main 
alpha helices, which assemble in a metal-dependent manner to form a ferroxidase 
centre at a dimer interface. EncFtn adopts an annular decamer structure in contrast to 
the 24-meric classical ferritins or 12-meric mini-ferritin (DPS). The resemblance of 
the dimeric EncFtn and monomeric classical ferritins suggests that it is likely that 
classical ferritin evolves from EncFtn because of the gene duplication. EncFtn is a 
catalytically active ferroxidase but with only a limited iron binding ability due to its 
open structure. The encapsulin itself is not able to oxidise Fe(II), but is able to store 
about 2200 iron ions. I have demonstrated that the EncFtn must be housed in the 
encapsulin to achieve a maximum loading of approximately 4200 iron ions. The 
encapsulin nanocompartments are widely-distributed in both eubacteria and archaeon 
with distinct life styles and represent a distinct class of iron storage system, where iron 
oxidation and mineralisation are distributed between two proteins.
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Lay Summary 
Iron as a basic element is essential for most living cells. But extra free iron in cells 
could damage cellular components. Nature has evolved a protein called ‘ferritin’ to 
maintain the iron concentration in a reasonable range in cells. Ferritins have a ball-like 
structure and enclose a central cavity where iron can be safely stored away from the 
rest of cells. I am interested in a new family of ferritins called ‘ferritin-like protein’, 
which has no clear information regarding its structure and function. My PhD thesis 
focused on three questions: 1. What is the protein structure of this ferritin-like protein? 
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1 Chapter 1 Introduction 
 Why is iron important to cells? 
Iron is the most abundant transition metal on earth and ubiquitous in almost all life 
forms (Theil & Raymond 1994). Iron is mainly involved in oxidoreductase to transfer 
electrons (Waldron et al. 2009). Iron can be bound by haem prosthetic groups of 
proteins, such as cytochrome oxidases (Svensson-Ek et al. 2002), catalases (Carpena 
et al. 2005) and peroxidases (Zámocký et al. 2015) that participate in the activation of 
molecular oxygen; haemoglobins and myoglobins that function as oxygen carriers 
(Ponka 1999); cytochromes involved in electron transport (Gursahani et al. 2008). Iron 
can also exist in proteins in a form of iron-sulphur clusters, such as ferredoxins, which 
function as electron carriers (Kümmerle et al. 2000). Furthermore, iron can be directly 
bound by protein side chains, including mononuclear non-haem iron enzymes; 
dinuclear non-haem iron enzymes such as ribonucleotide reductase; which participates 
in the early stages of DNA synthesis; as well as proteins engaged in iron storage 
(ferritins) and transport (transferrin) (Lill 2009; Crichton 2009). These iron-bound 
proteins are widely distributed across all Kingdoms except Lactobacillus plantarum, 
which has no iron containing enzymes (Archibald 1983). Iron is also pivotal in the host 
and pathogen interaction (Ratledge & Dover 2000; Johnson 2008). 
Iron exists in cells in more than one oxidation state, with the two most common 
valences—Fe(II) and Fe(III). The iron valence is largely dependent on the redox 
potential and pH of the environment. The oxidation state of iron is very important for 
cells due to the drastically different solubility of two iron ions. Fe(II) is very soluble; 
for instance, the solubility of ferrous ammonium sulphate is 0.68 M in water at 20°C. 
However, Fe(II) is very easily to oxidise into Fe(III) in aerobic environment and thus 
generates oxyhydroxide minerals in the presence of water. These minerals have a very 
poor solubility; for example, Fe(OH2)
+ has a solubility of 1.4×10-9 M at pH = 7 
(Chipperfield & Ratledge 2000). Since the cellular iron requirement is around 10-4 M 
(Theil 2003), the poor solubility of Fe(III) in physiological conditions limits the 
bioavailability of iron for cells. It also means that aerobic organisms have more 




anaerobic environment. While iron is essential for many biological processes the 
presence of iron ions within a cell poses a number of problems for biomolecules due 
to the Fe(II)-induced Fenton reaction (Wardman & Candeias 1996).   
 Fenton chemistry 
The evolution of organisms from anaerobes to aerobes has been partially influenced 
by the accumulation of di-oxygen in atmosphere. This accumulation was a direct result 
of cyanobacterial photosynthesis, which uses water as a hydrogen donor to produce 
sugars and di-oxygen. Fe(II) is stable under anaerobic and acidic conditions; however, 
it is readily oxidised by hydrogen peroxide, which is a by-product of aerobic 
respiration at physiological pH. This iron-catalysed hydrogen peroxide conversion to 
hydroxyl radicals was termed the Fenton reaction (Wardman & Candeias 1996; Fenton 
1876) and proceeds as follows:  
Fe2+ + H2O2 → Fe
3+ + ˙OH + OH− 
The hydroxyl radicals (˙OH) produced attack neighbouring molecules, causing 
endogenous DNA oxidation (Cadet et al. 1999), producing covalently bound protein 
aggregates (Davies 1987) and leading to lipid peroxidation (Ayala et al. 2014). This 
damage is mitigated by three major mechanisms in cells: compartmentalisation; 
antioxidant systems; and enzymes that directly degrade reactive oxygen species, such 
as  iron containing-superoxide dismutase,  superoxide reductase, and catalase (Riley 
1994; Sheng et al. 2014). The limited Fe(III) solubility and Fenton chemistry-related 
toxicity requires strict iron homeostasis in almost all organisms. Perturbation of 
intracellular iron concentration can lead to cellular damage and severe health problems, 
such as the iron-overloading in hemochromatosis and multiple metabolic disorders, or 
iron deficiency in anaemia (MacKenzie et al. 2008). 
 How do organisms regulate iron metabolism? 
1.3.1 Iron uptake 
Cellular iron metabolism includes iron uptake, storage, mobilisation, and regulation 
processes (Aisen et al. 2001). The iron availability differs for marine, terrestrial and 




take advantage of multiple iron uptake pathways (Sandy & Butler 2009). Iron is 
absorbed from soil or ocean through Fe(III) chelation by siderophores extracellularly-
secreted by microbes or organic acids, phenols and phytosiderophores in plants 
(Colombo et al. 2014). In human 60% of the iron resides in haemoglobin, making it a 
main source for pathogens to capture iron from their hosts (Theil & Raymond 1994). 
Therefore, haem-mediated iron acquisition has also been utilised for pathogens in 
addition to siderophores (Braun 2001). For vertebrates, iron can be assimilated from 
dietary components by the mucosal cells of jejunum and transported to the blood 
stream, followed by chelation and transport by transferrins (Ratledge & Dover 2000).  
1.3.2 Cellular iron storage 
Although the haem-iron in haemoglobin accounts for the majority of iron present in 
the human body, haem itself does not act as an iron sink or storage system. Instead, 
ferritins are the primary iron storage proteins in most living cells, maintaining the 
intracellular iron availability in addition to extracellular iron sources (Theil 1987). 
Ferritins are a family of self-assembling protein cages with diameters of around 7–12 
nm, enclosing a central cavity where iron can be reversibly stored as ferrihydrite 
(Fe2O3•H2O). Iron-free ferritin is referred to as apoferritin; the maximum iron 
sequestered within the ferritin cage is around 4500 iron ions (Ford et al. 1984). This 
iron sequestration ability grants ferritin dual functions in providing a cellular iron 
reserve and protecting cells from Fe(II) toxicity (Zhang & Orner 2011). Most 
organisms possess multiple ferritin genes, highlighting their key roles in iron 
homeostasis (Bai et al. 2015). As ferritins play such an essential role in iron regulation, 
their structure and function will be discussed in more details below. 
1.3.3 Iron release 
When cytosolic iron is depleted iron is released by endogenous ferritin iron storage 
proteins. The iron release from ferritin mineral core in vitro involves the addition of 
electrons to Fe(III) as well as water/protons to the oxo/hydroxo ferritin bridges (Theil 
et al. 2000). How iron is mobilised and released from ferritins in vivo is still poorly 
understood, four potential mechanisms regarding iron release are suggested as follows: 
(1) the iron stored in ferritin cage is in an equilibrium with cytosolic iron (Laulhère et 




et al. 2012); (2) Fe(III) in the mineral core is reduced by biologically relevant 
reductants, such as NADH/FMN (Mertz & Theil 1983),  before Fe(II) is released by 
chelators at the physiologically required rate (Watt & Jacobst 1988; Jones et al. 1978); 
(3) Fe(III) is released in eukaryotes through ferritin degradation within lysozymes 
(Kidane et al. 2006); (4) chaperones are involved in docking ferritin and directly 
removing Fe(III) (Carmona et al. 2013). Additionally, the haem groups in 
bacterioferritins was suggested to facilitate the reduction of Fe(III) mineral core and 
Fe(II) release via an electron transfer mechanism (Yasmin et al. 2011) involving 
ferredoxins which associate with bacterioferritin and possesses a [2Fe-2S] cluster. 
Ferredoxins are suggested to reduce the Fe(III) in bacterioferritin through electron 
transfer from cellular reducing agents such as NAD(P)H via the haem groups 
coordinated by the bacterioferritin (Weeratunga et al. 2009). It is also worth pointing 
out that iron scavenging by transferrin under physiological conditions is slower than 
the iron deposition in ferritin cages, making transferrin less possible as an iron release 
route. Lysozyme-dependent ferritin degradation may release iron in an uncontrollable 
way, which is not ideal in terms of isolating cells from Fe(II) toxicity. Overall, the iron 
release in vivo still needs more experimental evidence.  
 Ferritin family proteins 
1.4.1 Ferritin classification 
Ferritin was initially isolated from horse spleen in 1937 (Laufberger 1937); and the 
first crystal structure was determined in 1991 as a 24-meric protein cage with 432 
octahedral symmetry (Lawson et al. 1991). The subsequent discoveries of ferritins in 
other organisms, such as mouse, human, horse (Rucker et al. 1996; Hempstead et al. 
1997), soybean (Proudhon et al. 1996; Masuda et al. 2010a) and Escherichia coli 
(Hudson et al. 1993) revealed a similar architecture as the horse spleen ferritin, 
suggesting the importance of the conserved ferritin structure to its function. In 1998 
the first structure of a mini-ferritin was determined from protein isolated from E. coli  
cells, known for its role in DNA protection during oxidative stress (DPS), as a 12-
meric protein cage which suggested a distinct ferritin function (Grant et al. 1998). 
Mammalian ferritins are heteropolymers consisting of two subunits: H-chain and L-




with a root-mean-square deviation of Cα positions (RMSDCα) of 0.486 Å for 153 atoms. 
H-chain ferritin is predominant in heart and has a molecular weight of around 21 kDa, 
with 182 amino acids. L-chain ferritin is about 19 kDa, with 174 amino acids and 
predominates in liver (Theil 1987). Mammalian ferritins isolated from different tissues 
vary in the ratios of H-chain/L-chain from 2:22 to 20:4, suggesting tissue-specific iron 
storing ability. (Levi et al. 1994; Wang et al. 2006). Apart from H-/L-chain ferritins, 
amphibians have an additional type M ferritin, which has been characterised in 
bullfrog (FgMF, PDB ID: 1MFR) (Ha et al. 1999). H-chain (Levi et al. 1988) or M-
chain (Pereira et al. 1998) ferritin is responsible for the fast iron oxidation conferred 
by the ferroxidase centre (FOC) while L-chain ferritin does not possess ferroxidase 
centre (FOC) and is only involved in iron mineralisation (Wang et al. 2006; Levi et al. 
1994). 
There are three major classes of ferritins in microbes: bacterial ferritins (FTN), 
bacterioferritins (BFR), as well as DNA-binding protein from starved cells (DPS). 
They are able to catalyse the oxidisation of Fe(II) to Fe(III), and store iron in a mineral 
form in ferritin cages. But the chief role of DPS is not storing iron; instead, the ferrous-
loaded E. coli DPS was found to protect DNA from oxidative damage in a long 
distance through two steps: ferrous was oxidised in DPS with DNA charge transport-
dependent electron transfer, which was able to fill the guanine radical hole caused by 
the DNA oxidation and thus restore the DNA integrity (Arnold & Barton 2013). DPS, 
on top of ferroxidase activity, has also been found to possess peroxidase activity in 
Microbacterium arborescens (Pesek et al. 2011). Phosphate is suggested to be 
involved in the mammalian and bacterial ferritin cores and affect both iron deposition 
and release (de Silva et al. 1993; Watt et al. 1992; Watt et al. 2010). 
1.4.2 Ferritin architecture 
The quaternary structure of ferritin proteins is entirely critical to their function as iron 
stores (Crichton & Declercq 2010). The classical 24-meric ferritin fold consists of a 
four-helix bundle arranged in an up-down-down-up topology, followed by a short α5 
helix that lies roughly perpendicular to the central axis of four-helix bundle, a long 





Figure 1.4.1 The four-alpha helical ferritin fold. 
The ferritin fold is characterised by a four-alpha-helix bundle coordinating di-nuclear metal ions, 
followed by a short α5 in the C-terminus. (A) The arrangement of 24-meric ferritin fold is shown. 
(B) The front view of superimposed human H-chain ferritin (yellow cartoons, PDB ID: 2FHA) 
(Hempstead et al. 1997), M-type ferritin (cyan cartoons, PDB ID: 1R03 (Langlois d’Estaintot et 
al. 2004) and L-chain ferritin (grey cartoons, PDB ID: 2FG4) (Wang et al. 2006). (C) Back view 
of (B). (D) The arrangement of 12-meric DPS fold is shown. (E) The front view of superimposed 
E. coli bacterial ferritin (green cartoons, PDB ID: 1EUM) (Bou-Abdallah et al. 2014), 
Azotobacter vinelandii bacterioferritin shown in raspberry cartoons with di-iron bound in 
spheres (PDB ID: 2FL0) (Swartz et al. 2006), and E. coli DPS (slate cartoons , PDB ID: 1L8H). 
(F) The top view of (E) with alpha helices shown in cylindrical mode. Notably, DPS does not 
contain α5; instead, it possesses a short alpha-helical region in the loop connecting α2 and 
α3. 
The four-helix bundle coordinates iron ions in a di-nuclear ferroxidase centre, which 
is present in all classical ferritins except the L-chain ferritins (Levi et al. 1994). 
Twenty-four monomers of classical ferritin assemble into a 12-faced polyhedron with 
around 480 kDa molecular weight; this assembly has a 432 octahedral symmetry. This 
typical 24-meric spherical structure, which has an outer diameter of roughly 12 nm 
and an inner diameter of 8 nm, is common to eukaryotic ferritins, FTNs and BFRs 





Figure 1.4.2 Structure of microbial ferritins. 
The quaternary structures of FTN, BFR and DPS are shown in cartoon mode; a single 
monomer is coloured grey and bound iron ions in ferroxidase active sites are shown as orange 
spheres. (A) Structure of FTN from Pseudonitzchia multiseries (PDB ID: 4IWJ) (Pfaffen et al. 
2013). Grey lines and polygons depict the relationship between the symmetry axes of the 
ferritin cage: 2-fold, ellipse; 3-fold, triangle; 4-fold, square. (B) Structure of BFR from 
Desulfovibrio desulfuricans (PDB ID: 1NF4) (Macedo et al. 2003). The bound b-type haem 
groups are shown as yellow sticks between the protein monomers; due to the co-ordination of 
this flexible group the 2-fold axes between monomers are not true symmetry axes. BFR is 
shown in the same orientation as FTN. (C) Structure of DPS from Microbacterium arborescens 
(PDB ID: 2YJK) (Pesek et al. 2011). DPS is a dodecamer and has 2- and 3-fold symmetry 
axes; the relationship between these is illustrated with grey lines and a triangle and ellipse. 
This figure is adapted from (He & Marles-Wright 2015). 
Classical ferritins from various organisms and tissues differ in iron storage ability, 
suggesting that different types of ferritins have evolved specialised functions in their 
hosts and host tissues in multicellular organisms. Mammalian ferritin is able to store 
up to 4,500 iron ions in its cage (Ford et al. 1984). DPS, also called mini-ferritin, 
consists of 12 subunits arranged in a cage with 23 point group symmetry, with 9.5 nm 
outer diameter and 5 nm inner diameter; the central cavity can store up to 500 iron 
atoms (Zeth 2012). DPS differs from the classical 24-meric ferritin fold in four aspects: 
(1) α5 is missing in DPS; (2) DPS contains a short alpha helical region in the α2-α3 
loop; (3) the FOC of DPS lies at the two-fold symmetry interface instead of the centre 
of a monomer; (4) the α3 and α4 in DPS are shorter than the 24-meric ferritin 
counterparts (Figure 1.4.1 D–F and Figure 1.4.2 C). Several structures of L-chain 
ferritin have been determined including horse (Gallois et al. 1997), mouse (Granier et 
al. 2003) and human (Wang et al. 2006) variants. These show the FOC is missing; thus, 
rather than functioning in iron oxidation, the L-chain ferritin is suggested to facilitate 




structures, but BFR coordinates up to 12 b-type haem groups at the 2-fold symmetry 
axes between the subunits (Figure 1.4.2 B). The iron in these haem groups is 
coordinated by conserved methionine residues and it is suggested that the presence of 
haem helps release iron from iron minerals inside the BFR cage by facilitating electron 
transfer across the ferritin cage (Yasmin et al. 2011).  
1.4.3 Ferritin assembly/disassembly 
Some ferritin cages are very stable and are able to withstand temperatures up to 85°C, 
and the presence of chaotropic agents, such as 6 M urea, or guanidine, when the pH is 
above 3.5 (Listowsky et al. 1972). The in vitro assembly and disassembly of ferritins 
have been shown to be pH-dependent. The horse spleen apoferritin is found out to 
disassemble when pH is lower than 0.8 while the ferrihydrite core starts to aggregate 
under pH 2.1. However, the horse spleen apoferritin can only be reconstructed to 20-
mer when pH changes from 3.24–1.96 to neutral conditions. It is suggested to be 
related to the specific intersubunit interaction and requires other molecules to assist in 
the reassembly in vivo  (Kim et al. 2011). The self-assembly of ferritin relies on the 
intersubunit electrostatic interactions between two loops which connect α2 and α3 
perpendicular to the 2-fold symmetry axis, as shown in Figure 1.4.2 A (Bernacchioni 
et al. 2014). In E. coli BFR ferritin appears to assemble from a stable intermediate—
dimer species, as shown by alanine scanning mutagenesis of 2-fold, 3-fold or 4-fold 
symmetry interface residues, of which the formation of 24-meric BFR cage was 
abolished, but dimers remained (Zhang et al. 2010). The haem groups are suggested to 
be not essential for the assembly of bacterioferritin (Andrews et al. 1995). It was 
discovered in a bacterial ferritin from the archaeon Pyrococcus furiosus that the 
formation of the 24-meric ferritin cage is a prerequisite for fulfilling Fe(II) oxidation 
(Ebrahimi et al. 2015a). The assembly of ferritins has been engineered to be 
controllable by modifying the C2 interface residues to be specifically bound by copper 
ion at neutral pH, followed by disrupting the other C2 interfacial interaction, so that 




1.4.4 Iron binding sites in classical ferritins 
It is not easy to determine the iron binding in ferritins due to its relatively low-affinity 
binding at sites (Kd around 10
-5 M) other than the ferroxidase centre (Bertini et al. 
2012). The transient iron binding can be captured by slowing down the iron movement 
under anaerobic conditions or using competitors such as Mg(II) or Zn(II) (Ebrahimi et 
al. 2010). Four iron binding sites have been identified in HuHF based on time-
dependent iron soaking in anaerobic crystals (Figure 1.4.3), including di-iron (FeA and 
FeB) bound in the FOC, another two iron ions (FeC and FeD) bound in site C next to 
the FOC, two iron ions coordinated in the three-fold symmetry channel, as well as an 
iron ion found in the four-fold symmetry pore (Pozzi et al. 2015). The ferritin 
chemistry includes iron entry, oxidation, translocation, mineralisation and exit, which 
are separated in space and time (Theil et al. 2000). 
 
 
Figure 1.4.3 Iron binding sites in human H-chain ferritin. 
The structure of human H-chain ferritin (HuHF, PDB ID: 4YKH) is shown in cartoon mode with 
iron shown in spheres (Pozzi et al. 2015). The iron binding in different sites is highlighted in 
different colours. (A) 24-meric HuHF is shown in green cartoon with a monomer highlighted in 
rainbow colour. (B) The monomeric HuHF. (C) Rotated view of (B) by 90° displays the four 
iron binding positions. Di-iron (FeA and FeB) bound in the FOC is shown in red spheres and 
highlighted by a circle. A pentagon underscores two iron ions (blue spheres) coordinated in 
the FeC site close to the FOC. A triangle highlights two iron ions (green spheres) bound in the 
three-fold symmetry channel. A square highlights an iron ion (yellow sphere) bound in the four-




1.4.4.1 Ferroxidase catalytic site 
All classical ferritins except the L-chain ferritin possess a highly conserved FOC where 
two iron ions (FeA and FeB) are coordinated by at least three glutamic acid residues 
and one histidine residue, with metal coordination distances of 2.4 ± 0.3 Å (Ebrahimi 
et al. 2015b). The distance between the two iron ions is 3.5 ± 0.2 Å (Figure 1.4.4 A/B). 
In the FOC of HuHF, FeA in site A is coordinated by bidentate E27, monodentate E62 
and H65; FeB in site B is bound by bidentate E107, monodentate E62, and Y34, which 
is found 4.6 Å away from FeB (Figure 1.4.4 A/B). The tyrosine residue is highly 
conserved in classical ferritins and is suggested to facilitate Fe(II) oxidation as a 
single-electron molecular capacitor (Ebrahimi, Hagedoorn & Wilfred R Hagen 2013). 
Site A is more strongly conserved than site B in terms of the residues involved in iron 
coordination (Figure 1.4.4 A/B), which suggests differential binding affinities of the 
iron ions in the FOC (Ebrahimi et al. 2015b).  
The FOC functions as a catalytic site where Fe(II) can be oxidised by di-oxygen. This 
is supported by the abolished Fe(II) oxidation in the E62A or H65A mutants of 
recombinant HuHF (Sun et al. 1993). In the vicinity of the FOC there is a third iron 
(FeC) binding site (site C), which is located at a distance of 6.2-10 Å to FeA/FeB and 
towards the inner face of the ferritin cage (Figure 1.4.3 C and Figure 1.4.4 C/D). 
Among four aligned ferritins [HuHF, frog M-chain ferritin (FgMF), PfFtn and EcBfr], 
site C displays higher variability with different residues, conformations and numbers 
of iron ion than the FOC (Figure 1.4.4 C/D). Notably, the FOC is not always fully 
occupied with iron, which largely depends on crystallisation conditions such as pH; 
however, site C is either partially occupied or vacant (Ebrahimi et al. 2015b). This site 
C is highly conserved in bacterioferritins (Ebrahimi et al. 2015b); the mutation of 
conserved residues in site C of HuHF (Masuda et al. 2010b), bullfrog M-type ferritin 
(Behera & Theil 2014) or PfFtn (Ebrahimi et al. 2012) all lead to an abrogated iron 
oxidation, suggesting that site C is involved in the translocation of Fe(II)/Fe(III) 






Figure 1.4.4 Ferroxidase centre and gateway site of classical ferritins. 
Monomers of HuHF (PDB ID: 4YKH), FgMF (PDB ID: 4LQN), PfFtn (PDB ID: 2JD7) and EcBfr 
(PDB ID: 3E1M) were aligned in PyMOL with an overall RMSDCα < 0.7 Å. These are shown in 
green, cyan, orange and grey cartoons, respectively. (A) The di-iron centre is shown 
highlighted in an ellipse. (B) Enlargement of the region highlighted in (A) showing the highly-
conserved FOC (FeA-FeB), with labelled distances, in Ångströms, between di-iron and their 
coordinating residues of PfFtn. Iron binding residues are shown as sticks; FeA and FeB are 
shown as spheres and coloured according to their coordinating residues. (C) View of the 
aligned monomeric ferritins showing the FeC site highlighted with an ellipse. (D) Enlargement 
of the region highlighted in (C) showing the highly-variable FeC site (gateway site) of aligned 






1.4.4.2 Putative iron entry and exit sites in classical ferritins 
When cells have an abundance of Fe(II) it must traverse the ferritin shell from the 
cellular environment prior to Fe(II) oxidation in the FOC and deposition in ferritin 
cage; conversely, while cells are iron-depleted, ferritin has to release iron back to the 
cytoplasm. Understanding how ions/electrons transport into and out of the ferritin cage 
will provide insights into how cells regulate their iron concentrations. The iron entry 
and exit from ferritin has been studied using computational calculations of electrostatic 
gradients (Douglas & Ripoll 1998) and MD simulations (Laghaei et al. 2014), 
combined with biochemical assays (Theil et al. 2008), biophysical methods including 
isothermal titration calorimetry, and X-ray crystallography of relevant mutants of 
ferritin channels (Bou-Abdallah et al. 2003). In spite of the wealth of data and literature 
in the field, iron entry and release from ferritins is still not fully understood.  
Both the phase and oxidation state of iron change within the ferritin nanocage during 
its catalytic cycle. It is generally agreed that the pores at the three-fold symmetry axes 
of the classical ferritins are the major entry site for Fe(II) while the four-fold symmetry 
channels are the primary Fe(II) exit route out of the non-haem ferritin cage (X Yang 
et al. 2000). The 3-fold or 4-fold channel residues appear to be not conserved among 
ferritin proteins (Ebrahimi et al. 2015b). An example of iron translocation into and out 
of HuHF is demonstrated in Figure 1.4.5 (Pozzi et al. 2015). The pore size of both 3-
fold and 4-fold symmetry channel measured in the crystal structure of HuHF is about 
4.4–4.6 Å. The 3-fold symmetry pore is lined with negatively-charged residues (E134 
and D131) and is shaped as a hydrophilic funnel, which guides Fe(II) or other divalent 
cations to traverse the ferritin shell. The hexahydrated iron ions binding in the HuHF 
3-fold symmetry pore suggest that water may diffuse into ferritin from this 3-fold 
channel when hydrating Fe(II) (Figure 1.4.5 C). It has also been observed in horse L-
chain ferritin that the electrostatic gradient in 3-fold channel impedes the entry of 
anions but does not strictly limit the entry of monovalent cations via diffusion unless 
divalent cations are present (Takahashi & Kuyucak 2003). In another experiment, 
cations such as sodium or potassium are demonstrated to compete with Fe(II) for the 
negatively-charged 3-fold symmetry channel. In anions only phosphate and some 




while sulphate decreases the iron loading to a higher extent than cations and halides 
(Cutler et al. 2005). The specificity of anion transport into ferritin is suggested to be 
driven by the solubility of ferritin and anion complex. That is to say, if the anion prefers 
to form an insoluble substance with iron, this complex settles inside ferritin; if the 
anion tends to form soluble complex with iron, then iron hydroxide forms (Cutler et 
al. 2005). However, anions are repelled by the negatively-charged residues lining the 
3-fold pores, as supported by electrostatic calculations (Douglas & Ripoll 1998), and 
diffusion studies using nitroxide radical spin probes in conjunction with electron 
magnetic resonance spectroscopy (EPR) (Yang & Chasteen 1996; X Yang et al. 2000). 
This suggests that the entry of anions such as phosphate ions may rely on other process. 
The selectivity of divalent cations through 3-fold channel is also not clear. On top of 
charge selectivity, the pore size of the 3-fold symmetry channel also controls the 
substance entry. The EPR study reveals the entry of positively-charged spin probe with 
around 7–9 Å cross section through 3-fold symmetry channel, in which the spin probe 
serves as a model for similar sized reductants and chelators. The results suggest that 
the ferritin surface pore with around 4 Å size in the crystal structure may be somewhat 
flexible and adopt a breathing mode to accommodate the transport of molecules across 
the ferritin cage (X Yang et al. 2000; Yang & Chasteen 1996).  
The hydrophobic four-fold channel in human H-chain ferritin coordinates iron via 
H173 of four chains, which are located at inner side of ferritin shell (Figure 1.4.5 C/D). 
The large electrostatic potential gradient at the 4-fold symmetry channel presents an 
electric field from the inner cavity to the outer environment, suggesting that this 
channel serves to expel cations from ferritin cage (Douglas & Ripoll 1998). In 
Helicobacter pylori FTN structure the 4-fold channel can be the entry route of Fe(II) 
when more than 500 Fe(II) per 24-mer is loaded aerobically (Cho et al. 2009). The 
second possible role of 4-fold channels is to provide an exit for excess protons which 
are generated during the iron mineralisation process (Takahashi & Kuyucak 2003).  
It is not clear if the in vivo Fe(II) entry route remains the same as is shown in vitro 
experiments and if the iron entry routes are conserved among different members of the 
ferritin family from different organisms. An alignment of classical ferritin sequences 




in the 4-fold pore are only conserved in FgMF. Thus, it remains uncertain if the iron 
translocation model of HuHF holds for FTN and BFR. It has been proposed that there 
are another three putative Fe(II) entry routes in FTN and BFR apart from the 3-fold 
channel: (1) FOC channel, where Fe(II) directly moves to the FOC from the outer face 
of the nanocage and then to site C; (2) B-pore (intersubunit gap) where Fe(II) moves 
through and then translocates to the FOC, or site C; this has been seen as the principal 
iron entry route for E. coli bacterioferritin (Wong et al. 2014); (3) 4-fold channel where 
Fe(II) traverses the protein shell and moves to FOC or site C (Ebrahimi et al. 2015b).  
 
Figure 1.4.5 Iron entry/exit site of human H-chain ferritin. 
HuHF (PDB ID: 4YKH) is shown in surface mode in (A, B, D, E). (A) A red triangle highlights 
the 3-fold symmetry pore, which is a putative Fe(II) entry site. (B) A 90° rotation and cross-
section view of (A) is shown, in which the two iron ions (Fe1 and Fe2 in green spheres) bound 
in 3-fold channel are highlighted. (C) The coordination environment of the two iron ions in the 
entry site is shown, with amino acids show as sticks, iron shown as green spheres, and water 
as red spheres. Hexahydrated Fe1 is coordinated by bidentate E134 from three chains at a 
distance of 3.9–4.2 Å. Hexahydrated Fe2 is bound by monodentate D134 from three chains in 
2.6 or 3.6 Å as an alternate conformation. This differential iron binding leads to a funnel-like 
three-fold channel. (D) A square highlights the 4-fold symmetry pore, which is a putative iron 
exit site. (E) A 90° rotation and cross-section view of (D) is shown, in which an iron ion (Fe3) 
in green sphere bound in 4-fold channel is highlighted. (F) Fe3 in the 4-fold symmetry pore is 





Figure 1.4.6 Alignment of iron binding sites of classical ferritins. 
Human H-chain ferritin (HuHF, PDB ID: 4YKH), frog M-chain ferritin (FgMF, PDB ID: 4LQN), 
bacterial ferritin from P. furiosus (PfFtn, PDB ID: 2JD7), and bacterioferritin from E. coli (EcBfr, 
PDB ID: 3E1M) were aligned using Clustal W (Larkin et al. 2007; McWilliam et al. 2013). The 
sequence alignment was edited and displayed in Espript 3.0 (Robert & Gouet 2014) with red 
triangles underscoring FOC residues and black circles highlighting residues involved in binding 
FeC. Two black triangles highlight the residues binding two iron ions separately in the three-
fold channel of HuHF. A black square highlights the residue binding iron in the four-fold 
symmetry pore of HuHF. 
1.4.5 Ferritin chemistry 
1.4.5.1 Ferroxidase reaction 
The ferritin reaction stoichiometry has been studied in HuHF (Zhao et al. 2001), PfFtn 
(Ebrahimi et al. 2009), E. coli FTN (EcFtnA) (Bou-Abdallah et al. 2014) and E. coli 
BFR (EcBfr) (Xiaoke Yang et al. 2000) by measuring oxygen uptake and conventional 
and stopped-flow absorption spectrometry after aerobic ferritin titration with various 




ferroxidase assay to detect the formation of H2O2 (Zhao et al. 2001). In heterologously 
expressed eukaryotic ferritins the presence of L-chain does not affect the iron oxidation 
stoichiometry; instead, the L-chain facilitates the iron deposition in ferritin cage (Yang 
et al. 1998). Two possible equations for the iron oxidation catalysis were proposed as 
follows (Ebrahimi et al. 2015b): 
2Fe2+ + O2 + 2H+ → 2Fe3+ + H2O2  (1) 
3Fe2+ + O2 + 4H+ + e− → 3Fe3+ + 2H2O  (2) 
When two Fe(II) per FOC are loaded to non-haem classical ferritins, half Fe(II) is 
suggested to be oxidised according to equation (1); another half is oxidised via reaction 
(2). The third Fe(II) in reaction (2) could be oxidised in site C by O2 or hydrogen 
peroxide (H2O2) produced in (1). It has been suggested as a universal mechanism for 
ferroxidase reactions in non-haem classical ferritins of different organisms (Ebrahimi 
et al. 2015b). Therefore, when more than two Fe(II) per FOC are loaded to HuHF, 
PfFtn or EcFtnA, the stoichiometry of Fe(II) to O2 increases from 2–3 to about 3.4–
3.8. In HuHF and EcFtnA it has been proposed that the iron oxidation occurs in the 
FOC first; once the Fe(III) mineral core forms, the iron oxidation is catalysed on the 
mineral surface. However, in PfFtn the Fe(III) mineral core is not involved in Fe(II) 
oxidation. Instead, when the FOC and site C are both saturated by Fe(II), more Fe(II) 
oxidation occurs in the site C; together with some Fe(II) oxidation by hydrogen 
peroxide generated in reaction (1), the total stoichiometry of Fe(II):O2 will be roughly 
4:1 (Ebrahimi et al. 2015b).  
A blue/purple intermediate of the ferritin reaction forms within a millisecond and 
decays in less than 1 second; this is always observed in eukaryotic, bacterial and 
archaeal ferritins via monitoring the absorbance at 500–800 nm (Pereira et al. 1998). 
The molecular structure of blue intermediates occurring in HuHF (Bou-abdallah et al. 
2002) and FgMF (Pereira et al. 1998) have been identified as μ-peroxodiferric species 
(DFP) using Mӧssbauer spectroscopy and resonance Raman spectroscopy. The 
formation/decay of the blue intermediate (A650) has been used to monitor how 
mutations in the ferritin iron entry route affect the ferroxidase activity (Behera & Theil 
2014). Taken together, the ferroxidase reaction in ferritins involves Fe(II) binding to 




μ-peroxodiferric complex decays transiently to diferric oxo mineral precursors in 
transit to the cavity (Tosha et al. 2010). The composition of the Fe(III) mineral core in 
horse spleen ferritin has been identified as a mixture of magnetite, hematite and 
ferrihydrite using techniques such as transmission electron microscopy, X-ray 
absorption near edge spectroscopy and electron energy-loss spectroscopy, small-angle 
X-ray scattering and SQUID magnetic measurements  (Galvez et al. 2008). Phosphate 
has also been shown to facilitate the iron incorporation into ferritin (Polanams et al. 
2005); in P. furiosus FTN, phosphate stimulates the displacement of Fe(III) by Fe(II) 
in the FOC; however, phosphate does not alter the iron oxidation mechanism as the 
formation of blue intermediates is not affected by the presence of phosphate (Ebrahimi, 
Hagedoorn & Wilfred R. Hagen 2013). The native iron mineral core presents Fe: P ≈ 
1:1 in A. vinelandii ferritin, while Fe: P ≈ 8:1 in horse spleen ferritin (Rohrer et al. 
1990). The presence of phosphate in a reconstituted ferritin alters the mineral core 
from crystallinity to an amorphous state, as the phosphate layer forms on the mineral 
core surface (Trefry et al. 1978). 
1.4.5.2 Iron storage mechanism of classical ferritins 
The asymmetric FOC of non-haem 24-meric ferritins appear to be related to a proposed 
iron storage mechanism, of which Fe(III) mineralisation/deposition in the cavity of a 
bacterial ferritin from P. furiosus (PfFtn), as well as human H-chain ferritin (HuHF), 
is driven by the sequential displacement of Fe(III) by Fe(II) in the FOC (Ebrahimi et 
al. 2012). In E. coli bacterioferritin (EcBfr, PDB ID: 3E1M), the FOC consists of two 
additional residues: a bidentate E127 coordinating FeA and FeB; and H130 which binds 
FeB, making the FOC of EcBfr more symmetrical. It suggests that bacterioferritin may 
have a different iron storage mechanism due to the different di-iron coordination 
environment (Jameson et al. 2002). In EcBfr the di-Fe(III) bound by the FOC is 
suggested to work as a catalytic cofactor site. Briefly, when the mineral core is absent 
in the BFR cage, Fe(II) ions are oxidised in the site C along with the reduction of 
oxygen to hydrogen peroxide in the di-Fe(III)-FOC through an electron-transfer 
mechanism. When there is mineral core formed in the cavity, the Fe(II) oxidation 
occurs on the surface of the mineral core and the electrons are transported to the di-




ferritin cavity (Crow et al. 2009). This complicated iron storage pathway is poised 
based on the slower iron oxidation observed when Fe(III) is present in the FOC. 
However, this observation has also been explained using the displacement model as 
Fe(II) substitutes Fe(III) in the FOC firstly before the Fe(II) oxidation (Ebrahimi et al. 
2015b). In BFRs from Pseudomonas aeruginosa (Weeratunga et al. 2010), 
Azotobacter vinelandii (Swartz et al. 2006) and Desulfovibrio desulfuricans (Macedo 
et al. 2003), a common conformational change of the histidine residue in the FOC has 
been observed, suggesting a gating mechanism for iron translocation from the FOC to 
the cavity. 
1.4.6 Phylogenetic tree of ferritin family proteins 
The 24-meric ferritins including eukaryotic H-/M-/L-chain ferritins, bacterial ferritin 
and bacterioferritin, as well as 12-meric ferritins share the archetypal ferritin fold, in 
which the α1-α2 helical pair of the 24-meric ferritins is thought to be evolutionarily 
related to the α3-α4, as demonstrated by the alignment of two alpha-helical pairs in 
HuHF (Figure 1.4.7 A).  
 
Figure 1.4.7 The alpha-helical pair alignments of human H-chain ferritin and DPS. 
The α1-α2 helical pair of human H-chain ferritin (HuHF, PDB ID:4YKH) comprises residues 
14−76 while the α3-α4 helical pair comprises residues 95−159 (Pozzi et al. 2015). The α1-α2 
helical pair of M. arborescens DPS (PDB ID: 2YJK) contains residues 12−75, while the α3-α4 
helical pair contains residues 102−155 (Pesek et al. 2011). The two helical pairs were 
separately aligned by Clustal Omega (McWilliam et al. 2013; Sievers et al. 2011), followed by 
editing with Esprit 3.0 (Robert & Gouet 2014). (A) The alignment of the two alpha-helical pairs 
of HuHF. The red triangles highlight the FOC residues (FeA and FeB site); and the black circles 
underscore the FeC site. (B) The alignment of the two alpha-helical pairs of DPS. 
Although the protein sequence similarity of α1-α2 and α3-α4 is only 17%, the iron 
catalytic sites in the two helical pairs are well aligned. However, because the metal 




relatively low sequence identity, suggesting that the two alpha-helical pairs in DPS 
may be evolutionarily distant from the classical ferritins (Figure 1.4.7 B). 
The 24-meric ferritins were proposed to evolve from ancient rubrerythrins (Rr) or 
erythrins (Er)  due to an internal duplication of the alpha-helical pair; and rubrerythrins 
were considered more homologous to the common ancestor than ferritins 
(FTN/BFR/DPS) (Andrews 2010). Rr protein is generally found in obligate anaerobes, 
and functions as a peroxidase in Pyrococcus furiosus (Weinberg & Jenney 2004) or a 
ferroxidase from Desulfovibrio vulgaris (Bonomi et al. 1996) that protects cells against 
redox stress. Rr contains two domains: an N-terminal Er domain with four-helix 
bundle coordinating a di-iron centre (∼120 residues); and a rubredoxin (Rx) domain 
with a Fe-S4 site at the C-terminus (∼50 residues); both Er and Rx domains are 
required for the ferroxidase function (DeMaré et al. 1996). The Er domain structurally 
resembles ferritins regarding the ferritin fold as well as the conserved di-iron cluster. 
Therefore, S. Andrews suggested that entire ferritin families are likely to evolve from 
a simplistic two alpha-helices (i.e. α1-α2) without the loop linking α2 and α3; through 
gene duplication that a homo-dimeric four-helix bundle forms with anti-parallel 
arrangement (Andrews 2010).  
1.4.6.1 Ferritin-like proteins with or without encapsulin association 
 
Figure 1.4.8 Structure of ferritin-like protein NE0167 from Nitrosomonas europaea. 
The structure of NE0167 (PDB ID: 3K6C) is shown in cartoon mode and coloured by chain. 
The N- and C-termini have been highlighted, of which the N-termini of the structure cap the 
central channel while the C-termini point towards the outer surface. (A) The decamer ring-like 
structure has a diameter of 6.5 nm. (B) The side view of (A) possesses a height of 4 nm. (C) 




A ferritin-like protein with only two putative alpha helices is initially identified in 
Nitrosomonas europaea with a ring-like decamer structure deposited to the PDB 
(KEGG ID: NE0167, PDB ID: 3K6C) by the Midwest Centre for Structural Genomics 
(Figure 1.4.8). This decameric arrangement is radically different from all known 
ferritins (Chang et al. n.d.). NE0167 contains only 95 amino acids that constitute the 
two main alpha helices(α1-α2) followed by a short α3 helix. It is unclear what the 
physiological role of this ferritin-like protein is in its native host. A search of sequence 
databases for homologues of NE0167 identifies two classes of this family of proteins: 
the ferritin-like proteins and the ferritin-like protein with another protein associated in 
a conserved operon. The ferritin-like proteins are only found in microbes. In the latter 
case, the encoding gene is located upstream of a gene that encodes a protein 
structurally related to the gp5 capsid protein of the HK97 bacteriophage; this protein 
is called ‘encapsulin’ (Akita et al. 2007). This family of the ferritin-like proteins is 
termed the encapsulin associated ferritin-like proteins (EncFtn). EncFtn is structurally 
located inside the encapsulin shell through the interaction of a short C-terminal 
localisation sequence on the EncFtn with the interior surface of the encapsulin shell 
(Sutter et al. 2008). In some microbes, such as N. europaea, the ferritin-like protein 
does not have encapsulin associated in the genome and does not possess the C-terminal 
localisation sequence, these are thus termed the non-encapsulin associated ferritin-like 
protein (non-EncFtn).   
To understand how EncFtn and non-EncFtn relate to the well-characterised classical 
ferritins, seven classes of ferritins including FTN, BFR, DPS, mammalian ferritins (H-
/M-/L-chains), the Er domain of Rr protein, EncFtn and non-EncFtn were aligned 
progressively based on two criteria: (1) the FOC is conserved in classical ferritins; (2) 
the C-terminal localisation sequences of EncFtn family have a common pattern. The 
multiple sequence alignment result was displayed in Figure 7.2.1. See Section 2.10 




1.4.6.2 Evolutionary relationship of EncFtn and non-EncFtn 
Based on the multiple sequence alignment (Figure 7.2.1) a phylogenetic tree (Figure 
1.4.9) was built in MEGA7 (Kumar et al. 2016). It reveals an unambiguous 
classification of the different classes of the ferritin family, of which EncFtn class as 
represented by Rhodospirillum rubrum EncFtn (KEGG ID: Rru_A0973), stands for a 
unique ferritin clade. Based on the position of this group in the phylogenetic tree, it 
may be close to an ancestral form of ferritin. Interestingly, the non-EncFtn family may 
be closer to an ancestral ferritin than EncFtn as illustrated by the ‘root’ in Figure 1.4.9. 
The phylogenetic tree suggests EncFtn and non-EncFtn represent classes of ferritin 
that have diverged from the ancestral ferritin at an earlier stage than the classical 
ferritins; and the classical ferritin fold may have evolved from an ancestral form of 
ferritin that resembled the non-EncFtn or EncFtn through gene duplication and the 
introduction of a linker, ligating two monomers of EncFtn (Andrews 2010). 
There is a notable outlier in the EncFtn family proteins. In P. furiosus, and a number 
of other archaeal species, a single gene (PFC_05175) encodes a polypeptide that is 
made of N-terminal EncFtn fused with C-terminal encapsulin in a single open reading 
frame; furthermore, the C-terminal location sequence is missing in this fused EncFtn 
and Enc (Figure 7.2.1). It is worth pointing out that only the EncFtn domain of 
PFC_05175 (PFC_01575short) has been used in the alignment to increase the 
alignment confidence. Therefore, this phylogeny of EncFtn does not show the relations 
of PFC_05175-like proteins with fused EncFtn and encapsulin to other EncFtn families. 
Given that the PFC_05175-like proteins are only found in archaeon, it is possible that 






Figure 1.4.9 Phylogenetic tree of ferritin family proteins.  
A phylogenetic tree of ferritin family proteins was built using the Neighbour-Joining method 
(Saitou & Nei 1987) based on a step-wise amino acid sequence alignment of the four-helical 
bundle portions of ferritin family proteins (Figure 7.2.1). The tree is drawn to scale, with branch 
lengths in the same units as those of the evolutionary distances used to infer the phylogenetic 
tree; the likely root of the tree is indicated by a red arrow. The evolutionary distances were 
computed using the p-distance method (Nei & Kumar 2000) and are in the units of the number 
of amino acid differences per site. The rate of variation among sites was modelled with a 
gamma distribution (shape parameter = 2.5). The analysis involved 104 amino acid sequences. 
All ambiguous positions were removed for each sequence pair. There were a total of 262 





1.4.7 Biotechnology applications of ferritins 
Ferritins have a long history of applications in biotechnology due to its 
biocompatibility (Charlton et al. 2016), size, self-assembly (Zhang & Orner 2011) and 
stable architecture, which is easy to engineer and modify for useful purposes (He & 
Marles-Wright 2015). Iron-loaded (recombinant) ferritins have been used as contrast 
agents for medical imaging, such as electron cryo-tomography (Wang et al. 2011) and 
magnetic resonance imaging (Jin et al. 2014), since the iron mineral core inside ferritin 
possesses superparamagnetic property that enhances the nuclear relaxation rate 
(Chasteen & Harrison 1999). Apart from delivering exogenous iron nanoparticles to 
biological systems, cellular contrast can also be induced in vivo by coexpressing 
ferritin and transferrin receptor, which has been shown to increase the targeting 
efficiency of inheritable MRI reporter to nonvascular cells and even brain tissue 
(Deans et al. 2006). As nanoparticles have a range of potential applications in 
nanotechnology, ferritins can also be used to produce metallic nanoparticles; 
application of these are reviewed in detail in a number of publications (He & Marles-
Wright 2015; Zeth et al. 2016). For example, both P. furiosus bacterial ferritin 
(Kasyutich et al. 2010) and engineered human H-chain ferritin (Butts et al. 2008) have 
been employed to produce silver nanoparticles which have an antibacterial effect. 
Some metallic nanoparticles, such as Pt (Fan et al. 2011), Pd (Abe et al. 2008), Cu 
(Ceolín et al. 2008), Au (Fan et al. 2010) and TiO2 (Klem et al. 2008) can be produced 
from horse spleen apoferritin or other mammalian ferritin sources and work as 
chemical catalysts. But it remains to be seen if the industrial production is possible and 
if they offer any material advantages over chemically produced nanoparticles. Ferritin 
contains three types of interfaces—the interior surface, the exterior surface and 
intersubunit interface, each of which can be genetically/chemically modified to 
enhance the functionality of the protein complex. The outer surface of Helicobacter 
pylori bacterial ferritin has been engineered to display haemagglutinin (HA), which 
can generate 10 times more antibodies with improved potency than the traditional 
influenza vaccines due to the adjuvant effect achieved by the localisation of the HA 
displayed on the ferritin (Kanekiyo et al. 2013). Surface-modified HuHF with an RGD 
peptide attached is applied as a drug (doxorubicin) carrier to target tumours as RGD 




2013). The ability of phosphate incorporation into ferritin has been utilised to remove 
phosphate contamination in water by P. furiosus ferritin at an industrial-scale (Jacobs 
et al. 2010). 
 Encapsulin nanocompartment 
1.5.1 Encapsulin structure and function 
The first encapsulin protein was identified as a bacteriocin (linocin M18) from 
Brevibacterium linens (Valdés-Stauber & Scherer 1994). Its bacteriostatic effect was 
called into question because B. linens itself was used in the bacteriocin assay instead 
of pure encapsulin. Besides, the encapsulin homologues from Mycobacterium 
tuberculosis (Rosenkrands et al. 1998) and Thermotoga maritima (Hicks et al. 1998) 
have been tested regarding their bactericidal ability, and have both yielded negative 
results. The icosahedral encapsulin structures from the extremophilic archaeon P. 
furiosus (Pf-Enc) and hyperthermophilic bacterium T. maritima (Tm-Enc) were 
determined by X-ray crystallography from native expression (Akita et al. 2007; Sutter 
et al. 2008); while the encapsulin of the social bacterium Myxococcus xanthus (Mx-
Enc) overexpressed in E. coli was structurally determined by Cryo-electron 
microscopy (Cryo-EM) (McHugh et al. 2014). Both the Pf-Enc and Mx-Enc consist of 
180 subunits (12 pentamers plus 20 hexamers) and have T = 3 symmetry and 32–36 
nm diameter, while the Tm-Enc possesses only 60 subunits formed by 12 pentamers 





Figure 1.5.1 Protein structures of encapsulin nanocompartments. 
Encapsulin nanocompartments are presented in surface mode with cartoons highlighting the 
crystallographic asymmetric unit. (A) 180-meric encapsulin from P. furiosus (PDB ID: 2E0Z), 
T = 3, diameter 32–36 nm. (B) 60-meric encapsulin from T. maritima (PDB ID: 3DKT), T = 1, 
diameter 24 nm. The top representation shows the cut-off view, in which the red surface shows 
the C-terminal localisation sequence of the native EncFtn enclosed within the encapsulin. (C) 
180-meric encapsulin from M. xanthus (PDB ID: 4PT2), T = 3, diameter 32 nm. 
Tm-Enc is suggested to house no more than 12 copies of the decamer EncFtn based on 
the observation of C-terminal localisation sequences of EncFtn targeting the inner 
surface of the capsid (Sutter et al. 2008). Mx-Enc shows the presence of about 30,000 
iron ions and phosphate ions with a molar ratio of iron: phosphorus as 4:1 inside the 
cage, which is reminiscent of the iron mineral core inside ferritin cages (McHugh et 
al. 2014). Although there is no direct evidence of the enzymatic activities of 
encapsulins, it is reasonable to deduce the physiological role of the encapsulin 





1.5.2 Diversity of encapsulin nanocompartments 
So far 909 encapsulins have been found in 15 bacterial and 2 archaeal phyla with 
various habitats and lifestyles through systematic genome analysis (Giessen & Silver 
2016). The encapsulins house six types of cargo proteins: EncFtn (Sutter et al. 2008); 
dye-decolouring peroxidase (Dyp) (Rahmanpour & Bugg 2013); ferredoxin and 
hemerythrin (Giessen & Silver 2016); a ferritin homologue (BfrB), biophenyl 
dehydrogenase (BphB) as well as 7,8-dihydroneopterin aldolase (FolB) that is 
involved in folate biosynthesis (Contreras et al. 2014). These cargo proteins share the 
same feature with a characteristic C-terminal localisation sequence that can be 
recognised by certain types of encapsulins; in the case of ferredoxin the N-terminal 
sequence is targeting the encapsulin instead. It is worth mentioning that cargo proteins 
do not necessarily locate next to encapsulin in the genome. The number of cargo 
proteins encapsulated by one encapsulin nanocompartment ranges from 1 to 4, with 
different combinations of cargo species mentioned above (Giessen & Silver 2016). 
The presence of diversified encapsulin nanocompartments presents distinctive 
evolutionary advantages for microbes living in different habitats. 
To understand the functions of EncFtn the work presented in this thesis will focus on 
the EncFtn-encapsulin nanocompartments (EncFtn-Enc). The three typical types of 
EncFtn-Enc in terms of genomic context will be analysed based on a KEGG taxonomy 
search (Ogata et al. 1999). Thus it is possible that other microbes not deposited in 
KEGG database have not been considered. 
First of all, there are 34 species of bacteria with EncFtn-Enc genomic pattern over 
3723 bacterial species across 10 classes according to KEGG taxonomy, as exemplified 
by Tm-Enc, possess an encapsulin protein with an EncFtn protein docked inside 
through its C-terminal sequence (Figure 1.5.1 B). The C-terminal sequences of the 
EncFtn family proteins share similar motifs (LT/GI/VGSLK) (Figure 1.5.2). In these 
bacterial genomes, the encapsulin gene locates downstream of the EncFtn gene with a 




suggesting the possibility of an independent promoter for the encapsulin in some 
species.  
 
Figure 1.5.2 WebLogo of C-terminal localisation sequence of EncFtn family proteins. 
EncFtn family proteins were aligned by Clustal Omega (Sievers et al. 2011; Li et al. 2015). A 
WebLogo of the aligned C-terminal localisation sequences was generated (Crooks et al. 2004), 
indicating that the ‘LT/GI/VGSLK’ sequence is well conserved in EncFtn family proteins. 
Secondly, a single gene encoding a single protein with fused EncFtn and encapsulin is 
a shared feature for archaeal encapsulin nanocompartments, as illustrated in P. furiosus 
strain COM1 (PDB ID: 2E0Z) (Namba et al. 2005; Akita et al. 2007). Twenty-six 
archaeal species over 228 total archaea across three kingdoms have been found to 
possess this gene pattern based on the KEGG taxonomy (Ogata et al. 1999).  
The third class of EncFtn-Enc, found in M. xanthus, where three different EncFtn 
proteins are found associated with the encapsulin protein (MXAN_3556) (McHugh et 
al. 2014). These three proteins all possess the C-terminal localisation sequence 
(MXAN_3557, MXAN_4464 and MXAN_2410), but only the MXAN_3557 gene is 
locating next to the encapsulin gene. Among three EncFtn proteins only MXAN_2410 
does not possess the conserved FOC residues (McHugh et al. 2014). The genomic 
location of the EncFtn proteins are not necessarily adjacent to the encapsulin gene in 
the genome. In the Myxococcus fulvus genome, genes LILAB_30455 (EncFtn) and 
LILAB_25765 (Enc) are widely separated; as are the ones found in the Archangium 
gephyra genome, AA314_04443 (EncFtn) and AA314_05059 (Enc). Some bacterial 
genomes also harbour more than one encapsulin nanocompartment locus; these may 
be induced in response to different environmental signals, or have different cellular 
functions. Eubacterium limosum contains ELI_2650 (EncFtn)- ELI_2651 (Enc) and 
ELI_0383 (EncFtn)- ELI_0384 (Enc). The two EncFtn proteins share 83% protein 




1.5.3 Applications of encapsulins 
The encapsulin nanocompartment resembles a virus capsid in terms of its structural 
and mechanical properties. The self-assembly of encapsulin has been studied by native 
mass spectrometry as addition of dimers; and the encapsulation of native protein or 
heterologous protein with the same localisation sequence reduces the stability of 
encapsulin nanocompartments (Snijder et al. 2016). Heterologous cargo proteins such 
as fluorescent proteins have been co-expressed with T. maritima (Cassidy-Amstutz et 
al. 2016) or Rhodococcus erythropolis encapsulins (Tamura et al. 2014) by appending 
the characteristic C-terminal localisation sequences of EncFtn or Dyp, resulting in the 
encapsulation of these heterologous proteins. The Rhodococcus jostii encapsulin has 
been shown to disassemble at pH 3.0 and reassemble at pH 7.0, allowing the in vitro 
encapsulation of heterologous cargo with the localisation tag (Rahmanpour & Bugg 
2013). A short peptide with a high affinity towards Fc region of immunoglobulin G 
(FcBP) has been successfully inserted into encapsulin sequence, allowing the display 
of this peptide on the encapsulin outer surface. These FcBP-Enc nanocompartments 
conjugated with fluorescent probe can be applied to visualise specific cancer cells 
(Moon et al. 2014). The encapsulin surface has also been used to display a viral 
haemagglutinin in order to produce antibodies with higher potency and broader 
influenza virus immunity than traditional vaccines (Kanekiyo et al. 2015). It is 
certainly worth exploring more biotechnological applications of encapsulins, due to 
their range of functions, stability and ease of modification and the analogies between 
encapsulin and classical ferritins. 
1.5.4 Relationship between encapsulin nanocompartments and ferritins 
In addition to the presence of genes encoding encapsulin and EncFtn, bacteria with 
these loci still possess genes encoding other ferritin family proteins, ranging from none 
(eg. Wolinella succinogenes, Clostridium stercorarium, Eubacterium limosum and 
Halothermothrix orenii) to 0–2 DPS, and 0–5 BFR/FTN based on a KEGG taxonomy 
search. It is not clear why microbes produce such a large complex when other ferritins 
are also present in their genomes. The function of encapsulin nanocompartments is 
likely to be related to the enclosed enzyme; that is protecting cells from toxic 





Encapsulin nanocompartments have been found in at least 1% of all bacteria and 10% 
of archaea from distinct ecological niches, with no clear link in terms of their lifestyles. 
Understanding the structure and function of encapsulin nanocompartments will aid in 
understanding the basic biochemistry and physiological role of encapsulins and inform 
future work on their application as platforms for biotechnology applications. In this 
thesis, an encapsulin nanocompartment from Rhodospirillum rubrum will be 
characterised structurally and functionally to understand the biochemistry of these 
intriguing protein complexes. R. rubrum is a versatile bacterium which can live 
aerobically by respiration in the dark or anaerobically via photosynthesis (Thore et al. 
1969). The structures of EncFtn homologues from a halophilic bacterium Haliangium 
ochraceum (Fudou et al. 2002), and the extremophilic archaeon P. furiosus, will also 
be investigated to compare the EncFtn proteins from organisms from distinct habitats. 
The key research questions that will be addressed in this thesis are: 
 What is the structure of EncFtn?  
 How does EncFtn assemble? 
 How does the EncFtn structure justify its function? 
 What is the function of the encapsulin nanocompartment of R. rubrum? 





2 Chapter 2 Materials and methods 
All chemicals used in this work were purchased from Sigma-Aldrich unless otherwise 
stated. Plasmids pET-28a(+) and pACYCDuet1 used in the study were purchased from 
Novagen. Plasmid pET-28a-GG-RFP was constructed in the Marles-Wright Lab, 
which is based on modified pET-28a(+) with BsaI-RFP-BsaI replacing the original 
multiple cloning sites for compatibility with the CIDAR MoClo standard (Iverson et 
al. 2016). R. rubrum ATCC 11170 genomic DNA was purchased from DSMZ 
(Germany).  
 Cloning 
Open reading frames encoding proteins from R. rubrum were amplified by PCR using 
R. rubrum genome as the template and KOD Hot Start DNA Polymerase (Novagen). 
The amplification of genes Hoch-EncFtnS (Hoch_38361-98) and Pfc-EncFtnS 
(PFC_051751-99) are based on gene templates codon optimised for E. coli expression 
and produced as double stranded gBlocks (IDT): Hoch_3836 and PFC_05175, 
respectively. Primers used in this study are listed in Table 2.1.1 and Table 2.1.2. PCR 
reactions were carried out according to the manufacturer’s instructions. The resulting 
PCR product was visualised on a 1% agarose TAE gel and purified before digestion 
by appropriate restriction enzymes. The digested DNA was ligated with the similar 
digested plasmid before transforming E. coli TOP10 competent cells. The DNA 
insertion was confirmed by sequencing the plasmid extracted from transformed cells. 
All cloning except for Hoch-EncFtnS was conducted using traditional cloning method 
while in the case of Hoch-EncFtnS MoClo cloning with digestion and ligation in one 




2.1.1 Plasmid information 
All constructs were made based on plasmids pACYCDuet-1, pET-28a(+) or pET-28a-GG-RFP (Figure 2.1.1). Constructs of encapsulin 
nanocompartment-related proteins were shown in Table 2.1.1. Constructs of R. rubrum EncFtn mutants were shown in Table 2.1.2.  
 
Figure 2.1.1 Plasmid maps. 
Three maps of plasmids (A) pACYCDuet-1, (B) pET-28a(+) and (C) pET-28a-GG-RFP were generated by Bioedit software (Hall 1999). The red arrows 
in each plamid highlights the multiple cloning site for insertion of DNA. pACYCDuet-1 has chloramphenicol resistance casette, while both pET-28a(+) and 




2.1.2 Construct design 
The short construct of Rru-EncFtn, Rru_A09731-96 with C-terminal hexahistidine tag 
(Rru-EncFtnSH) was designed based on a multiple sequence alignment of ferritin-like 
proteins (Error! Reference source not found.). The C-terminal region was predicted to b
e unstructured in the structure of protein NE0167 from N. europaea (PDB ID: 3K6C) 
(Chang et al. n.d.). The C-terminal sequence of EncFtn was also suggested to be 
involved in docking into the inner surface of encapsulins in T. maritima (Sutter et al. 





Table 2.1.1 Constructs of encapsulin nanocompartment related proteins. 
Bases underscored in primers highlights the recognition site of endonuclease. Bases in bold are complementary to the DNA sequence of their target 
genes.  











































































Table 2.1.2 Constructs of Rru-EncFtnSH or Rru-EncFtn-Enc based mutants. 
Mutants of Rru-EncFtnSH and co-expressed Rru-EncFtn-Enc were designed based on plasmids pET-28a-Rru-EncFtnSH and pAYCDuet-1-Rru-EncFtn-
Enc using site-directed mutagenesis kit, respectively. The primer information was listed in the table.  





































2.1.2.1 Traditional restriction enzyme cloning 
Genes of interest were amplified by PCR from genomic or existing plasmid DNA. 
Briefly, each 50 μl PCR reaction contains: 10 ng plasmid or 100 ng bacterial genome 
as the template; 1.5 μl of 10 μM forward primer; 1.5 μl of 10 μM reverse primer; 45.5 
μl PCR Master Mix (5 μl of 10 x buffer for KOD Hot Start DNA Polymerase 
(Novagen), 3 μl of 25 mM MgSO4, 5 μl of 2 mM dNTPs and 32.5 μl ddH2O); 1 μl 
KOD Hot Start DNA Polymerase (1.0 U/μl). To optimise PCR reactions additional 1 
μl DMSO or additional 25 mM MgSO4 could be supplemented. Thermocycling 
conditions include 95°C and 2 min for polymerase activation, 95°C and 20 s for 
denaturation, [lowest primer Tm]°C and 10 s for annealing, followed by 10–20 s 
extension at 70°C. The final step of PCR involves 70°C and 2 min. PCR product was 
stored at 4°C before resolving on 1% agarose gel. PCR product was either purified by 
recovering from gels or directly using QIAquick PCR Purification kit (Qiagen). Both 
DNA fragments and vector were digested at 37°C for 1 hr with appropriate restriction 
endonucleases (Fermentas FastDigest) by double digestion. Cut vector was purified by 
recovering from a 1% agarose gel. Digested DNA was purified directly using 
QIAquick PCR Purification kit. Ligation of cut DNA and plasmid was achieved by 
mixing at 10:1 to 3:1 molar ratio at room temperature for 1 hr with the T4 ligase and 
ligase buffer (Thermo Fisher Scientific). 5 μl ligation product was transformed into 50 
μl competent TOP10 cells and left on ice for 20–30 min before heat shock at 42°C for 
1 min. Cells were cooled on ice for 2 min before supplementing with 200 μl LB 
medium and incubated at 37°C and 900 rpm for 1 h. All cells were spread on LB with 
antibiotic plates. Negative control of transformation was also set up in parallel without 
plasmid transformed. Plates were incubated at 37°C overnight. Single colonies were 
incubated in 10 ml LB supplemented with appropriate antibiotic for plasmid 
propagation. Plasmids were purified from the cells using the Qiagen Miniprep kit 
based on the manufacturer instructions. Gene insertion was confirmed by Sanger 
sequencing of the resulting plasmid (Edinburgh Genomics).  
2.1.2.2 CIDAR MoClo cloning 
The CIDAR MoClo cloning method is based on the Golden Gate method which uses 
Type IIs restriction enzymes, which cut outside their recognition site, to allow the one-




et al. 2016). Hoch-EncFtnS was amplified via PCR with BsaI recognition sites and 
appropriate four base-pair overhangs appended to the 5’ of the sense/anti-sense 
primers. The PCR product was purified as described above, followed by digestion and 
ligation with pET-28a-GG-RFP in one tube. Briefly, 10 μl system contains 1 μl of ~ 
90 ng/μl Hoch-EncFtnS (~ 300 bp), 1 μl of ~50 ng/μl pET-28a-GG-RFP (~ 6 kbp), 1 
μl of 10x T4 ligase buffer, 2 μl of 5 U/μl T4 ligase, 1 μl of 10 U/μl BsaI and 2 μl ddH2O. 
The reaction was run in a PCR machine with 25 cycles of 37°C, 1.5 min and 16°C, 3 
min. Further digestion was carried out at 50°C for 5 min to deactivate the DNA ligase, 
with enzyme deactivation at 80°C for 10 min. 5 μl of the resulting product was 
transformed into 50 μl competent E. coli TOP10 cells as described above. Colonies 
without red fluorescence from the RFP reporter were screened for positive insertion, 
which was subsequently confirmed by plasmid isolation and Sanger sequencing. 
2.1.2.3 Site-directed mutagenesis 
Site directed mutagenesis was carried out to introduce mutations to genes encoding R. 
rubrum encapsulin nanocompartment related proteins. Forward and reverse primers 
were designed to be complementary to each other with single or multiple mutations 
introduced. A 15–20 bp flanking sequence on both 5’ and 3’ of the mutation sites were 
required for primer design. 50 μl PCR system contains 45.5 μl PCR Master Mix, 1 μl 
of 10 μM forward primer, 1 μl of 10 μM reverse primer, 70 ng plasmid as template 
(pET-28a-Rru-EncFtnSH or pACYCDuet-1-Rru-EncFtn-Rru-Enc) and 0.5 μl of 1 
U/μl KOD Hot Start Polymerase. PCR reactions were run in steps including 95°C, 2 
min, 8–15 cycles of 95°C, 20 s, 57°C, 30 s, 70°C and 4 min. 10 μl product was 
transformed into 100 μl competent TOP10 cells as described in 2.1.2.1. Mutations 
were confirmed by Sanger sequencing. 
 Protein production and purification 
A single colony of E. coli BL21(DE3) or E. coli Tuner(DE3) cells, transformed with 
protein expression plasmid, was transferred into 10 ml LB medium, or 100 ml M9 
minimal medium (MM), supplemented with appropriate antibiotic, such as 50 ng/µl 
kanamycin (in H2O) for pET-28a(+) or pET-28a-GG-RFP based constructs, or 34 
ng/µl chloramphenicol for pACYCDuet-1 based constructs dissolved in ethanol. The 




pre-culture was then inoculated into 1 litre of LB medium and incubated at 37°C with 
200 rpm shaking. Recombinant protein expression was induced at OD600 = 0.6 by the 
addition of 1 mM isopropyl β-D-1-thiogalactopyranoside (IPTG) and the temperature 
was reduced to 18°C for overnight incubation. Cells were pelleted by centrifugation at 
4000 x g for 20 min at 4°C, and resuspended in a ten-fold (volume per gram of cell 
pellet) of PBS to wash cells before a second centrifugation at 4000 x g for 20 min. 
Cells were resuspended in 10-times (v/w) of appropriate lysis buffer for the 
purification method used (Table 2.2.1) and lysed by sonication on ice, with ten cycles 
of 30-second burst of sonication at 10 µm amplitude and 30 seconds of cooling. Cell 
lysate was clarified by centrifugation at 20,000 x g, 4°C for 30 min, followed by 
filtration using a 0.45 µm syringe filter (Millipore). All the subsequent protein 
purification steps were performed on an ÄKTA workstation in The Edinburgh Protein 
Production Facility. Buffers used in the study are listed in Table 2.2.1. 
Buffer name Composition 
HisA 50 mM Tris-HCl, 500 mM NaCl, 50 mM imidazole, pH 8.0 
HisB 50 mM Tris-HCl, 500 mM NaCl, 500 mM imidazole, pH 8.0 
QA 50 mM Tris-HCl (pH 8.0) 
QB 50 mM Tris-HCl (pH 8.0), 1 M NaCl 
GF 50 mM Tris-HCl (pH 8.0), 150 mM NaCl 
CD 10 mM sodium phosphate, 150 mM NaF, pH 7.94 
HEPES 50 mM HEPES-NaOH, 150 mM NaCl, pH 8.0 
Table 2.2.1 Buffer list. 
Buffers containing Tris and NaCl were prepared using 1 M Tris-HCl (pH 8.0) and 5 M NaCl 
stock solutions. 
2.2.1 Preparation of minimal medium 
To prepare the defined M9 minimal medium the following recipe was used. 1 litre of 
5x M9 salts containing 64 g Na2HPO4·7H2O or 85.49 g Na2HPO4·12H2O, 15 g 
KH2PO4, 2.5 g NaCl and 5 g NH4Cl, pH 7.4 was autoclaved before using. 40% (w/v) 
glucose or 40% (v/v) glycerol was filtered through 0.22 µm sterile syringe filter 
(Millipore) and stored at −20oC before using in the medium. 2 M MgSO4 and 1 M 
CaCl2 were separately prepared and filtered before using. 1 litre of M9 minimal 
medium(MM) contains 1x M9 salts, 0.4% glucose or glycerol, 2 mM MgSO4, 0.1 mM 




2.2.2 Preparation of selenomethionine-labelled proteins 
Selenomethionine (SeMet)-labelling has been widely used in X-ray crystallography as 
a basic method of experimental phasing (Hendrickson et al. 1990). Here protein (Rru-
EncFtnSH) was labelled with SeMet which allows the metal and Se analysis by 
inductive coupled plasma mass spectrometry (ICP-MS), which was conducted by Dr. 
Emma Tarrant and Dr. Kevin J. Waldron in the Institute for Cell and Molecular 
Biosciences of Newcastle University. Protein of interest was expressed in methionine 
auxotrophic E. coli strain B834(DE3) and grown in SeMet medium. SeMet 
incorporation rate was estimated by subjecting the protein to liquid chromatography-
mass spectrometry (LC-MS), which was conducted by Dr. David Clarke in the School 
of Chemistry, University of Edinburgh.  
2.2.2.1 Selenomethionine medium 
SeMet medium contains 1x M9 salts, 0.4% (w/v) glucose, 19 L-amino acids (except 
methionine) at 40 μg/ml of each and vitamin mixtures as shown in Table 2.2.2, Table 
2.2.3 and Table 2.2.4. SeMet was freshly dissolved just before the supplementation to 
the medium. 1 M MgSO4 and 10x M9 salts were autoclaved separately before using. 
Stock solutions of glucose and vitamin mixtures were filtered through 0.22 μm syringe 
filter (Millipore), respectively, before using in the medium.  
 
Table 2.2.2 SeMet medium. 
SeMet is always freshly dissolved before using in the final medium. 
 
Table 2.2.3 L-Amino acids I and II. 
L-Amino acids I and II are prepared separately and dissolved for at least 1 hour before using 

















Volume 2 ml 100 ml 10 ml 10 ml 10 ml 1 ml 4 ml to 1 litre
SeMet 
medium 
Ala Arg Asn Asp Cys Gln Glu Gly His Ile Leu Lys Pro Ser Thr Val H2O
to 50 ml












Table 2.2.4 Vitamin mixtures. 
Vitamin mixtures are transferred to aliquots of 1 ml and stored at −20°C. 
2.2.2.2 Production of selenomethionine-labelled protein 
On day 1, plasmid of interest was transformed into methionine auxotrophic E. coli 
B834(DE3) competent cells and grown on LB plate with certain antibiotic at 37°C 
overnight. On day 2, a single colony was inoculated into 10 ml LB with appropriate 
antibiotic added and incubated at 37°C and 250 rpm overnight. On day 3, 100 ml LB 
was inoculated with 1 ml overnight culture and incubated at 37°C and 250 rpm for 2–
3 hrs until OD600 achieved 0.2–0.4. E. coli cells were pelleted by centrifugation at 4000 
x g for 10–15 min and washed twice in SeMet medium (without SeMet and specific 
antibiotic) in order to remove the trace methionine from the LB medium. Then the 
pellet was resuspended in 10 ml SeMet medium and inoculated into 2 flasks of 500 ml 
SeMet medium (without SeMet and specific antibiotic). Appropriate antibiotics were 
supplemented to the flask before removing 10 ml culture to a 50 ml Falcon tube and 
incubating alongside as a non-Met control. Subsequently, SeMet was added to the flask 
and incubated at 37°C for 6 hrs when glucose was used as carbon source or 12 hrs 
when glycerol was used until the OD reached ~ 0.6. It is optional to leave the flask at 
4°C for 1 hr prior to the induction by 1 mM IPTG at 18°C overnight (16–20 hrs). The 
cold shock before induction sometimes increases the soluble expression of proteins. 
On day 4, SeMet-grown cells were harvested by centrifugation as mentioned above. It 
is worth noting that all SeMet waste requires disposal as toxic waste according to toxic 
waste disposal rules in the university. 
2.2.3 SDS-PAGE 
Sodium dodecyl sulphate polyacrylamide gel electrophoresis (SDS-PAGE) was 
applied to analyse the proteins purified from each purification step. 15% or 18% 
polyacrylamide separating gel and 5% stacking gels were cast using the Mini-
PROTEAN Tetra Cell (Bio-Rad) according to Table 2.2.5. 5 µl protein samples or cells 






to 10 ml10 mg
Vitamin 






SDS, 30% (v/v) glycerol, 5% (v/v) ß-mercaptoethanol and 0.02% (m/v) bromophenol 
blue) and heated at 100°C for 10 min. Samples were centrifuged at 15,870 x g for 1 
min before loading the supernatant to each well of SDS-PAGE gel, which was then 
run in 1x SDS-PAGE running buffer. 10 litres of 10x SDS-PAGE running buffer 
contains 300 g Tris base, 1440 g glycine, 100 g SDS, pH 8.3. 
 
Table 2.2.5 SDS-PAGE protocol. 
This protocol is used according to 4 polyacrylamide gels of 1 mm thickness. 24 ml of 15% or 
18% separating gel is prepared firstly and added to the casting glasses, followed by covering 
with 0.5 ml isopropanol for each gel. The isopropanol is decanted after separating gel 
solidifying in 30 min. Subsequently, 6 ml of 5% stacking gel is mixed and added to the top of 
separating gel. A comb is inserted to cast wells. The stacking gel solidifies in about 1 hr before 
comb can be removed for sample loading. 
2.2.4 Immobilized metal ion affinity chromatography purification 
Recombinant proteins produced with hexa-histidine tags were purified by Immobilized 
Metal Ion Affinity Chromatography (IMAC). Clarified cell lysate was loaded onto a 5 
ml HisTrapTM FF column (GE Healthcare) pre-equilibrated in HisA buffer (50 mM 
Tris-HCl, pH 8.0, 500 mM NaCl and 50 mM imidazole) at 1.5 ml/min. Unbound 
proteins were washed from the column with HisA buffer in 5 column volumes (CVs), 
or until the A280 reading stabilised, at 2.5 ml/min. His-tagged proteins were then eluted 
by 50% HisA buffer and 50% HisB buffer (50 mM Tris-HCl, pH 8.0, 500 mM NaCl 
and 500 mM imidazole) at 1 ml/min in 4 CVs. The IMAC column was then washed 
with 100% HisB and regenerated by washing with H2O (2 CVs), 0.5 M NaOH (5 CVs), 
H2O (5 CVs), and stored in 20% ethanol (5 CVs). Protein fractions containing the 
protein of interest were identified by SDS-PAGE and pooled and concentrated to 2 ml 
prior to gel-filtration purification. 
Gel percentage (%) 5 Gel percentage (%) 18 15
H2O (ml) 4.08 H2O (ml) 3.12 5.52
30% Polyacrylamide (ml) 1.02 30% Polyacrylamide (ml) 14.4 12
1 M Tris-HCl (pH 6.8) (ml) 0.75 1.5 M Tris-HCl (pH 8.8) (ml) 6 6
10% SDS(μl) 60 10% SDS(μl) 240 240
10% Ammonium persulfate (μl) 60 10% Ammonium persulfate (μl) 240 240
TEMED (μl) 6 TEMED (μl) 9.6 9.6
Total volume (ml) 6 Total volume (ml) 24 24
Separating gelStacking gel




2.2.5 Anion exchange chromatography purification 
Recombinant proteins produced without affinity tags were purified by anion exchange 
chromatography (AEC) using a 12 ml Q Sepharose™ Fast Flow ion exchange column 
(packed in the JMW laboratory). Cells were lysed and pelleted as mentioned above in 
section 2.2. Crude extract was loaded onto a Q Sepharose column pre-equilibrated 
with QA buffer (50 mM Tris-HCl, pH 8.0). Unbound samples were washed with 5 
CVs of QA buffer. Bound proteins were eluted with a linear gradient of 0–100% QB 
buffer (50 mM Tris-HCl, pH 8.0, 1 M NaCl) over 20 CVs at 2.5 ml/min. Fractions 
containing the protein of interest were identified by 15% or 18% acrylamide SDS-
PAGE. Fractions were pooled and concentrated before subsequent purification by size-
exclusion chromatography.  
2.2.6 Size-exclusion chromatography purification 
2.2.6.1 Calibration of S200 size-exclusion gel filtration chromatography column 
To calibrate the HiLoad 16/600 Superdex 200 (S200) Size-Exclusion Chromatography 
(SEC) column, gel filtration calibration kits (low molecular weight and high molecular 
weight) were used according to the GE Healthcare Life Science product information 
booklet. The elution volume (Ve) of each protein sample with known molecular weight 
was recorded. The void volume (Vo) of the S200 SEC column was determined using 
Blue Dextran 2000. Then the Kav values were calculated for each protein sample 
according to the equation: Kav = (Ve−V0) / (Vc−V0). Vc = geometric column volume. 
The final calibration curve was plotted based on Kav vs. log molecular weight. The 
molecular weight of unknown proteins can be estimated according to the calibration 
curve. 
2.2.6.2  SEC purification 
Around 2 ml of protein was injected onto an S200 16/60 SEC column (GE Healthcare) 
pre-equilibrated in GF buffer (50 mM Tris-HCl, pH 8.0, 150 mM NaCl) at a flow rate 
of 1 ml/min. All chromatography steps were performed at 8°C. Protein fractions of 1.8 
ml were collected after the column void volume (40 ml) in 96-well deep-well blocks. 
Fractions were analysed by 15% or 18% SDS-PAGE and those containing the protein 




using 0.5 M NaOH (1.5 CVs) and then ddH2O (2.5 CVs). 1.2 CVs of 20% ethanol was 
used as a bacteriostatic agent for storage of the column. 
2.2.7 Sucrose cushion/gradient ultracentrifugation purification 
Coexpressed encapsulin associated ferritin and encapsulin (Rru-EncFtn-Enc), 
encapsulin protein (Rru-Enc) were purified based on a modified protocol used by M. 
Sutter (Sutter 2008). GF buffer was used to resuspend the cell pellet and produce 
sucrose solutions at 38% and 50% (w/v) sucrose. Solutions of 10%, 20%, 30% and 40% 
(w/v) sucrose were prepared by diluting 50% (w/v) sucrose in GF buffer. Crude extract 
was obtained by centrifuging lysed cells at 34,000 x g and 4oC for 20 min and filtered 
through 0.45 μm syringe filter. To remove RNA and ribosomal contamination, the 
crude extract was supplemented with 50 μg/ml RNase A and rotated at 10 rpm at room 
temperature for 2 hrs, followed by centrifugation at 48,300 x g and 4°C for 20 min and 
filtering through 0.45 μm syringe filter. 
2.2.7.1 Sucrose cushion production 
Around 28 ml protein sample was loaded to the top of 10 ml of 38% sucrose cushion 
(Figure 2.2.1 A/B) in to a 38.5 ml Ultraclear tube (Beckman) and centrifuged at 
100,000 x g (rotor SW28, 23600 rpm) and 4oC for 21 hrs in a Beckman Coulter 
Ultracentrifuge Optima XPN-100. Maximum acceleration and ‘5’ deceleration mode 
was used to keep the minimal disruption when pelleting. Subsequent to 
ultracentrifugation 5 ml fractions were removed from top to bottom into 15 ml Falcon 
tubes and labelled as 1–7 from top to bottom. After 35 ml of fractions were removed, 
three fractions of 1 ml were removed into 1.5 ml Eppendorf tubes. The pellet was 
resuspended in ~9 ml GF buffer on a vortex mixer. The insoluble portion of the pellet 
was removed by centrifugation at 10,000 x g and 4oC for 15 min in Beckman Avanti 
J-25 centrifuge with the rotor JA-25.50. Samples from each fraction were analysed by 
15% or 18% SDS-PAGE and fractions containing the protein of interest were pooled 
for subsequent purification steps.  
2.2.7.2 Sucrose gradient centrifugation 
Sucrose gradient was set up in a 38.5 ml Ultraclear tube (Beckman) according to 
Figure 2.2.1 A/C. Around 13 ml of filtered supernatant from sucrose cushion 




Samples were split into multiple tubes for better separation of the protein of interest 
from contaminants. Protein samples on the sucrose gradient were centrifuged at 
100,000 x g and 4oC for 17 hrs. Three 5 ml fractions were removed from the top of the 
tube; the remaining liquid was removed as 0.75 ml fractions and placed in 1.5 ml 
Eppendorf tubes. The protein content of each fraction was quantified by the 
measurement of absorbance at 280 nm (A280) and protein purity was estimated based 
on the protein/DNA ratios (A260/A280) via NanoDrop 2000 UV-Vis Spectrophotometer 
(Thermo Scientific). 
 
Figure 2.2.1 Sucrose cushion/gradient setup. 
(A) Two 38.5 ml Ultraclear tubes were placed on a foam base with tips set up to allow the 
sucrose cushion (38%) or gradient (10%–50%) to be gently settled. (B) Sucrose cushion was 
set up in an Ultraclear tube with 10 ml of 38% sucrose in the bottom and 28 ml protein in GF 
buffer on the top. (C) Sucrose gradient was set up as five gradients of 5 ml sucrose ranging 
from 50% to 10% with 13 ml protein in GF buffer topping up. 
 Transmission electron microscopy 
Negative stain transmission electron microscopy (TEM) imaging was performed on 
purified encapsulin, EncFtn, and co-purified encapsulin/EncFtn. Purified protein at 0.1 
mg/ml concentration was spotted on glow-discharged 300 mesh carbon-coated copper 
grids and excess liquid wicked off with Whatman filter paper (grade 1, diameter 24.0 
cm). The grids were washed with 10 l distilled water and blotted with filter paper 




Grids were imaged using a Philips CM120 transmission electron microscope and 
images were collected with a Gatan CCD camera. The microscope was later updated 
to JEOL JEM-1400 operating at 80 kV with a magnification up to 2,000,000X. The 
camera was updated to GATAN One View.  Images were analysed using ImageJ (NIH) 
and size-distribution histograms were plotted using Prism6 (GraphPad software). Here 
uranyl acetate was used because the heave ions readily interacted with the electron 
beam and produced image contrast. When uranyl acetate was added to protein sample, 
the stain would surround the protein but was excluded from the protein volume. The 
electron beam can pass the protein sample easier than the surrounding space, leading 
to the observation of a dark background and the morphology of a white protein 
(Barreto-Vieira & Barth 2015).  
 Peptide mass fingerprinting 
Proteins can be identified by peptide mass fingerprinting which involves three steps: 
protein separation by SDS-PAGE, trypsin digestion, and peptide identification by the 
matrix-assisted laser desorption/ionization time-of-flight mass spectrometry (MALDI-
TOF MS) (Thiede et al. 2005). Firstly, protein was separated on SDS-PAGE gel as 
single bands, which were then cut into 2 mm x 1 mm pieces. Prior to trypsin digestion, 
protein bands were washed in 300 µl of 200 mM NH4HCO3 (ABC) and 50% 
acetonitrile (ACN) at room temperature for 30 min; this was repeated twice. The 
protein band was then centrifuged at 15000 x g and the supernatant was discarded. The 
protein band was then incubated in 300 μl 20 mM DTT, 200 mM ABC, 50% ACN at 
room temp for 1 hour, followed by instant wash in 300 μl 200 mM ABC, 50% ACN 
for three times. Cysteines were alkylated by adding fresh 100 μl 50 mM iodoacetamide 
(IAA), 200 mM ABC, 50% ACN at room temperature in dark for 20 min. Protein band 
was subsequently washed in 500 μl 20 mM ABC, 50% ACN for 3 times. The protein 
band was then centrifuged at 15,870 x g for 2 min and remove the supernatant. 
Subsequently, the protein band was covered with ACN for at least 5 min until the gel 
turned white. Gel pieces were dried with tube cap open after decanting ACN. Trypsin 
stock was prepared by adding 50 μl of 50 mM ABC to a new vial of trypsin powder 
(Sigma-Aldrich) at 4°C, splitting into small aliquots and stored at −80°C. 30 μl trypsin 
working solution including 29 μl of 50 mM ABC and 1 μl trypsin stock solution was 




bands was set up alongside to provide an internal calibration peak for MALDI-MS. 
All tubes with trypsin digestion were sealed with Parafilm M and incubated at 32°C 
for 16–24 hrs. 
On the second day, protein samples were centrifuged and sonicated for 10 min. 0.5 μl 
digested peptide was spotted on a MALDI gold plate with 0.5 μl α-cyano-4-
hydroxycinnamic acid matrix (Sigma-Aldrich). When samples were analysed in 
MALDI-MS, peptide mass peaks were detected with baseline correction, noise filter, 
peak deisotoping as well as mass calibration against trypsin autolysis peak. Peaks were 
then searched on Mascot Server (Matrix Science) against ‘Swiss-Prot’ or ‘NCBInr’ 
databases for significant hits. Parameters were set up as following: 100 ppm as peptide 
tolerance, carbamidomethyl as fixed modifications and oxidation on methionine as 
variable modifications.  
It is worth mentioning two points: (1) gloves should be worn to avoid the 
contamination; (2) small proteins might get an insignificant searching results, of which 
a comparison with virtual trypsin digestion result would be helpful. 
 Protein crystallisation, X-ray data collection and analysis 
2.5.1 Protein crystallisation screening and optimisation 
Protein purified through IMAC or AEC and then SEC was concentrated to around 10 
mg/ml. Protein concentration was estimated based on calculated extinction 
coefficients at 280 nm (Simonian & Smith 2001). Proteins were screened for 
crystallisation against the following commercial crystallisation kits: PEG/ION screen 
from Hampton Research; JCSG-plus, Structure Screen, and MIDAS from Molecular 
Dimensions. 
An Art Robbins Gryphon nanolitre pipetting robot was used to dispense 65 μl of each 
crystallisation screen from a master screen kit into a MRC 96-well crystallisation plate. 
0.1 μl reservoir solution was pipetted into each crystallisation well, followed by 0.2 
and 0.1 μl protein dispensed into the top and bottom crystallisation wells by the 
nanodispenser. The sitting-drop vapour-diffusion crystallisation plate was sealed by 
X-Seal Manual Adhesive Sealer XCS-384 (FluidX) using transparent and self-




conditions were then optimised in Linbro 24-well plates based on protein crystal hits 
found in 96-well plates.  
In optimisation trays, crystallisation drops were set up using the hanging drop vapour 
diffusion method using 24 well Linbro plates. Well solution was set up at 1 ml final 
volume. Glass coverslips were set up with the ratio of protein to well solution as 1 μl: 
1 μl, 1 μl: 2 μl and 2 μl: 1 μl and wells were sealed with vacuum grease (Corning). 
Plates were stored at 292 K for one week to two months.  
2.5.2 Crystal soaking and mounting 
Crystals were harvested from 96 and 24 well plates using a LithoLoop (Molecular 
Dimensions Limited); transferred briefly to a cryoprotection solution containing well 
solution supplemented with 20 % (v/v) PEG 200; and subsequently flash cooled in 
liquid nitrogen. For iron (II) soaking, crystals were transferred into a cryoprotectant 
with 1 mM FeSO4 or Fe(NH4)2(SO4)2 dissolved in 0.1 % (v/v) HCl for different time 
intervals and back soaked in a cryoprotectant without iron (II) prior to flash cooling in 
liquid nitrogen.  
2.5.3 X-ray diffraction data collection and processing 
All crystallographic datasets were collected on the macromolecular crystallography 
beamlines at Diamond Light Source (Didcot, UK) at 100 K using Pilatus 6M detectors. 
An X-ray fluorescence spectrum (MCA) was performed to indicate the presence of 
metal in the protein crystal. A fluorescence edge scan was carried out to precisely 
determine the peak and inflection points of the absorption edge of any anomalously 
scattering metals present in the crystal. Most diffraction data were collected at 10–100 
eV above the theoretical Fe-K edge or experimentally determined E(peak) to maximise 
the anomalous peaks of iron, leading to a recordable resolution of 2 Å due to the 
limitation of crystal-to-detector distance. The triple mutant E32A-E62A-H65A of Rru-
EncFtnSH was collected at 1.5 Å in order to increase the resolution limit when no iron 
was bound in this mutant. 
Diffraction data were integrated and scaled using XDS (Kabsch 2010); the 
crystallographic point group and space group were determined by Pointless and 




cut-off used for structure determination and refinement was determined based on the 
completeness (>95%), I/sigI (>1.5) and CC1/2 (>0.5) criterion of Karplus and 
Diederichs (Karplus & Diederichs 2012).  
2.5.4 Crystallographic model building and refinement 
The structure of Rru-EncFtnSH was determined by molecular replacement using 
protein NE0167 (PDB ID: 3K6C) as the search model, which had been modified to 
match the sequence of the target protein using Chainsaw (Stein 2008). A single 
solution comprising three decamers in the asymmetric unit was found by molecular 
replacement using Phaser MR (McCoy et al. 2007). The initial model was rebuilt using 
Phenix.autobuild (Adams et al. 2010) followed by cycles of refinement with 
Phenix.refine (Afonine et al. 2012), with manual rebuilding and model inspection in 
Coot (Emsley et al. 2010). Each refinement cycle in Phenix.refine included ten 
macrocycles of bulk solvent correction, anisotropic scaling, coordinate refinement, 
individual B-factors and occupancy refinement. The refinement target weights 
included scale factor for X-ray/stereochemistry weight (wxc_scale) as 0.5; for X-
ray/ADP weight (wxu_scale) as 1.0; stereochemistry weight scale (wc) as 1.0; ADP 
weight scale (wu) as 1.0. The refinement program has been repeated several cycles 
until the Rwork, Rfree and stereochemical restraints have achieved convergence. In the 
final stage of the refinement, water molecules and hydrogens were added to the protein 
model automatically in Phenix and further inspected in Coot manually. The final 
model was also refined with torsional NCS restraints (2.5° for restraint sigma and 15° 
for restraint limit), as well as anomalous group refinement if anomalous peaks have 
been detected. 
Refmac5 had been used in the early stage of refinement (Pannu et al. 1998; Steiner et 
al. 2003) before Phenix.refine was used. As a fast refinement tool, refmac5 was able 
to produce a good starting model for further refinement with Phenix.refine. However, 
as two refinement programs have many differences such as weight factors, continually 
switching between refmac5 and phenix.refine would lead to unsuccessful refinement. 
The structures of Rru-EncFtnSH mutants and homologues were determined by 
molecular replacement using a modified monomeric or decameric Rru-EncFtnSH 




2.5.5 Crystallographic model analysis 
The crystallographic model was validated using MolProbity (Chen et al. 2010). 
Structural superimpositions were calculated using the secondary-structure matching 
(SSM) (Krissinel & Henrick 2004) algorithm implemented in Coot (Emsley et al. 
2010). Crystallographic figures were generated with PyMOL (Schrodinger 2015). 
Protein interface interactions were calculated using the PDBePISA server (Krissinel 
& Henrick 2007). The metals modelled in proteins have been validated by the 
CheckMyMetal server (Zheng et al. 2014). See appendices for the CheckMyMetal 
reports of all EncFtn proteins listed in this thesis.  
 Biochemical analyses and assays 
2.6.1 Ferroxidase assay 
Ferrous iron stock was made by dissolving 0.1 M Fe(NH4)2(SO4)2 in 0.1% (v/v) HCl 
in anaerobic conditions. Diluted Fe(II) solutions were also prepared anaerobically in 
0.1% (v/v) HCl. Protein solutions were prepared by diluting purified protein samples 
in GF buffer (50 mM Tris-HCl, pH 8.0 and 150 mM NaCl) anaerobically. Ferroxidase 
activity was initiated by adding 450 μl protein to 50 μl of acidic Fe(NH4)2(SO4)2 at the 
final concentration of 100 µM and 20 µM in the air, respectively. The ferroxidase 
activity was measured by monitoring the Fe(III) formation which gives rise to the 
change of the absorbance at 315 nm (Bonomi et al. 1996). Absorbance at 315 nm was 
recorded every second over 1800 seconds using a quartz cuvette in a JASCO V-730 
UV/VIS spectrophotometer (JASCO Inc.). In recombinantly coexpressed 
nanocompartments the ratio of EncFtn to Enc was assumed as 2 to 1, assuming each 
of the twelve pentameric vertices of the icosahedral encapsulin were occupied with 
decameric EncFtn. The data are presented as the mean of three technical replicates 
with error bars indicating one standard deviation from the mean. Proteins used here 
were from a single preparation. 
2.6.2 Peroxidase assay 
The peroxidase activity of Rru-EncFtnSH was determined by measuring the oxidation 
of a chromogenic substrate ortho-phenylenediamine (OPD) by H2O2 (Pesek et al. 
2011). Rru-EncFtnSH decamer and monomeric fractions purified from minimal media 




Tris-HCl (pH 8.0). Different concentrations of OPD were prepared by diluting the 
stock solution in 50 mM Tris-HCl (pH 8.0). 100 μl of each diluted OPD was added to 
a 96-well plate in 3 replicate wells. 1 μl of 32 μM protein was supplemented into each 
well to a final concentration of 160 nM, followed by the addition of 2 μl of 30% H2O2. 
After 15 minutes shaking in the dark, the reaction was stopped by adding 100 μl of 0.5 
M H2SO4. The peroxidase activity was measured by monitoring the absorbance at 490 
nm in the SpectraMax M5 Microplate Reader (Molecular Devices Corporation) (Pesek 
et al. 2011).  
 Iron content analysis of protein samples 
2.7.1 Inductively Coupled Plasma Mass Spectrometry (ICP-MS) analysis 
ICP-MS has been wildly used in determining isotropic composition in a semi-
quantitative or quantitative manner. ICP-MS can detect most elements in the periodic 
table with detection limits below part per trillion. Protein samples were diluted 50-fold 
into a solution of 2.5 % HNO3 (Suprapur, Merck) containing 20 µg/l Pt as internal 
standard. Matrix-matched elemental standards (containing analyte metal 
concentrations 0–1000 µg/l) were prepared by serial dilution from individual metal 
standard stocks (VWR) with identical solution compositions, including the internal 
standard. All standards and samples were analysed by ICP-MS using a Thermo X-
series instrument operating in collision cell mode (using 3.0 ml min−1 flow of 8% H2 
in He as the collision gas). Isotopes 44Ca, 56Fe, 66Zn, 78Se, and 195Pt were monitored 
using the peak-jump method (100 sweeps, 25–30 ms dwell time on 5 channels per 
isotope, separated by 0.02 atomic mass units) in triplicate. This experiments have been 
carried out by Dr. Emma Tarrant and Dr. Kevin J. Waldron in the Institute for Cell and 




2.7.2 Ferrozine assay 
 
Table 2.7.1 Fe(II) loading experiment.  
8.5 µM proteins including Rru-EncFtnSH decamer fractions (73sH), Rru-Enc (0974), coexpressed Rru-EncFtn and Rru-Enc (7374) and horse spleen 
apoferritin (apo-HsFtn) were mixed with Fe(NH4)2(SO4)2 in 0.1% (v/v) HCl at various concentrations at room temperature for 3 hrs, respectively. This 
system was topped up with GF buffer to 100 µl. Protein with 0.1% (v/v) HCl (label: 10, 20, 30, 40) and Fe(II) with GF buffer (label: 50) were both set up 
as controls. Protein samples were centrifuged, of which the supernatant was desalted to remove the free Fe in solutions. Fe control was also desalted to 
determine the desalting efficiency which turns out to be over 95%. 
Label: 50






Label 11 12 13 14 15
Fe stock (mM) 0.8 1.7 2.9 4.5 6.0
Final Fe loading (µM) 39.9 84.0 147.0 224.0 301.0
Fe/73sH-10mer (per 1mer) 5 10 17 26 36
Label 21 22 23 24 25 26 27
Fe stock (mM) 4.5 6.0 9.0 14.0 20.0 30.0 40.0
Final Fe loading (µM) 224.0 301.0 450.0 700.0 1000.0 1500.0 2000.0
Fe/0974 (per 1mer) 26 35 53 82 118 176 235
Label 31 32 33 34 35 36 37
Fe stock (mM) 4.5 6.0 9.0 14.0 20.0 30.0 40.0
Final Fe loading (µM) 224.0 301.0 450.0 700.0 1000.0 1500.0 2000.0
Fe/7374 (per 1mer) 26 35 52 80 115 172 230
Label 41 42 43 44 45 46
Fe stock (mM) 0.0 0.9 4.3 12.8 25.5 34.0
Final Fe loading (µM) 0.0 42.5 212.5 637.5 1275.0 1700.0







Fe(II) loading (10-40 were numbers to label all tubes)
Label: 10
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In order to determine the maximum iron loading capacity of different EncFtn and Enc 
samples an iron loading experiment was carried out according to Table 2.7.1. For the 
analysis of encapsulin compartments, 8.5 μM EncFtn-Enc and 8.7 μM Encapsulin 
were diluted in GF buffer and both were mixed with various concentrations of 
Fe(NH4)2(SO4)2 (prepared in 0.1% (v/v) HCl). To assay the iron loading capacity of 
EncFtn, 8.5 μM of decameric Rru-EncFtnSH was diluted in GF buffer and mixed with 
various concentrations of Fe(NH4)2(SO4)2 (prepared in 0.1% (v/v) HCl) as before. 
Protein and iron mixtures were incubated at room temperature for 3 hrs. Precipitated 
protein and iron oxides in the samples were removed by centrifugation at 15,871 x g 
for 10 min. Free iron ions in solution were removed through buffer exchange using 
ZebaTM spin desalting columns (7 kDa cut-off, Thermo Fisher Scientific). The protein 
concentration of each sample was determined using the Pierce Microplate BCA assay 
kit (Thermo Fisher Scientific). A protein standard curve was plotted according to the 
manufacturer instruction. The iron content in the samples was determined using a 
modified ferrozine assay (Riemer et al. 2004). In this assay 100 μl of protein sample 
was mixed with 100 μl mixture of equal volume of 1.4 M HCl and 4.5% (w/v) KMnO4 
and incubated at 60°C for 2 hrs. Prior to this incubation 20 μl of the iron-detection 
reagent (6.5 mM ferrozine, 6.5 mM neocuproine, 2.5 M ammonium acetate, and 1 M 
ascorbic acid dissolved in H2O) was added to the cooled tube. After a 30 min 
incubation, 200 μl of the solution was transferred to a 96-well plate and the absorbance 
at 562 nm was measured on a plate reader Spectramax M5 (Molecular Devices). A 
standard curve for iron concentration was plotted using various concentrations of 
FeCl3 (in 0.1% (w/v) HCl) diluted in the gel-filtration buffer (curve available in Figure 
5.6.1). Both the ferrozine and BCA microplate assays were performed using three 
technical repeats. Samples analysed by ICP-MS were prepared in the same way by 
mixing protein and ferrous ions and desalting. The proteins used in the iron loading 
experiment came from a single preparation. Horse spleen apo-ferritin was incubated 
with Fe(II) according to Table 2.7.1 as a positive control group. 2.5 mM Fe(II) was 
incubated with GF buffer alongside to detect the desalting efficiency of the ZebaTM 




 Protein assembly analysis 
2.8.1 SEC-MALS 
Size-exclusion chromatography (ÅKTA-Micro; GE Healthcare) coupled with multi 
angle light scattering was used to determine the molecular mass of gel-filtration 
fractions of Rru-EncFtnSH in solution. Firstly, sample components were separated by 
SEC based on the hydrodynamic size, followed by running through UV detector, 
multiple light scattering detectors at fixed angles (Viscotek SEC-MALS 20) and 
refractive index detector (Viscotek VE3580, Malvern Instruments). The major 
advantage of gaining light scattering data as a function of scattering angle is the radius 
of gyration (Rg) can be calculated to give the size of the molecules. In the case of SEC, 
if the scattering molecules are relatively big and the light scattering varies with angle, 
which makes the Rg measurement important for the precise determination of the molar 
mass of the molecules when the anisotropy comes into play. The molar mass of the 
polypeptide portion of the protein sample (MMpp) can be calculated as follows (Folta-
Stogniew 2006): 
MMpp = K * (LS)(UV) / [A * (RI)
2] 
Where K is the calibration constant of the SEC-MALS system as determined from the 
calibration curve generated using the same protein buffer and BSA protein standards; 
LS is the response from light scattering detector; UV equals to A280; RI is the response 
from the refractive index detector; A is the extinction coefficient of the polypeptide 
and expressed as A0.1%280 (mg/ml). 
Here the protein concentration was determined by measurement of absorbance at 280 
nm using a calculated extinction coefficient (ε0.1%) of 1.462 mg−1 ml cm−1 for Rru-
EncFtnSH. 100 μl of 1.428 mg/ml decameric fraction and 4.027 mg/ml monomeric 
fraction were run individually on a Superdex 200 10/300 GL size exclusion column 
pre-equilibrated in 50 mM Tris-HCl (pH 8.0), 150 mM NaCl at 22 ˚C with a flow rate 
of 0.5 ml/min. Light scattering, refractive index (RI) and A280nm were analysed by a 
homo-polymer model (OmniSEC software, v 5.1; Malvern Instruments) using the 
following parameters: the extinction coefficient (dA/dc) at 280 nm was 1.46 AU ml 




2.8.2 Mass spectrometry 
For native Mass Spectrometry or nano-electrospray ionisation mass spectrometry 
(nESI-MS) analysis, all protein samples were buffer exchanged into 100 mM 
ammonium acetate (pH 8.0; adjusted with dropwise addition of 1% ammonia solution) 
using Micro Biospin® Chromatography Columns (Bio-Rad, UK) prior to analysis and 
the resulting protein samples were analysed at a final concentration of ~ 50 μM 
(monomer concentration). In order to obtain iron-bound Rru-EncFtnSH, 100 μM or 
300 μM of freshly prepared FeCl2 was added to apo-Rru-EncFtnSH (monomer 
fractions) immediately prior to buffer exchange into 100 mM ammonium acetate (pH 
8.0). Samples were analysed on a quadrupole ion-mobility time of flight instrument 
(Synapt G2, Waters Corp., Manchester, UK), equipped with a nanomate 
nanoelectrospray infusion robot (Advion Biosciences). Instrument parameters were 
carefully tuned to preserve non-covalent protein complexes. After optimisation, 
typical parameters were: nanoelectrospray voltage 1.54 kV; sample cone 50 V; 
extractor cone 0 V; trap collision voltage 4 V; source temperature 80°C; and source 
backing pressure 5.5 mbar. For improved mass resolution the sample cone was raised 
to 155 V. Ion mobility mass spectrometry (IM-MS) was performed using the 
travelling-wave mobility cell in the Synapt G2, employing nitrogen as the drift gas. 
Typically, the ion mobility separation (IMS) wave velocity was set to 300 m/s; wave 
height to 15 V; and the IMS pressure was 1.8 mbar. For collision cross section 
determination, IM-MS data was calibrated using denatured equine myoglobin and data 
was processed using Driftscope v2.5 and MassLynx v4.1 (Waters Corp., UK). 
Theoretical collision cross sections (CCS) were calculated from pdb files using 
IMPACT software v. 0.9.1 (Marklund et al. 2015). In order to obtain information on 
the topology of the EncFtn assembly, gas-phase dissociation of the Fe-associated 
EncFtn complex was achieved by increasing the sample cone and/or trap collision 
voltage prior to MS analysis. All nESI-MS and IM-MS were performed by Dr. David 
Clarke and Sam Huges in the School of Chemistry, The University of Edinburgh. 
2.8.3 Native PAGE analysis of proteins 
Native polyacrylamide gel electrophoresis (PAGE) or nondenaturing PAGE was 
applied to analyse the protein oligomeric states in native state. A 12% native 




1 M Tris-HCl (pH 8.5), 140 µl of 10% ammonium persulfate, 6 µl TEMED and 4.76 
ml H2O. Samples for native PAGE were diluted with 5 x protein loading buffer 
containing 62.5 µl of 1 M Tris-HCl (pH 8.5), 200 µl glycerol, 687 µl H2O and 10 µl 
of 1% bromophenol blue. Native PAGE gels were running in 1 x running buffer, which 
was diluted from 5 x Native PAGE running buffer (15.1 g Tris-base, 94 g glycine and 
1 L H2O). 5 µl protein mixed with 5 µl of 5 x loading buffer was loaded into 12% 
Native PAGE, which was running in cold room at 200 V for 60–70 min. 7.5 µg bovine 
serum albumin protein in GF buffer was used as a marker. The staining and destaining 
procedures are the same to SDS-PAGE protocol.  
2.8.4 Analytical gel-filtration chromatography 
For analysis of the multimeric state of Rru-EncFtnSH proteins by analytical gel 
filtration 25 μl of 90 µM protein was loaded into Superdex 200 PC 3.2/30 column (GE 
Healthcare Life Sciences) at 15°C with GF buffer running at 0.05 ml/min and pressure 
limit 0.45 MPa. In order to use analytical gel-filtration (AGF) to determine how metal 
ions influence the assembly of EncFtn, 90 µM Rru-EncFtnSH monomer fractions were 
mixed with equal molar concentrations of metal ion solutions including FeSO4 in 0.1% 
(v/v) HCl, Fe(NH4)2(SO4)2, FeCl3, CoCl2, calcium acetate (CaAc), ZnSO4 and MnCl2 
at room temperature for 2 hrs before analysis by AGF. 90 µM Rru-EncFtnSH decamer 
fractions were loaded to the AGF column as a control for protein assembly. Both 
monomer and decamer fractions of Rru-EncFtnSH incubated at room temperature for 
2 hrs, or overnight, were also analysed as controls to show the stability of the protein 
samples in the absence of additional metal ions. 
 Protein concentration determination 
2.9.1 Extinction coefficient calculation 
Protein concentration were evaluated using A280 extinction coefficients calculated by 
ExPASy ProtParam (Gasteiger et al. 2005). Briefly, ProtParam tool website 
(http://web.expasy.org/protparam/) uses protein sequence uploaded to calculate the 
extinction coefficient in units of M−1·cm−1 and Abs 0.1% (=1 mg/ml). Protein 
absorbance at 280nm (A280) was measured using a Thermo Fisher Scientific NanoDrop 
2000, or JASCO V-550 UV-Vis Spectrophotometer. Protein concentration in the unit 




concentration in the unit of mol/l were calculated using the A280 / (M
−1·cm−1) extinction 
coefficient (Simonian & Smith 2001). 
2.9.2 BCA microplate assay 
Protein concentrations determined by the BCA microplate assay were carried out 
according to the manufacturer instructions of the PierceTM BCA Protein Assay Kit 
(Thermo Fisher Scientific) using the microplate procedure. Briefly, 25 μl of protein 
sample or Bovine Serum Albumin (BSA) standard (25–1000 μg/ml) was pipetted into 
a 96-well plate (Greiner) in three technical repeats. BCA working solutions were 
prepared by mixing A and B solutions in 50:1 ratio; 200 μl of the working solution 
was added to each well with proteins or BSA standard and mixed on a shaker for 30 s 
before covering plate and incubating at 37°C for 30 min. A control experiment was 
performed with 200 μl working solution with 25 μl GF buffer in three repeats. The 
plate was cooled to room temperature prior to absorbance measurement at 562 nm 
(A562) on a microplate reader SpectraMax M5 (Molecular Devices). BSA standards 
were prepared in Table 2.9.1. The standard curve was plotted using normalised A562 
against protein concentration (μg/ml).  
 
Table 2.9.1 Bovine Serum Albumin standards. 
Bovine Serum Albumin (BSA) protein standards 1.5 mg/ml and 1 mg/ml were prepared by 
diluting the 2 mg/ml commercial stock. The 750, 500, 150 and 100 µg/ml BSA samples were 
prepared by diluting the 1.5 or 1 mg/ml samples. 250 and 50 µg/ml samples were made from 
the dilution of 500 µg/ml sample. The 25 µg/ml sample was prepared from the dilution of 250 
µg/ml. 
GFB buffer (μl) BSA (ul)
1500 75 225 μl * 2 mg/ml
1000 150 150 μl * 2 mg/ml
750 75 75 μl * 1.5 mg/ml
500 150 150 μl * 1 mg/ml
250 75 75 μl * 500 ug/ml
150 135 15 μl * 1.5 mg/ml
100 135 15 μl * 1 mg/ml
50 135 15 μl * 500 ug/ml
25 135 15 μl * 250 ug/ml
0 135 0





 Multiple sequence alignment and phylogenetic tree construction 
The ferritin superfamily contains 24-meric mammalian ferritins (H-/M-/L-chains), 
bacterial ferritin (FTN), bacterioferritin (BFR) and erythrin domain of rubrerythrin 
protein (ER), 12-meric mini-ferritin (DPS) and ferritin-like proteins with shorter 
sequences. The multiple protein sequence alignment of ferritin superfamily was 
initially carried out using programs such as Clustal Omega (Sievers et al. 2011; Li et 
al. 2015; McWilliam et al. 2013) and PROMALS3D (Pei et al. 2008). The alignment 
of the conserved ferroxidase centres among ferritin family proteins except DPS and L-
chain ferritin has been used to estimate the alignment quality. However, because of the 
diverged ferritin classes, the one-step alignment failed to produce an aligned 
ferroxidase centre. Therefore, a progressive alignment was performed by setting up 
local alignment first. Mammalian ferritins were aligned using T-coffee (Notredame et 
al. 2000) or Clustal Omega as the seed of alignment. Then FTN family was aligned 
using T-coffee, which was further added to the aligned mammalian ferritins and 
aligned by MAFFT (Katoh et al. 2002). For evolutionarily diverged proteins the matrix 
BLOSUM 45 was used in this study. The other ferritin families including BFR, ER, 
DPS and ferritin-like proteins were added in a step-wise manner and aligned by 
MAFFT gradually. Apart from the conserved ferroxidase centre, the C-terminal 
localisation sequences of encapsulin-associated ferritin-like proteins (EncFtn) were 
also conserved, which has been taken into account when assessing the alignment 
quality. To rule out the bias introduced by the alignment order, the order of progressive 
alignment has been altered, which did not affect the alignment of both FOC and C-
terminal location sequence of EncFtn. The phylogenetic tree was built in MEGA7 
using Neighbour-joining method. 500 of bootstrap replications were applied in the 
phylogeny test. p-distance model (Nei & Kumar 2000)was used in the substitution 
model for amino acid substitutions. The rate of variation among sites was modelled 
with a gamma distribution (shape parameter = 2.5). The analysis involved 104 amino 
acid sequences. All ambiguous positions were removed for each sequence pair (Kumar 




 The modelling of encapsulin nanocompartments 
The modelling of encapsulin nanocompartments was carried out in PyMOL manually. 
Firstly, T. maritima encapsulin (Tm-Enc) was loaded into PyMOL 1.8 as a 60-mer 
using ‘PDB analysis-Assemblies’ in the plugin. Secondly, Rru-EncFtn was loaded into 
PyMOL and a decamer was docked on top of a pentamer of Tm-Enc along its 5-fold 
symmetry axis using ‘translate’ and ‘rotate’ related command lines. Once a decamer 
of Rru-EncFtn was docked to Tm-Enc, the C-terminal position of Rru-EncFtn should 
be adjacent to the localisation peptide found in Tm-Enc structure (PDB ID: 3DKT). 
This docking was repeated 12 times to constitute a full encapsulin nanocompartment. 
This manual docking process was relatively labour-intensive and could possibly give 
rise to clashes in the protein-protein interface. Another docking program ‘HADDOCK’ 
can be introduced as a tool to validate this manual docking result (Van Zundert et al. 
2016). In addition, the protein-protein interaction between a decamer of Rru-EncFtn 
and another decamer, or between a decamer of Rru-EncFtn and its docking pentamer 
of Tm-Enc, can be evaluated using PDBePISA server (Krissinel & Henrick 2007); this 





3 Chapter 3 Purification, structure, and assembly of R. 
rubrum EncFtn 
 Introduction 
R. rubrum EncFtn (KEGG ID: Rru_A0973) shares 57% protein sequence identity with 
protein NE0167 (PDB ID: 3K6C) from N. europaea (Chang et al. n.d.). The C-
terminus of NE0167 is located outside its ring-like decameric structure, suggesting 
that C-terminal his-tag of R. rubrum EncFtn (Rru-EncFtn) may not interfere with the 
structure assembly. Based on the sequence alignment of Rru-EncFtn and NE0167, a 
construct with the first 96 amino acids of Rru-EncFtn and a C-terminal hexahistidine 
tag (Rru-EncFtnSH) was designed (Figure 3.1.1). A full-length gene Rru_A0973 was 
inserted into the pACYCDuet-1 vector and expressed in E. coli as Rru-EncFtn; and 
the truncated gene Rru_A09731-96 was inserted into pET-28a(+) and expressed with C-
terminal his-tag as Rru-EncFtnSH. Both constructs were overexpressed in E. coli cells. 
Rru-EncFtnSH was further characterised in two aspects: protein assembly and crystal 
structure. 
 
Figure 3.1.1 Protein sequence alignment of Rru-EncFtn and NE0167. 
A sequence alignment of Rru-EncFtn (Rru_A0973) and NE0167 was performed using Clustal 
Omega (McWilliam et al. 2013; Sievers et al. 2011) and edited with Esprit 3.0 (Robert & Gouet 
2014). The secondary structure of protein NE0167 (PDB ID: 3K6C) is shown above each row 
of the alignment. The Rru-EncFtnSH protein (Rru_A0973sH) contains 1–96 amino acids of 




 Protein purification 
3.2.1 Calibration of HiLoad 16/600 Superdex 200pg gel-filtration column 
Size-exclusion gel-filtration chromatography provides a means to estimate the 
molecular weight or size (Stokes radius) of proteins under certain buffer and 
temperature conditions. The molecular weight of unknown proteins can be determined 
by comparing the elution volume related parameter Kav to those calculate from known 
calibration standards run on the same column. Here a calibration curve for a HiLoad 
16/600 Superdex 200pg column was prepared by running LMW/HMW calibration kits 
(GE Healthcare) to measure the elution volume (Ve) of each protein standard (Figure 
3.2.1 A). The void volume (Vo) of S200 column was estimated based on the retention 
volume of blue dextran 2000. The Kav value was derived based on the equation:  
Kav = (Ve – Vo) / (Vt – Vo)  
Where Vt equals to the total bed volume of particular column. Kav was then plotted 
against the logarithm of molecular weight of protein standards (Figure 3.2.1 B). It 
should be borne in mind that protein shape also affects the Kav-based molecular weight 
estimation and the assumption that the protein samples are approximately spherical. 
 
Figure 3.2.1 Chromatographic separation and calibration curve for HiLoad 16/600 
Superdex 200 pg column. 
(A) Chromatogram of HiLoad 16/600 Superdex 200 pg gel-filtration column calibration using 
blue dextran 2000 (B, blue solid curve), MixA (red dashed curve) and MixB (black dashed 
curve) in which blue dextran determines the void volume. MixA contains ferritin (F, 440 kDa), 
conalbumin (C, 75 kDa), carbonic anhydrase (CA, 29 kDa) and ribonuclease A (R, 13.7 kDa). 
MixB consists of ovalbumin (O, 44 kDa), aprotinin (Apr, 6.5 kDa), ribonuclease A and aldolase 




3.2.2 Rru-EncFtn purification 
The recombinant Rru-EncFtn protein possesses 140 amino acids with a predicted 
molecular weight of 15,192.74 Da, and an isoelectric point (pI) of 4.75 (Gasteiger et 
al. 2005); this untagged protein was purified using anion exchange chromatography 
(AEC) with a 12 ml Q Sepharose™ Fast Flow ion exchange column (Figure 3.2.2).  
 
Figure 3.2.2 Anion exchange chromatography purification of Rru-EncFtn using a Q 
sepharose column.  
(A) Q Sepharose purification chromatogram of Rru-EncFtn. Fractions from A4 to A9 were flow-
through. Proteins were eluted by a linear gradient over 20 column volumes from 0–1 M NaCl 
as fractions from B12 to F10. (B) Fractions from (A) were analysed by 15% SDS-PAGE, in 
which only fractions C9–D1 showed a band at 15 kDa, corresponding to the monomer size of 
Rru-EncFtn. The monomer and dimer sized bands were highlighted by black arrows. 
Fractions with the protein of interest, assessed by the presence of bands at an estimated 
molecular weight of 15 kDa on 15% SDS-PAGE were pooled and concentrated to 2 
ml prior to Size-Exclusion Chromatography (SEC) using a HiLoad 16/600 Superdex 
200 pg column (Figure 3.2.3). The SEC purification chromatogram of Rru-EncFtn 




Fractions analysed by 15% SDS-PAGE showed that the first peak (fractions C5–C7) 
showed two major bands at around 15 kDa and 30 kDa, corresponding to the 
approximate monomer and dimer size of full-length Rru-EncFtn. The second peak 
(fractions C12–C15) showed a major band at around 15 kDa, consistent with the 
monomer size. These bands were excised from the gel and subjected to MALDI-TOF 
peptide mass fingerprinting (PMF), and were all identified as the R. rubrum ferritin-
like protein, Rru-EncFtn. It is noteworthy that there is no cysteine in Rru-EncFtn 
protein, it is unclear what form of the protein correlates with the dimer size band on 
SDS-PAGE. According to the calibration curve of the SEC column (Figure 3.2.1) and 
SDS-PAGE analysis, the two chromatographic peaks indicate the presence of different 
oligomeric states of Rru-EncFtn during the SEC purification.  
 
Figure 3.2.3 Size exclusion chromatography purification of Rru-EncFtn using HiLoad 
16/600 Superdex 200 pg column.  
(A) Gel-filtration chromatogram of Rru-EncFtn. Proteins were eluted by GF buffer into fractions 
C5–C15, of which two major chromatogram peaks were found at 62 ml and 82 ml. (B) 15% 
SDS-PAGE analysis of fractions C5–C15. The C5–C7 peak in (A) corresponds to two major 
bands around 15 and 30 kDa while the C12–C15 peak in (A) is congruous with a main band 




The SEC purification of Rru-EncFtn were repeated several times from different 
batches of E. coli grown in LB medium (Figure 3.2.4). Each purification run displayed 
two major chromatographic peaks around 62 and 82 ml but with distinct peak ratios. 
It indicated that alteration of oligomeric states of Rru-EncFtn might be a result of 
different levels of trace elements in the different batches of LB media used in these 
experiments. 
 
Figure 3.2.4 Overlay of size exclusion chromatograms of Rru-EncFtn purified by SEC 
HiLoad 16/600 Superdex 200 pg column. 
Rru-EncFtn purification from E. coli BL21(DE3) grown in three batches of LB media showed 
different gel-filtration profiles in black solid, red dashed and blue dotted curves. They all 




3.2.3 Rru-EncFtnSH purification 
Rru-EncFtnSH (Rru-EncFtn1–96 with C-terminal hexa-histidine tag) contains 116 
amino acids and has a molecular weight of 13,325.67 Da and a pI of 5.34 as predicted 
by ExPASy ProtParam tool (http://web.expasy.org/protparam/) (Gasteiger et al. 2005). 
The protein was purified by IMAC and showed two major bands around 13 kDa and 
27 kDa from eluted fractions, corresponding to the monomer and dimer size of Rru-
EncFtnSH, respectively (Figure 3.2.5). 
 
Figure 3.2.5 15% SDS-PAGE analysis of IMAC purified Rru-EncFtnSH. 
Rru-EncFtnSH protein was purified using a 5 ml HisTrap FF column manually and subjected 
to SDS-PAGE analysis. Lane M: protein ladder; Lane 1: cell lysate; lane 2: flow-through; lane 
3: unbound proteins washed by hisA buffer; lane 4–5: protein eluted by 50% hisA mixed with 
50% hisB buffer; lane 6–7: protein eluted by 100% hisB buffer. 
Fractions with protein of interest were pooled and concentrated to 2 ml for SEC 
purification (Figure 3.2.6). The Rru-EncFtnSH displayed higher purity than Rru-
EncFtn after two-step purification due to the presence of His-tag. The S200 SEC 
purification of Rru-EncFtnSH displayed three chromatographic peaks. Peak1 
(fractions A2–A7) was consistent with the void volume of the column (46 ml). Since 
the S200 column has the separation range between 10–600 kDa, peak1 is likely to be 
aggregated material, or high-order oligomers of the protein. Peak2 (Fractions A11–B9) 
separated as a mixture of the 13 kDa and 26 kDa bands by SDS-PAGE, consistent with 




C5) resolved as a 13 kDa band by SDS-PAGE, with a minor band around 26 kDa. 
These bands at 13 kDa and 26 kDa were both identified as Rru-EncFtn by PMF. 
According to the disassembly experiment in Figure 3.5.5, the dimer bands seen on the 
SDS-PAGE might be the dimer with metal association, which will be discussed later 
in Section 3.5.3. 
 
Figure 3.2.6 Size exclusion chromatography purification of Rru-EncFtnSH using HiLoad 
16/600 Superdex 200 pg column. 
(A) Gel-filtration chromatogram of Rru-EncFtnSH. Proteins were eluted using GF buffer into 
fractions A2–C5, of which three chromatogram peaks are shown. (B) 15% SDS-PAGE 
analysis of fractions A2–C5. Three peaks of (A) correspond to a mixture of dimer size band 






 Oligomeric states of Rru-EncFtnSH 
3.3.1 Rru-EncFtnSH purified from MM ± Fe(II) 
Figure 3.3.1
 
Figure 3.3.1 Overlay of SEC chromatograms of Rru-EncFtnSH purified from MM with 
and without Fe(NH4)2(SO4)2. 
Rru-EncFtnSH purified from MM ± Fe(II) displayed two major chromatographic peaks in 
different ratios, consistent with the purification profile from LB medium. The higher proportion 
of oligomer in the left peak is seen in the sample purified from MM + Fe(II), suggesting that 
Fe(II) facilitates the oligomerisation of Rru-EncFtnSH. Fractions from two chromatographic 




3.3.2 Determination of Rru-EncFtnSH oligomeric states by SEC-MALS 
. 








Figure 3.3.2 SEC-MALS analysis of Rru-EncFtnSH oligomeric states on a Superdex 200 
10/300 GL column. 
Red solid curve indicates the calculated molecular weight (MW) of Rru-EncFtnSH fractions. 
Black dashed curve indicates A280. (A) Sample Rru-EncFtnSH-FP1 showed two peaks, 
corresponding to 132 kDa and 15 kDa, respectively. (B) Sample Rru-EncFtnSH-FP2 showed 
a decamer peak (126 kDa) and a monomer peak (13 kDa). The molecular weight of the major 
peak (decamer) in FP1 sample was consistent with the theoretic decamer size (133 kDa); the 
MW of major peak (monomer) in FP2 was equivalent to the theoretic monomer size (13 kDa), 
indicating that Rru-EncFtnSH appeared as a mixture of decamer and monomer in solution. 
 
3.3.3 Metal quantification by inductively coupled plasma mass 
spectrometry 
Given the observation that the presence of iron ions in medium affected the protein 
assembly of Rru-EncFtnSH, the iron binding of purified Rru-EncFtnSH was analysed 
by Inductively Coupled Plasma with Mass Spectrometry (ICP-MS). Fractions of 
SeMet-labelled Rru-EncFtnSH purified from SEC were subjected to ICP-MS analysis 
by Dr. Emma Tarrant and Dr. Kevin Waldron (Institute for Cell and Molecular 




elements to different detection limits. Although the measurement of both S and Se by 
ICP-MS are problematic due to the interference of dioxygen (16O2) on 
32S and 40Ar2 
on 80Se; the detection of Se proves to be easier in practice. That is why the SeMet-
labelled Rru-EncFtnSH were used to estimate the protein concentration in ICP-MS 
instead of the native protein. 
The plasmid pET-28a-Rru-EncFtnSH was transformed into methionine auxotrophic E. 
coli B834(DE3) cells, which were incubated in SeMet medium to allow the 
substitution of methionine by the analogue SeMet during protein synthesis. 1 mM 
Fe(NH4)2(SO4)2 was supplemented to the SeMet medium to ensure the iron 
incorporation of Rru-EncFtnSH. The SeMet-labelled Rru-EncFtnSH was then purified 
by IMAC and SEC. The SEC chromatogram along with the SDS-PAGE analysis 
showed results consistent with previous purifications, with a high proportion of 
decamer peak and a low abundance of monomer peak in the presence of iron in the 
SeMet medium (Figure 3.3.3), suggesting that the selenium labelling did not alter the 
assembly of Rru-EncFtnSH. The A315 was also monitored to indicate the higher iron 
content in decamer fractions whereas in monomer fractions the A315 was undetected 
(Bonomi et al. 1996) (Figure 3.3.3). Each fraction was subjected to ICP-MS analysis, 
of which 100 times more iron was detected in the decamer peak fraction than the 
monomer fraction (Figure 3.3.3 A & Table 3.3.1). 
The SeMet incorporation rate was determined as 100% through LC-MS by Dr. David 
Clarke (School of Chemistry, University of Edinburgh). The LC-MS result also 
confirmed that the recombinant Rru-EncFtnSH sequence only contains two 
methionines due to the N-terminal methionine being excised by the methionine 
aminopeptidase in vivo (Frottin et al. 2006). Therefore, the Rru-EncFtnSH 
concentration can be derived as half of the Se concentration detected by ICP-MS. The 
sub-stoichiometric iron binding of Rru-EncFtnSH was deduced based on ICP-MS 






Figure 3.3.3 SEC purification of SeMet-labelled Rru-EncFtnSH with Fe content detected 
by A315 and ICP-MS. 
(A) SEC purification chromatogram of SeMet-labelled Rru-EncFtnSH using HiLoad 16/600 
Superdex 200 pg column. Protein concentration was monitored by A280 (black curve). Fe 
content was detected by A315 (red dashed curve). Blue circles stands for the Fe content of 
each fraction (B3–C5) analysed via ICP-MS by Dr. Emma Tarrant and Dr. Kevin Waldron 
(ICMB, Newcastle University). (B) 18% SDS-PAGE analysis of fractions in (A). The decamer 
fractions displayed two major bands around 13 kDa and 26 kDa as well as a minor band of 
130 kDa in the peak fractions. The monomer fractions present mainly 13 kDa bands, 
correponding to monomeric Rru-EncFtnSH. ICP-MS data coupled with A315 show that Fe 




















Ca Fe Zn Se 
10mer 
66.49 n.d. 6.67 n.d. 24.60 12.30 0.54 
68.29 n.d. 28.41 0.003 124.49 62.25 0.46 
70.09 2.85 93.68 2.43 301.73 150.87 0.62 
71.89 6.85 120.59 3.65 379.76 189.88 0.64 
73.69 1.85 64.41 0.79 240.58 120.29 0.54 
75.49 0.9 21.12 n.d. 101.65 50.82 0.42 
77.29 n.d. 6.21 n.d. 42.63 21.31 0.29 
79.09 0.1 2.43 n.d. 26.54 13.27 0.18 
 80.89 0.95 1.50 n.d. 22.30 11.15 0.14 
 82.69 n.d. 0.20 n.d. 29.20 14.60 0.01 
1mer 
84.49 n.d. 0.10 n.d. 34.94 17.47 0.006 
86.29 n.d. 0.004 n.d. 28.85 14.43 n.d. 
88.09 n.d. n.d. n.d. 17.35 8.67 n.d. 
89.89 n.d. n.d. n.d. 5.54 2.77 n.d. 
91.69 n.d. n.d. n.d. 0.13 0.07 0.21 
Table 3.3.1 ICP-MS data of SeMet-labelled Rru-EncFtnSH fractions purified from SEC. 
Rru-EncFtnSH was purified as a SeMet derivative from E. coli B834(DE3) cells grown in SeMet 
medium supplemented with 1 mM Fe(NH4)2(SO4)2. Fractions from size-exclusion gel filtration 
were collected, acidified and analysed by ICP-MS. Rru-EncFtnSH concentration was 
calculated based on the presence of two SeMet per mature monomer. Samples where the 
element was undetectable are labelled with n.d.. 
 
Taken together, both A315 and ICP-MS results suggested that the decamer and 
monomer of Rru-EncFtnSH differ in iron content. These results merited further 
investigation on questions as follows: (1) can the oligomeric state of Rru-EncFtnSH 
be altered in the presence of different metals in vitro? (2) Does Rru-EncFtnSH have a 
preference for a particular oxidation state of iron? To answer these questions, Rru-





 Structure analysis of Rru-EncFtnSH 
3.4.1 Crystallisation and structure determination of Rru-EncFtnSH 
Rru-EncFtnSH was purified from E. coli BL21(DE3) cells grown in LB medium using 
Q Sepharose AEC to minimise the interference of nickel carried over from an IMAC 
column, followed by SEC purification. The monomer and decamer fractions were 
pooled separately and concentrated to around 11 mg/ml before crystallisation trials 
using commercial kits described in Section 2.5.1. Rru-EncFtnSH crystals were 
initially found in the PEG/Ion-C4 screen solution (Hampton Research), which includes 
0.2 M calcium acetate hydrate (CaAc) and 20% (w/v) PEG 3350. The crystallisation 
of Rru-EncFtnSH was further optimised in a mixture of 14% (w/v) PEG 3350 and 0.15 
M calcium acetate (CaAc) using hanging-drop vapour diffusion. Rod-like crystals of 
0.2–0.3 mm in length formed in around five days; these were then transferred into a 
cryo-protectant solution containing 14% (w/v) PEG 3350, 0.15 M CaAc and 20% (v/v) 
PEG 200, before flash cooling in liquid nitrogen. Both monomer and decamer fractions 
crystallised and diffracted to slightly different resolution limits as 2.0 Å and 2.3 Å, 
respectively, of which the X-ray diffraction datasets of monomer fractions were 
collected at beamline I04 (Diamond Light Source) and used in the structure 
determination for the best data statistics. The structure of Rru-EncFtnSH was 
determined by molecular replacement in space group P 1 21 1, to 2.0 Å resolution, 
using PDB ID: 3K6C as the search model (see Table 3.4.1 for X-ray data collection 
and refinement statistics). All structure figures were generated using PyMOL 1.8 










  Rru-EncFtnSH 
Data collection   
Beamline I04 
Wavelength (Å) 1.73 
Resolution range (Å) 49.63–2.06 (2.10–2.06) 
Space group P 1 21 1 
Unit cell (Å) a 98.18 
                  b  120.53 
                  c  140.3 
              β (°) 95.36 
Total reflections 1,264,922 (41,360) 
Unique reflections 197,873 (8,766) 
Multiplicity 6.4 (4.7) 
Anomalous multiplicity 3.2 (2.6) 
Completeness (%) 99.2 (88.6) 
Anomalous completeness (%) 96.7 (77.2) 
Mean I/sigma(I) 10.6 (1.6) 
Wilson B-factor 26.98 
Rmerge 0.123 (0.790) 
Rmeas 0.147 (0.973) 
CC1/2 0.995 (0.469) 
CC* 0.999 (0.846) 
Image DOI 10.7488/ds/1342  
Refinement  
Rwork 0.171 (0.318) 
Rfree 0.206 (0.345) 
Number of non-hydrogen atoms 23,222 
  macromolecules 22,276 
  ligands 138 
  water 808 
Protein residues 2,703 
RMS(bonds) (Å) 0.012 
RMS(angles) (°) 1.26 
Ramachandran favored (%) 100 
Ramachandran allowed (%) 0 
Ramachandran outliers (%) 0 
Clash score 1.42 
Average B-factor (Å2) 33.9 
  macromolecules 33.8 
  ligands 40.4 
  solvent 36.2 
PDB ID 5DA5  
Table 3.4.1 Rru-EncFtnSH X-ray data collection and refinement statistics. 
Statistics for the highest-resolution shell are shown in parentheses. Friedel mates were 





The crystallographic asymmetric unit contained thirty monomers of Rru-EncFtnSH 
with visible electron density for residues 7–96 in each chain. The protein chains were 
arranged as three identical annular decamers, each with D5 symmetry. The decamer 
has a diameter of 7 nm and thickness of 4 nm. The arrangement of ten monomers in 
alternating orientation forms the decamer of Rru-EncFtnSH, which assembles as a 
pentamer of dimers. Each monomer lies at 45° relative to the vertical central-axis of 
the ring, with the N-termini of alternating subunits capping the center of the ring at 
each end, while the C-termini are arranged around the circumference (Figure 3.4.1 A–
B). The central hole in the ring is 2.5 nm at its widest in the center of the complex, and 
1.5 nm at its narrowest point near the outer surface, although it should be noted that a 
number of residues at the N-terminus are not visible in the crystallographic electron 
density and these may occupy the central channel. The surface of the decamer has 
distinct negatively charged patches, both within the central hole and on the outer 






Figure 3.4.1 Ring-like decamer structure of Rru-EncFtnSH. 
Top view of (A) Rru-EncFtnSH decamer structure is shown in cartoon mode and coloured by 
chain with N-termini reaching the central ring and C-termini stretching towards outer surface. 
Iron ions are shown as red spheres in the dimer interface. Calcium ions are shown in grey 
spheres bound in dimer interfaces or as surface residues. (B) Side view of decameric Rru-
EncFtnSH. (C–E) Electrostatic surface of Rru-EncFtnSH decamer. The solvent accessible 
surface of Rru-EncFtnSH is shown and coloured by electrostatic potential as calculated using 
the APBS plugin in PyMOL (Baker et al. 2001). Negatively charged regions are coloured red 
and positive regions in blue, neutral regions in grey. (C) View of the surface of the Rru-
EncFtnSH decamer looking down the central axis. (D) Orthogonal view of (C). (E) Cutaway 





3.4.2 Rru-EncFtnSH structure analysis 
The Rru-EncFtnSH monomer consists of an N-terminal 310-helix followed by two 4 
nm long antiparallel alpha-helices—α1 (amino acid residues 17–45), α2 (49–76) and 
a shorter 1.4 nm long C-terminal α3 (78–87) (Figure 3.4.2 A); α1 and α2 are arranged 
with their long axes at 158.63° to each other (Figure 3.4.2 B); α3 projects at 114.61° 
to α2.  
Two monomers, arranged in an antiparallel manner, assemble into a FOC interface 
with metal (Fe and Ca) ions bound by negatively charged residues (Figure 3.4.3 C); 
and a non-FOC interface with neutral-charged residues (Figure 3.4.3 D). According 
to PDBePISA analysis (http://www.ebi.ac.uk/msd-srv/prot_int/cgi-bin/piserver) on 
interface interaction (Krissinel & Henrick 2007), there are no sulphide bridges, or 
covalent bonds in the structure. The non-FOC interface is stabilised by 20 hydrogen 
bonds and 14 salt bridges, of which 33% surface area is buried. The FOC interface, 
burying 17% surface area, consists of 10 hydrogen bonds, 8 salt bridges and a number 
of metal ions (Table 3.4.2). One point to be noted is that the PDBePISA server does 
not calculate the contribution of metal binding to FOC interface, indicating that the 
interaction of FOC interface might have been underestimated. The two dimer 
interfaces will be compared later by the disassembly experiment via collision-induced 







Figure 3.4.2 Rru-EncFtnSH structure analysis. 
Rru-EncFtnSH structure is presented in cartoon mode and coloured by chain. (A) Schematic 
representation of the secondary structure of Rru-EncFtnSH monomer. (B) Monomer structure 
of Rru-EncFtnSH. (C) Structure of Rru-EncFtnSH dimer consists of four alpha-helical bundles 
with metal ions bound as red and grey spheres in the interface. (D) Structure of Rru-EncFtnSH 






Figure 3.4.3 Rru-EncFtnSH dimer interfaces. 
(A) Three chains of Rru-EncFtnSH are shown in cartoon mode and coloured by chain with 
bound metal ions shown as spheres. (B) The chain M is shown as surface mode and coloured 
by electrostatic potential as calculated using the APBS plugin in PyMOL with red patch 
indicating negatively-charged residues and blue as positively-charged residues (Baker et al. 
2001). (C) Non-FOC interface: dimer interface without metal binding is rich in hydrophobic 
residues. (D) FOC interface: dimer interface with metal binding in negatively-charged 






Table 3.4.2 Interaction of Rru-EncFtnSH dimer interfaces analysed by PDBePISA. 
Three chains of Rru-EncFtnSH with FOC and non-FOC interfaces were calculated by 
PDBePISA server (Krissinel & Henrick 2007) to estimate the interaction of two types of 
interfaces. The contribution of metal binding to FOC interface was not listed here, leading to 
an underestimation of the FOC interface. 
No. Chain M  Dist. [Å] Chain N No. Chain L  Dist. [Å] Chain M
 1  ARG  22 [HH21]  2.03  ASP  40 [ OD2] 1  ASN  21 [HD21]  1.99  THR  47 [ OG1] 
 2  HIS   9 [ H  ]  2.05  GLN  41 [ OE1]  2  TYR  39 [ HH ]  1.66  GLU  32 [ OE2] 
 3  LYS  16 [ H  ]  2.19  ASP  44 [ OD2]  3  SER  46 [ OG ]  3.82  ASN  21 [ OD1] 
 4  TYR  87 [ HH ]  1.75  GLU  64 [ OE2]  4  THR  47 [ H  ]  2.41  ASN  21 [ OD1] 
 5  PHE  89 [ H  ]  2.25  GLU  71 [ OE1]  5  HIS  65 [ ND1]  3.51  GLU  62 [ OE2] 
 6  THR  90 [ H  ]  2.28  GLU  71 [ OE2]  6  ARG  75 [HH11]  2.36  GLU  50 [ OE2] 
 7  LYS  63 [ HZ3]  2.18  ASP  77 [ OD1]  7  THR  47 [ OG1]  1.92  ASN  21 [HD21] 
 8  ARG  75 [HH21]  2.25  THR  90 [ OG1]  8  GLU  32 [ OE2]  1.75  TYR  39 [ HH ] 
 9  ARG  75 [HH22]  2.18  GLY  92 [ O  ]  9  ASN  21 [ OD1]  2.49  THR  47 [ H  ] 
 10  ARG  75 [HH12]  2.18  GLY  92 [ O  ]  10  GLU  62 [ OE2]  3.62  HIS  65 [ ND1] 
 11  ASP  40 [ OD2]  1.98  ARG  22 [HH21] 
 12  GLN  41 [ OE1]  1.86 HIS   9 [ H  ] 
 13  ASP  44 [ OD2]  2.20 LYS  16 [ H  ] 
 14  GLU  64 [ OE2]  1.85  TYR  87 [ HH ] 
 15  GLU  71 [ OE1]  2.22  PHE  89 [ H  ] 
 16  GLU  71 [ OE2]  2.35  THR  90 [ H  ] 
 17  ASP  77 [ OD1]  1.97  LYS  63 [ HZ2] 
 18  THR  90 [ OG1]  2.09  ARG  75 [HH21] 
 19  GLY  92 [ O  ]  2.03  ARG  75 [HH12] 
 20  GLY  92 [ O  ]  2.28  ARG  75 [HH22]
No. Chain M  Dist. [Å] Chain N No. Chain L  Dist. [Å] Chain M
 1  HIS  23 [ ND1]  3.43  ASP  37 [ OD1] 1  HIS  65 [ ND1]  3.72  GLU  62 [ OE1] 
 2  HIS  23 [ ND1]  2.63  ASP  37 [ OD2]  2  HIS  65 [ ND1]  3.51  GLU  62 [ OE2] 
 3  ARG  22 [ NH2]  3.94  ASP  40 [ OD1]  3  HIS  65 [ NE2]  2.70  GLU  61 [ OE1] 
 4 ARG  22 [ NE ]  3.44  ASP  40 [ OD2]  4  ARG  75 [ NH1]  2.92  GLU  50 [ OE2] 
 5  ARG  22 [ NH2]  2.87  ASP  40 [ OD2]  5  ARG  75 [ NH1]  3.92  GLU  50 [ OE1] 
 6 LYS  63 [ NZ ]  3.07  ASP  77 [ OD1]  6  GLU  62 [ OE1]  3.84  HIS  65 [ ND1] 
 7 LYS  63 [ NZ ]  3.10  ASP  77 [ OD2]  7  GLU  62 [ OE2]  3.62  HIS  65 [ ND1] 
 8  ASP  37 [ OD1]  3.38 HIS  23 [ ND1]  8  GLU  61 [ OE1]  2.68  HIS  65 [ NE2] 
 9  ASP  37 [ OD2]  2.65 HIS  23 [ ND1] 
 10  ASP  40 [ OD1]  3.86  ARG  22 [ NH2] 
 11  ASP  40 [ OD2]  3.36 ARG  22 [ NE ] 
 12  ASP  40 [ OD2]  2.77  ARG  22 [ NH2] 
 13  ASP  77 [ OD1]  2.83  LYS  63 [ NZ ] 










3.4.3 Metal/ligand binding in Rru-EncFtnSH 
The electron density maps of the initial Rru-EncFtnSH model displayed significant 
positive peaks in the mFo-DFc map at the centre of the FOC dimer interface (Figure 
3.4.4). As Rru-EncFtnSH decamerises in the presence of Fe(II), diffraction data were 
collected at the experimentally determined iron absorption K-edge (1.731 Å, 100 K). 
An anomalous difference Fourier map was calculated using these data (Figure 3.4.5). 
 
Figure 3.4.4 Putative metal/ligand-binding sites in Rru-EncFtnSH FOC dimer interface. 
A dimer of Rru-EncFtnSH is shown as sticks and coloured by pink and yellow. (A–B) Wall-
eyed stereo view of metal/ligand-binding sites in Rru-EncFtnSH FOC dimer interface with 
2mFo-DFc electron density superimposed, shown in blue mesh and contoured at 1.0 σ. The 
mFo-DFc map is shown in green mesh and contoured at 4 σ. The NCS averaged anomalous 
map shown in orange mesh and contoured at 20 σ. (C) Metal/ligand binding sites labelled in 
red are from chain M in pink while black labels with a prime symbol correspond to chain L in 
yellow.  
The anomalous difference map showed two peaks between residues E32, E62, H65 
and Y39 of two adjacent monomers with an NCS averaged anomalous peak height 
around 67 σ, and a statistically smaller peak near residues E31, E34 of two 
neighbouring chains with an NCS averaged anomalous peak height of around 45 σ 
(Figure 3.4.4). Modeling metal ions into these peaks and refinement of the anomalous 
scattering parameters allowed us to identify these as two iron ions and a calcium ion, 
respectively. When iron ions were modelled in the E31-E34 positions, the B-factors 
and occupancies failed to be refined to a reasonable range. While ICP-MS data 
indicated that there were negligible amounts of calcium in the purified protein (Table 
3.3.1), the presence of 140 mM calcium acetate in the crystallisation solutions 




and E34 residues might have also coordinated iron or calcium in the crystal structure, 
leading to an averaged smaller anomalous peak. An additional region of asymmetric 
electron density near the di-iron binding site in the mFo-DFc map was modeled as 
glycolic acid (GOA), a breakdown product of the PEG 3350 used for crystallisation 
(Figure 3.4.5). 
 
Figure 3.4.5 Wall-eyed stereo view of the FOC dimer interface of Rru-EncFtnSH. 
Protein residues are shown as sticks with pink and yellow carbons for the different subunits. 
Iron ions are shown as red spheres and calcium ions as grey spheres; and the glycolic acid 
(GOA) is shown with green carbon atoms bridging the di-iron. The 2mFo-DFc electron density 
map is shown as a blue mesh contoured at 1.0 σ. The NCS averaged anomalous map obtained 
from data collected at the Fe K-edge is superimposed as an orange mesh and contoured at 
20 σ. 
3.4.4 Ferroxidase centre (FOC) 
In the FOC dimer interface of Rru-EncFtnSH there is a two-fold symmetrical di-iron 
centre, with two iron ions coordinated by E32, E62, H65 and Y39 from two adjacent 
chains. Each iron is coordinated by one histidine nitrogen (H65) and five carboxyl 
oxygens. Four of these oxygen ligands are supplied by bidentate glutamate carboxyl 
(E32’ from chain L and E62 from chain M). The other one arises from monodentate 
E62’ of chain L. E62 from both chains straddles two iron ions. 
The Fe–Fe distance is 3.5–3.7 Å, Fe–Glu–O distances between 2.3 and 2.5 Å, and Fe–




the di-nuclear ferroxidase center found in ferritin (Bertini et al. 2012). The distance of 
Fe–Tyr39–O is 4.8 Å, which is beyond the classic iron coordination distance (Harding 
et al. 2010). Tyr39 is highly conserved in ferritin family proteins; and is suggested to 
be involved in facilitating  oxidation by acting as a single-electron molecular capacitor 
(Ebrahimi, Hagedoorn & Wilfred R Hagen 2013). 
 
Figure 3.4.6 Ferroxidase centre (FOC) of Rru-EncFtnSH. 
The FOC consists of E32, E62, H65A and Y39 from two adjacent monomers shown in pink 
(chain M) and yellow (chain L) sticks. Glycolic acid (GOA) is highlighted in green carbons 
bound above the di-iron (red spheres). Distances between iron and amino acid residues or the 




Due to experimental limitations it was not possible to differentiate the oxidation state 
of the iron in the FOC. X-ray absorption spectroscopy can be used to study the dynamic 
iron oxidation states in protein crystals (Antonyuk & Hough 2011) and solutions 
(Toussaint et al. 2009); and Mӧssbauer spectroscopy and electron paramagnetic 
resonance (EPR) (Ebrahimi et al. 2012; Bou-Abdallah et al. 2014) can be applied to 
examine the valence state of iron in protein solutions. 
It is interesting to note that both monomer and decamer fractions of Rru-EncFtnSH 
were able to crystallise into an annular decamer structure without any additional iron 
ions in the crystallisation or soaking conditions, indicating that Rru-EncFtnSH 
scavenged even trace amount of iron ions from environment. In our experiments it was 
impossible to get iron-free structures even when iron-free monomer fractions were 
applied. The absence of iron supplementation during protein production or 
crystallisation still gave rise to a fully occupied FOC with di-iron in the final structure, 
implying that the FOC has a very high affinity for iron ions.  
3.4.5 Calcium binding sites 
Apart from iron ions bound in the Rru-EncFtnSH FOC, there are a number of calcium 
ions bound by surface residues (D44, D48, E50, W72, N76 and E91) as no anomalous 
peaks around these surface residues have been detected. The calcium ions coordinated 
in the FOC dimer interface of Rru-EncFtnSH can be categorised into two sites: metal 
ion entry site and metal ion exit site (Figure 3.4.7).  
The metal ion entry site locates at the inner circumference of the decamer structure 
with one Ca(II) per dimer. It is composed of residues E31 and E34 from two chains. 
Ca(II) is bound by four carboxyl oxygens from monodentate E31 and E34 of two 
chains, along with three water molecules. The coordination distances between Ca(II) 
and binding residues, or water are 2.5 ± 0.2 Å. This heptacoordinate geometry is 
common in crystal structures with calcium ions bound (Figure 3.4.7 A) (Katz et al. 
1996). The metal ion exit sites are partially occupied by Ca(II) present at the outer 
circumference of the decamer structure. In Figure 3.4.7 B, two Ca(II) are bound by 
H57, E61 and E64 from both chains in the FOC dimer interface and are 5.2 Å apart. 




and 4.7 Å. It has not escaped our notice that in the asymmetric unit Ca(II) is missing 
in the metal ion exit site of eleven dimers while another two dimers only contain a 
single Ca(II). 
 
Figure 3.4.7 Calcium binding sites in Rru-EncFtnSH FOC dimer interface. 
Ca(II) is shown in grey spheres coordinated by two monomers shown in sticks and coloured 
in yellow and pink. Distances between Ca(II) and binding residues or Ca–Ca are labelled as 
numbers with Å as the unit. (A) Metal ion entry site consists of E31 and E34 from two adjacent 
monomers. Ca(II) is coordinated by three water molecules (red crosses) with grey dashed 
lines linked as well as carboxylate oxygens from E31 and E34 of two chains. (B) Metal ion exit 
site consists of H57, E61 and E64 from both yellow and pink chains coordinating two Ca(II). 
As the FOC is located between the two calcium binding sites, iron has to translocate 
from either metal ion entry site or exit site to the FOC. This implies that the calcium 
binding sites in the crystal structure are very likely to be an alternative iron transition 
site under native conditions. 
To validate the iron binding in metal ion entry/exit sites, efforts have been made to 
increase the anomalous peaks of iron in calcium binding sites by soaking Rru-
EncFtnSH crystals aerobically in cryo-protectant solutions with 1 mM acidic 
Fe(NH4)2(SO4)2 from 2 minutes to 1 hour, and then flash soaking back to cryo-
protectant solutions to remove free iron ions, or without back soaking. However, they 
all failed to increase the occupancy of these sites by iron as would be indicated by 




might be related to the low concentration of iron in aerobic soaking, leading to about 
1.3 iron per monomeric Rru-EncFtnSH, which is insufficient to occupy the metal ion 
entry site, or compete with 140 times more calcium from the crystallisation solution. 
We also observed that with longer iron soak under aerobic conditions, diffraction from 
the crystals decayed rapidly, indicating higher levels of radiation damage from the 
absorbance of X-rays by the additional iron ions in the crystal.  
Rru-EncFtnSH was shown to decamerise in solution in the presence of Co(II), Zn(II) 
or Fe(II) (Figure 3.5.2 and Figure 3.5.4). Co(II) resembles Fe(II) in terms of binding 
geometry and distance in protein structures (Harding et al. 2010) and its ability to form 
dinuclear centres. Attempts have been made to obtain an Rru-EncFtnSH structure with 
Co(II) coordinated instead of Fe(II) by co-crystallising the iron-free monomer 
fractions with CoCl2 or crystal soaking in CoCl2. However, these experiments failed 
to yield a structure with no iron ions bound; or the diffraction resolution was not high 
enough to determine the metal binding in structures. Apart from Co(II), Rru-EncFtnSH 
crystals have also been soaked in Zn(II), of which the metal binding sites were still 
occupied by iron and calcium ions. Collectively, all those observations indicate that 
Rru-EncFtnSH has higher binding affinity towards Fe(II) than any metal of the ions 
tested in our protein assembly experiments (Figure 3.5.2 and Figure 3.5.4). 
3.4.6 Unstructured monomeric Rru-EncFtnSH determined by ion 
mobility mass spectrometry 
Since the monomer structure of Rru-EncFtnSH was not available from X-ray 
crystallography, ion mobility-mass spectrometry (IM-MS) was used to analyse the 
monomer conformation in the gas phase, based on different mobilities in an electric 
field. The IM-MS analysis of the monomeric Rru-EncFtnSH at pH 8.0 revealed that 
the metal-free protein monomer exists in a wide range of charge states (+6 to +16) and 
adopts many conformations in the gas phase with CCSs ranging from 12 nm2 to 26 
nm2 (Figure 3.4.8). These observations are indicative of an unstructured protein with 
little secondary or tertiary structure (Beveridge et al. 2014). Thus, IM-MS studies 
indicate that the monomer is at least partially unstructured and that the higher order 
structure is mediated/stabilized by metal binding, an observation that is in agreement 




forming the FOC in Rru-EncFtnSH, is required to stabilise the 4-helix bundle dimer 
interface, essentially reconstructing the classical ferritin-like fold. Once stabilised, 
these dimers readily associate as pentamers, and the overall assembly adopts the 
decameric ring arrangement observed in the crystal structure. 
 
Figure 3.4.8 Native IM-MS analysis of the apo-Rru-EncFtnSH monomer. 
(A) Mass spectrum of apo-Rru-EncFtnSH monomer acquired from 100 mM ammonium acetate 
pH 8.0 under native MS conditions. The charge state distribution observed is bimodal, with 
peaks corresponding to the 6+ to 15+ charge states of apo-monomer Rru-EncFtnSH (neutral 
average mass 13194.3 Da). (B) left, the arrival time distributions (ion mobility data) of all ions 
in the apo-Rru-EncFtnSH charge state distribution displayed as a greyscale heat map (linear 
intensity scale). (B) right, the arrival time distribution of the 6+ (orange) and 7+ (green) charge 
state (dashed coloured‐box) has been extracted and plotted; the arrival time distributions for 
these ion is shown (ms), along with the calibrated collision cross section,  (nm2). (C) The 
collision cross section of a single monomer unit from the crystal structure of the Fe-loaded 
Rru-EncFtnSH decamer was calculated to be 15.8 nm2 using IMPACT v. 0.9.1. The +8 to +15 
protein charge states have observed CCS between 20–26 nm2, which is significantly higher 
than the calculated CCS for a Rru-EncFtnSH monomer taken from the decameric assembly 
crystal structure (15.8 nm2). The mobility of the +7 charge state displays broad drift-time 
distribution with maximal consistency with CCS of 15.9 and 17.9 nm2. Finally, the +6 charge 
state of Rru-EncFtnSH has mobility consistent with a CCS of 12.3 nm2, indicating a more 
compact / collapsed structure. It is clear from this data that apo-Rru-EncFtnSH exists in several 
gas phase conformations. The range of charge states occupied by the protein (6+ to 15+) and 
the range of CCS in which the protein is observed (12.3 nm2–26 nm2) are both large. In addition, 
many of the charge states observed have higher charge than the theoretical maximal charge 
on spherical globular protein, as determined by the De La Mora relationship (ZR = 0.0778√m; 
for the Rru-EncFtnSH monomer ZR = 8.9) (Fernandez de la Mora 2000). As described by 




3.4.7 Comparison of Rru-EncFtn and a bacterial ferritin 
Rru-EncFtn, as a representative of EncFtn, was compared with a classical ferritin 
PfFtn—a bacterial ferritin from P. furiosus (KEGG ID: PF0742, PDB ID: 2JD7) in 
four aspects: secondary structure, tertiary structure, quaternary structure, as well as 
metal binding sites.  
Although the primary sequence of Rru-EncFtn was only 17% shorter than PfFtn (Tatur 
et al. 2007), an FOC dimer of Rru-EncFtn is equivalent to a monomer of PfFtn as a 
four-helical bundle of ferritin fold (Figure 3.4.9 A/B). The linker connecting α2 and 
α3 of PfFtn was congruent with the start of the C-terminal helix of one Rru-EncFtn 
monomer and the N-terminal 310 helix of the second monomer. The structural 
alignment of the Rru-EncFtnSH FOC dimer with the monomeric PfFtn also revealed 
a striking similarity, indicating that the two families of proteins have essentially the 
same architecture around the di-iron center (Figure 3.4.9 B). When superimposing the 
biological assembly of Rru-EncFtnSH with PfFtn, the central ring of Rru-EncFtnSH 
corresponded to the external surface of PfFtn, while the outer circumference of Rru-
EncFtnSH was congruent with the inner mineralisation surface of PfFtn (Figure 3.4.9 
C). The size of the Rru-EncFtn decamer is 7 nm in contrast with 12 nm for the PfFtn 
24-mer. The alignment of decameric Rru-EncFtnSH and 24-meric PfFtn suggested that 
the FOC of Rru-EncFtnSH is essentially oriented the opposite way in terms of the 






Figure 3.4.9 Structure alignments of Rru-EncFtn and P. furiosus bacterial ferritin (PfFtn).  
(A) Secondary structure overview of a dimer of Rru-EncFtn and a PfFtn (KEGG ID: PF0742, 
PDB ID: 2JD7) monomer (B) Structural alignment of the Rru-EncFtnSH FOC dimer (pink and 
yellow alpha helices in cartoon view; two Fe(III) shown in red spheres; a Ca(II) shown in a 
white sphere) and a PfFtn monomer (green alpha helices in cartoon view; three Fe(III) shown 
in green spheres). The proteins align with a RMSDC of 2.52 Å over α1-α2 residues.  The red 
arrow and dashed rectangle highlight the top view of alignment and indicate the proposed iron 
moving route from the ferroxidase centre to the mineralisation site in the ferritin cage. (C) 
Biological assembly alignment between Rru-EncFtnSH and PfFtn shown in surface and 
cartoon modes. The red dashed rectangle with the red arrow indicates the top view in (B). The 
scale bar indicates the diameter of Rru-EncFtnSH decamer as 7.6 nm and PfFtn 24-mer as 




3.4.8 Alignment of the metal binding sites of Rru-EncFtnSH and a 
bacterial ferritin 
The metal binding site alignment of Rru-EncFtn and PfFtn has been highlighted in 
Figure 3.4.10. The superimposing FOCs of Rru-EncFtnSH and PfFtn presented the 
fact that with respect to the quaternary structure of the proteins, the FOC of Rru-
EncFtn faces in the opposite direction relative to the bacterial ferritin, and is essentially 
inside out regarding the iron storage space (Figure 3.4.9 B and Figure 3.4.10 A). The 
FOC of PfFtn coordinates three iron ions: with FeA and FeB bound in the conserved 
di-iron centre; with a third iron ion, FeC, bound in site C, at 7.5 and 6.3 Å distance to 
FeA and FeB, respectively (Tatur et al. 2007). Site C was suggested to be a weaker 
binding site, a conserved gateway for Fe(II) translocation to the FOC, and likely to be 
the exit site of Fe(III) from the FOC as well (Ebrahimi et al. 2012).  
The alignment of the FOCs of Rru-EncFtnSH and PfFtn revealed the conservation of 
the di-iron centre between these ferritin family proteins. The main difference between 
the two proteins lies in the totally symmetric FOC of Rru-EncFtnSH, which is a 
consequence of its formation at the interface of two monomers; and the asymmetric 
FOC of PfFtn, at the centre of the single-chain four-helix bundle. In the PfFtn residues 
equivalent to H65 of one subunit of Rru-EncFtnSH in the FOC dimer correspond to 
E130 in the FOC of PfFtn, and one of the tyrosine residues (Y39) in the Rru-EncFtnSH 
FOC dimer is absent in the PfFtn (Figure 3.4.10 B). The different coordination 
environments of FeA and FeB in PfFtn gives rise to a stronger binding affinity for iron 
in the FeA site and weaker binding affinities in the FeB and FeC sites (Ebrahimi et al. 
2012). It is postulated that the two iron ions bound in the FOC of Rru-EncFtnSH have 
equivalent binding energies due to the symmetrical FOC. The alignment of metal 
binding sites of two proteins also uncovered a distinct metal binding site in Rru-
EncFtnSH, which bound a calcium ion in the crystal structure (Figure 3.4.10 A, left 
side). The presence of the novel calcium binding site in Rru-EncFtnSH suggested a 
distinct metal ion entry route from classical ferritins. The overlay of the metal ion exit 
site in Rru-EncFtnSH and site C of PfFtn displayed a poor correspondence between 
the two proteins, except for the E61’ of Rru-EncFtnSH, which superimposed on E49 
of PfFtn (Figure 3.4.10 C). This showed the relatively low conservation of the third 




the open structure of Rru-EncFtnSH along with the everted iron storage directionality 
led to the question: how can iron be stored in Rru-EncFtn while iron ions move from 
the inner channel to the outer surface? Is Rru-EncFtnSH catalytically active to catalyse 




metal binding sites in 
the Rru-EncFtnSH 
dimer and the PfFtn 
monomer.  
(A) Metal binding sites 
shown in stick mode with 
Rru-EncFtnSH 
displayed as yellow and 
pink sticks; with the 
PfFtn monomer shown 
in green. The red arrow 
and red dashed 
rectangle are consistent 
with panels B and C in 
Figure 3.4.9, 
highlighting the iron 
storage direction of 
PfFtn. The blue dashed 
rectangle highlights the 
overlay of ferroxidase 
centres. The green 
dashed rectangle 
highlights the 
comparison of non-FOC 
binding sites. (B) Side 
view of blue dashed 
area from (A) with Rru-
EncFtnSH residues 
labelled in black and 
PfFtn residues labelled 
in green. Red spheres 
highlight the two iron 
ions coordinated by the Rru-EncFtnSH FOC including E32, E62, H65 and Y39 from pink chain 
and E32’, E62’, H65’ and Y39’ from yellow chain. Green spheres highlight FeA coordinated by 
E17, E50 and H53 of PfFtn; with FeB coordinated by E50, E94, E130. Q127 coordinates both 
FeA and FeB at 3.7 Å (Tatur et al. 2007). (C) Side view of green dashed area from (A). White 
spheres highlight two Ca(II) coordinated in the Rru-EncFtnSH dimer interface by H57, E61 
and E64 from the pink chain and H57’, E61’ and E64’ from yellow chain. The green sphere 
highlights the third iron ion (FeC) binding site E49, E126, E129 and E130 in PfFtn, among 
which only E49 is conserved between PfFtn and Rru-EncFtnSH (E61’). (A) and (B) suggest 
the conservation of ferroxidase centre between Rru-EncFtnSH and PfFtn. (A) also delineates 
a Ca(II) bound at the entry site (E31, E34, E31’ and E34’) in Rru-EncFtnSH, which does not 




 Assembly and disassembly of Rru-EncFtnSH 
3.5.1  
To quantify the Rru-EncFtnSH oligomerisation in the presence of Fe(II) in vitro, nano-
electrospray ionisation mass spectrometry (nESI-MS, or native MS) was performed by 
Sam Huges and Dr. David Clarke (School of Chemistry, The University of Edinburgh). 
50 µM Rru-EncFtnSH monomer fractions in 100 mM NH4 Acetate buffer (pH 8.0) 
were mixed with FeCl2 at various concentrations prior to nESI-MS analysis. nESI-MS 
allows the measurement of the molecular weight of native proteins without disturbing 
protein assembly (Konijnenberg et al. 2013).  
 
Figure 3.5.1 Native mass spectrometry and ion mobility analysis of iron loading in Rru-
EncFtnSH. 
All spectra were acquired in 100 mM ammonium acetate, pH 8.0 with a protein concentration 
of 50 μM. (A) Native nanoelectrospray ionization (nESI) mass spectrometry of Rru-EncFtnSH 
at varying iron concentrations. A-I, nESI spectrum of iron-free Rru-EncFtnSH displays a 
charge state distribution consistent with Rru-EncFtnSH monomer (blue circles, 13,194 Da). 
Addition of 100 μM (A-II) and 300 μM (A-III) Fe(II) results in the appearance of a second higher 
molecular weight charge state distribution consistent with a decameric assembly of Rru-
EncFtnSH (green circles, 132.6 kDa). (B) Ion mobility (IM)-MS of the iron-bound holo-Rru-
EncFtnSH decamer. Top, Peaks corresponding to the +22 to +26 charge states of a homo-
decameric assembly of Rru-EncFtnSH are observed (132.6 kDa). Top Insert, Analysis of the 
24+ charge state of the assembly at m/z 5528.2 Th. The theoretical average m/z of the 24+ 
charge state with no addition metals bound is marked by a red line (5498.7 Th); the observed 
m/z of the 24+ charge state indicates that the Rru-EncFtnSH assembly binds between 10 
(green line, 5521.1 Th) and 15 Fe ions (blue line, 5532.4 Th) per decamer. Bottom, the arrival 
time distributions (ion mobility data) of all ions in the Rru-EncFtnSH charge state distribution 
displayed as a greyscale heat map (linear intensity scale). Bottom right, the arrival time 
distribution of the 24+ charge state (dashed blue box) has been extracted and plotted. The 





In Figure 3.5.1 A, the mass to charge ratio of the monomeric Rru-EncFtnSH are 
plotted, showing the charge state distribution of the protein sample. The charge states 
from 12+ to 6+ correspond to 13.194 kDa, consistent with theoretical monomer size 
of 13.19453 kDa. Under these conditions, no significant higher order assembly was 
observed in the monomeric Rru-EncFtnSH and the protein did not have any 
coordinated metal ions. Titration with Fe(II) directly before native MS analysis 
resulted in the appearance of a new charge state distribution, consistent with an Rru-
EncFtnSH decameric assembly (+22 to +26; 132.65 kDa) (Figure 3.5.1 A II–III). 
After instrument optimisation, the mass resolving power achieved was sufficient to 
assign iron-loading in the complex to 10–15 iron ions per decamer (Figure 3.5.1 B, 
inset top right), consistent with the presence of 10 iron ions in the FOC and the 
coordination of iron in the E31/34-site (metal ion entry site) occupied by calcium in 
the crystal structure (Δmass ~0.67 kDa). MS analysis of Rru-EncFtnSH after addition 
of further Fe(II) did not result in iron loading higher than this stoichiometry. These 
data suggest that the decameric assembly of Rru-EncFtnSH does not accrue iron in the 
same manner as classical ferritin, which is able to sequester more than 4000 iron ions 
within its nanocage (Mann et al. 1986).  
Ion mobility-mass spectrometry (IM-MS), using a Travelling Wave Ion Mobility 
(Triwave) system from Waters Synapt instruments, separates molecules based on size 
and shape in addition to the measurement of mass to charge ratios. IM-MS 
characterises a molecular structure by estimating the collision cross section values 
(CCS) (Kanu et al. 2008). IM-MS analysis of the Rru-EncFtnSH decameric assembly, 
collected with minimal collisional activation, suggested that it consists of a single 
conformation with a CCS of 58.2 nm2 (Figure 3.5.1 B). The CCS can also be 
calculated as 58.7 nm2 using the ‘IMPACT’ tool based on the crystal structure of Rru-
EncFtnSH (Marklund et al. 2015), which is in agreement with the IM-MS result. 
Rru-EncFtnSH bound up to fifteen iron ions per decamer as suggested by native mass 
spectrometry, whereas the crystal structure displayed ten iron ions in the five FOCs, 
five Ca(II) in metal entry site and a number of Ca(II) bound by surface residues. The 
discrepancy between this iron loading experiment and the MS and crystallographic 




a subset of these may be those that are occupied by the calcium ions in the crystal 
structure.  
3.5.2 Metal-dependent assembly of Rru-EncFtnSH 
Since metalloproteins are able to bind metal ions in various affinities as suggested by 
the Irving-William series (Waldron & Robinson 2009), the possibility that the 
assembly of Rru-EncFtnSH is influenced by various metals was investigated. Native 
PAGE and analytical gel-filtration were used to evaluate protein oligomerisation in the 
presence of divalent metal ions. To further differentiate the protein preference for 
ferric or ferrous iron, solutions of iron salts in the different oxidation states were 
employed in these experiments.  
3.5.2.1 Native PAGE 
Rru-EncFtnSH monomer and decamer fractions were separately pooled from MM 
purification and titrated with equimolar concentrations of metal ions for 2–3 hrs before 
being subjected to native PAGE (Figure 3.5.2 A–B) and SDS-PAGE analysis (Figure 
3.5.2 C–D). Native PAGE separates proteins based on charge to mass ratio. Compared 
to the monomer sample without metal ions, bands of higher mass-charge ratio were 
visible on the native PAGE gel in the presence of Fe(II), Co(II), Zn(II) or Mn(II) at 
1:1 molar ratio (Figure 3.5.2 A), of which only the titration of Fe(II) led to stable 
decamer and dimer bands when subjected to SDS-PAGE (Figure 3.5.2 C). By contrast, 
the effect of Ca(II), Mg(II) or Fe(III) supplementation on Rru-EncFtnSH 
decamerisation was minimal at equimolar ratio (Figure 3.5.2 A). The addition of metal 
to the Rru-EncFtnSH decamer did not show significant changes in the assembly by 
native PAGE (Figure 3.5.2 B). There was a faint band around 60 kDa on SDS-PAGE 
(Figure 3.5.2 D) when Ca(II) was loaded to equal molar Rru-EncFtnSH decamer, 
suggesting that Ca(II) could contribute to its stability of Rru-EncFtnSH to a certain 
degree (Figure 3.5.2 D). It also confirms the Ca(II) binding in metal ion entry site of 
Rru-EncFtnSH structure. 
These results revealed that Rru-EncFtnSH binds to Fe(II), Co(II), Zn(II) and Mn(II) at 
equimolar concentrations to produce species consistent with the formation of a 




complexes of the monomer; however, these results do not eliminate the possibility that 
the multimerisation of Rru-EncFtnSH can be induced by higher concentrations of these 
metals. 
 
Figure 3.5.2 PAGE analysis of the effect of metal ions on the oligomeric state of Rru-
EncFtnSH.  
50 µM Rru-EncFtnSH monomer fractions (Rru-EncFtnSH-1mer) or decamer (Rru-EncFtnSH-
10mer) samples were mixed with equal molar metal ions including Fe(II), Co(II), Zn(II), Mn(II), 
Ca(II), Mg(II) and Fe(III), which were analysed by Native PAGE alongside SDS-PAGE. (A) 10% 
Native PAGE analysis of Rru-EncFtnSH monomer fractions mixed with various metal solutions; 
(B) 10% Native PAGE analysis of Rru-EncFtnSH decamer fractions mixed with various metal 
solutions; (C) 15% SDS-PAGE analysis on the mixtures of Rru-EncFtnSH monomer fractions 
and metal solutions; (D) 15% SDS-PAGE analysis on the mixtures of Rru-EncFtnSH decamer 




3.5.2.2 Analytical Gel-filtration 
In order to validate the influence of metal binding on protein assembly as indicated by 
Native PAGE and SDS-PAGE, the metal titration experiment was performed using 
Rru-EncFtnSH monomer fractions at 90 µM with subsequent analysis by analytical 
gel-filtration (AGF) chromatography using Superdex 200 PC 3.2/30 column (Figure 
3.5.4). To assess the possibility that protein multimerisation was affected by the 
protein concentration AGF was performed at 90 and 700 µM protein concentration 
(Figure 3.5.3). The slight shift in the main chromatographic peak is consistent with 
the dimerisation of Rru-EncFtnSH, however the relative proportions of the two peaks 
seen do not change. This indicates that while the monomer/dimer equilibrium is 
influenced by protein concentration the formation of Rru-EncFtnSH decamer is not 
influence by protein concentration. 
 
Figure 3.5.3 Concentration-dependent Rru-EncFtnSH assembly analysed by AGF using 
Superdex 200 PC 3.2/30 column. 
700 µM Rru-EncFtnSH monomer fractions had been diluted into 90 µM in GF buffer; both 
samples were resolved by AGF with the left y-axis demonstrating the 90 µM protein while the 
right y-axis highlighting the 700 µM protein. The chromatogram comparison shows that Rru-
EncFtnSH monomer peak shifted towards dimer at the higher concentration, suggesting the 
concentration-dependent protein equilibrium between dimer and monomer states. 
This ‘metal loading-AGF’ experiment was performed over three consecutive days, so 
the protein monomer was run each day as a control to demonstrate the influence of 
time-dependent protein oligomerisation. The AGF results showed that Rru-EncFtnSH 
tends to equilibrate between monomer and decamer; and forms higher-order 




Fe(II), Co(II) or Zn(II) to monomeric Rru-EncFtnSH induces the formation of protein 
decamers; while the addition of Fe(III), Ca(II) and Mg(II) has little effect on protein 
assembly. However, AGF results disagreed with native PAGE data with respect to the 
minimal impact of Mn(II) on Rru-EncFtnSH assembly. More experiments need to be 
done to confirm the Mn(II) effect on the protein assembly as well as how metal to 
protein loading ratios alter the assembly. 
 
Figure 3.5.4 Analytical gel-filtration analysis on metal ions affecting the oligomeric 
states of Rru-EncFtnSH in solution. 
90 µM Rru-EncFtnSH monomer fractions (73sH-1mer) were mixed with molar equivalent metal 
ion at room temperature for 2 hrs prior to analytical gel-filtration analysis. These metal 
solutions were freshly prepared including FeSO4 in 0.1% (v/v) HCl, Fe(NH4)2(SO4)2, CoCl2, 
MnCl2, ZnSO4, CaAc, MgSO4 and FeCl3. 90 µM Rru-EncFtnSH decamer fractions (73sH-
10mer) were analysed via AGF as a control. Black arrows pointing to the void volume suggest 
the aggregate formed in protein samples. (A) suggests that Rru-EncFtnSH decamerises in the 
presence of Fe(II). (B) highlights the decamerisation effect of Co(II) and Zn(II), while Fe(III) 
and Mn(II) could not decamerise Rru-EncFtnSH as an equal molar addition. (C) Ca(II) and 
Mg(II) had no effects on Rru-EncFtnSH decamerisation.  This AGF experiment has been 
repeated twice using different batches of proteins, which has generated the similar pattern. 




3.5.3 Disassembly of Rru-EncFtnSH by collision-induced dissociation 
(CID) tandem mass spectrometry 
The gas phase disassembly of the decameric Rru-EncFtnSH was performed using 
collision-induced dissociation (CID) tandem mass spectrometry (CID-TMS). Under 
the correct CID conditions, protein assemblies can dissociate with retention of subunit 
and ligand interactions, and thus provide structurally-informative evidence as to the 
topology of the original assembly; this has been termed ‘atypical’ dissociation (Hall et 
al. 2013). For Rru-EncFtnSH, this atypical dissociation pathway was clearly evident; 
CID of the Rru-EncFtnSH decamer resulted in the appearance of a dimeric Rru-
EncFtnSH subcomplex containing 0, 1, or 2 iron ions (Figure 3.5.5). In light of the 
crystal structure, this observation can be rationalised as dissociation of the Rru-
EncFtnSH decamer by disruption of the non-FOC interface with at least partial 
retention of the FOC interface and the FOC-Fe.  
The CID-TMS experiment provided an added-value to the PDBePISA server analysis 
of dimer interface interaction, revealing that FOC dimer interface is more stable than 
the non-FOC dimer interface because of the iron binding. This observation also 
supports the crystallographic assignment of the overall topology of Rru-EncFtnSH 
structure as a pentameric assembly of dimers with two iron ions located at the FOC 
dimer interface. In addition, this analysis provides evidence that the overall 
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dissociation of the holo-Rru-EncFtnSH decamer primarily occurred via ejection of a highly 
charged monomer (blue circles), leaving the ‘stripped’ complex (a 9mer; 118.7 kDa; yellow 
circles). The mass of the ejected-monomer is consistent with apo-Rru-EncFtnSH (13.2 kDa), 
suggesting unfolding of the monomer (and loss of Fe) occurs during ejection from the complex. 
This observation of asymmetric charge partitioning of the sub-complexes with respect to the 
mass of the complex is consistent with the “typical” pathway of dissociation of protein 
assemblies by CID (Hall et al. 2013). In addition, a third, lower abundance, charge state 
distribution is observed which overlaps the Rru-EncFtnSH ejected monomer charge state 
distribution; this region of the spectrum is highlighted in (B). This distribution is consistent with 
an ejected Rru-EncFtnSH dimer (orange circles). Interestingly, closer analysis of the individual 
charge state of this dimeric CID product shows that this sub-complex exists in three forms – 
displaying mass consistent with an Rru-EncFtnSH dimer binding 0, 1, and 2 Fe ions. This is 
highlighted in (C), where the 15+ charge state of the Rru-EncFtnSH dimer is shown; three 
peaks are observed with m/z 1760.5, 1763.8, and 1767.0 Th—the lowest peak corresponds 
to neutral masses of 26392.5 Da [predicted Rru-EncFtnSH dimer, (C572H884N172O185S2)2—
26388.6 Da]. The two further peaks have a delta-mass of ~+50 Da, consistent with Fe binding. 
These are observed as partial ‘atypical’ CID fragmentation of the decameric complex—i.e. 
fragmentation of the initial complex with retention of subunit and ligand interactions. A 
schematic summary of these results is displayed in (D). The high stability of this iron-bound 
dimer sub-complex is largely dependent on the metal coordination at the dimer interface, 
increasing the strength of the dimer interface. Taken together, these observations support our 
findings that the topology of the decameric Rru-EncFtnSH assembly is arranged as a 




 Summary and discussion 
Recombinant Rru-EncFtnSH existed as both monomer and decamer in solution; and 
these different forms of the protein differed in the amount of iron associated with the 
protein. Both monomer and decamer fractions crystallised into an annular decamer 
structure with an FOC dimer interface that coordinated di-iron in the FOC and calcium 
in metal ion entry/exit sites, as well as non-FOC dimer interface without metal binding. 
Iron ions were able to induce the decamerisation of Rru-EncFtnSH based on the iron 
supplementation to protein or medium. Analytical gel-filtration and native PAGE 
experiments confirmed that Fe(II) rather than Fe(III) induced the assembly of Rru-
EncFtnSH, suggesting the high binding specificity of Rru-EncFtnSH towards Fe(II). 
Further metal titration experiments showed that Co(II) and Zn(II) were also able to 
induce the decamerisation of Rru-EncFtnSH possibly due to the similar coordination 
environment with iron ion. The Fe(II) titration into monomeric Rru-EncFtnSH 
instantly followed by nESI-MS experiment, only showed the decreasing monomer and 
increasing decamer. The absence of dimer from the MS spectra suggested that the 
formation of FOC dimer is rate-determining step. The IM-MS experiment indicated 
that the Rru-EncFtn monomer was partially-unstructured while the decamer was a 
compact structure with mainly -helical character. CID-TMS disassembly 
experiments indicated that the FOC dimer interface was more stable than non-FOC 
interface.  
Apart from the influence of metals on Rru-EncFtnSH assembly, Rru-EncFtnSH also 
displayed time-dependent equilibrium between monomer and decamer. The 
concentration-dependent shift of oligomeric state has only been observed between 
monomer and dimer. Given that no metal was supplemented, it was very likely that 
the high concentration favours the formation of non-FOC dimer; or the protein was 
soaking up trace metal from the solution in a very slow rate. 
Taken together, it was postulated that under physiological conditions Rru-EncFtnSH 
assembled from monomer to FOC dimer due to the presence of Fe(II); once assembled, 
a pentamer of FOC dimers formed a ring-like decamer structure. It was also possible 
that the monomeric fractions, at high concentration during crystallisation, formed non-




was formed, the decamer was assembled alongside the occupation of the metal ion 




4 Chapter 4 Structures of R. rubrum EncFtn mutants 
 Introduction 
The crystal structure of Rru-EncFtnSH revealed three metal binding sites: FOC (E32, 
E62, H65, Y39), metal ion entry site (E31, E34) and metal ion exit site (H57, E61 and 
E64). To understand how these metal binding sites influenced the structure, assembly, 
and biochemistry of Rru-EncFtnSH, several point mutants in the FOC and metal ion 
entry site were designed based on residues coordinating the bound metal ions. These 
mutants were constructed in the pET-28a-Rru-EncFtnSH and pACYCDuet-1-Rru-
EncFtn-Rru-Enc expression vectors. The Rru-EncFtnSH mutants were heterologously 
expressed in E. coli BL21(DE3) for studies on protein structure, assembly and 
biochemistry. The co-expressed Rru-EncFtn and Rru-Enc mutants were also generated 
for biochemical studies; however, these will be investigated in future work. 
The FOC mutants include single mutations: E32A, E62A, H65A; double mutation: 
E32A-E62A; and triple mutation: E32A-E62A-H65A (3A). Single mutations, E32D 
and E62D, were also constructed to determine the metal binding specificity of the FOC 
as these mutants would provide more space for metal association due to the shorter 
side chain of aspartic acid residue than the glutamic acid residue. The metal ion entry 
site mutants include E31A and E34A. The side chain of W38 was not seen in the 
electron density map of the Rru-EncFtnSH WT structure possibly due to its flexibility. 
Since W38 is involved in the FOC dimer interface and is spatially close to E34, it is 
very interesting to understand how the mutation of W38 affects the protein assembly. 
Therefore, a single mutation W38G, double mutation E31A-W38G and triple mutation 
W38G-E31A-E34A (WEE) were prepared for protein assembly study. In this chapter, 
the assembly of Rru-EncFtnSH with FOC mutations was also studied to reveal how 




 Purification and crystallisation of Rru-EncFtnSH mutants 
All pET-28a-Rru-EncFtnSH based mutants were purified from E. coli cells grown in 
LB medium by IMAC and SEC, followed by crystallisation using methods described 
in Section 2.5.  
4.2.1 Purification of Rru-EncFtnSH based FOC mutants 
In Figure 4.2.1, the SEC chromatograms of Rru-EncFtnSH bearing single FOC 
mutations, E32A and E62A, displayed a decamer peak, while the H65A mutant 
displayed a monomer peak, indicating that the H65A mutation disrupted the formation 
of the Rru-EncFtnSH decamer. The single mutant E62D displayed a major decamer 
peak while E32D showed a monomer peak. Both double mutation E32A-E62A and 
triple mutation E32A-E62A-H65A displayed a broader chromatographic peak, 
suggesting that both mutants destabilised Rru-EncFtnSH decamer assembly. SDS-
PAGE analysis of the purified E32A, E62A and E62D proteins displayed a monomer 
and a dimer band (Figure 4.2.2 A/D/E), which was reminiscent of the wild-type 
purification from LB medium or MM + Fe(II). This results suggest that E32A, E62A 
and E62D mutants did not significantly disrupt the protein assembly. Other mutants 
including E32D, H65A, E32A-E62A and E32A-E62A-H65A displayed a monomer 
band on SDS-PAGE (Figure 4.2.2 B/C/F/G), which was consistent with the SEC 
purification chromatograms and thus suggested that these four mutants have disrupted 
the formation of the decameric form of Rru-EncFtnSH. It is worth pointing out that 
the intensity of the dimer sized bands of these mutants were much lower than the 
counterparts of WT (Figure 3.2.6); this observation can be explained by the weakened 







Figure 4.2.1 Size exclusion chromatograms of Rru-EncFtnSH FOC mutants purified 
from LB medium using HiLoad 16/600 Superdex 200 pg column. 
FOC mutants including single mutations E32A, E32D, H65A, E62A, E62D, double mutation 
E32A-E65A and triple mutation E32A-E62A-H65A were purified through an S200 gel-filtration 
column. The red vertical lines highlight the peak position of WT decamer while the grey vertical 
lines highlight the position of WT monomer. Peak fractions were labelled as retention volume 
(ml) and analysed by SDS-PAGE in Figure 4.2.2. E32A, E62A and E62D display a major peak 
close to the WT decamer while E32D and H65A display a major peak close to the WT 
monomer. Double mutation E32A-E62A and triple mutation E32A-E62A-H65A display a 
broader chromatographic peak between WT decamer and monomer peak. The 
chromatographic observations suggest that E32A, E62A and E62D largely have kept the 
protein decamer assembly; E32D and H65A totally destablise the protein assembly, E32A-





Figure 4.2.2 SDS-PAGE analysis of Rru-EncFtnSH FOC mutants purified via a SEC 
HiLoad 16/600 Superdex 200 pg column. 
Peak fractions from SEC purified Rru-EncFtnSH mutants were subjected to 15% or 18% SDS-
PAGE analysis: (A) E32A, (B) E32D, (C) H65A, (D) E62A, (E) E62D, (F) E32A-E62A and (G) 
E32A-E62A-H65A. E32A, E62A, E62D display two major bands on SDS-PAGE gels, 
corresponding to the monomer and dimer size of the mutants. E32D, H65A and double 




4.2.2 Mutants of Rru-EncFtnSH metal ion entry site  
Four mutants of Rru-EncFtnSH were constructed in the metal ion entry site, including 
single mutations: E31A, E34A, W38G; and triple mutation: E31A-E34A-W38G. 
These variants of Rru-EncFtnSH were purified by IMAC and SEC, followed by SDS-
PAGE analysis. The SEC chromatograms of four mutants all displayed a major 
decamer peak (Figure 4.2.3). The SDS-PAGE analysis of E31A and E34A mutants 
showed a mixture of monomer and dimer bands, in analogy to the wild-type protein. 
However, W38G and triple mutation E31A-E34A-W38G displayed only a monomer 
band. The peak fraction (B7) in the W38G SEC chromatogram showed a weak 
decamer-sized band aside from the monomer band. Therefore, it can be summarised 
that the single alanine mutation of E31 or E34 does not affect the protein assembly 
while the glycine mutation of W38—an FOC-dimer interfacing residue destablised the 
Rru-EncFtnSH assembly. The disassembly effect of W38G mutation has been 






Figure 4.2.3 Size exclusion gel-filtration purification of Rru-EncFtnSH entry site mutants 
using HiLoad 16/600 Superdex 200 pg column. 
(A) Chromatograms of Rru-EncFtnSH-E31A, E34A, W38G and triple mutation E31A-E34A-
W38G subjected to SEC are shown. The red vertical lines highlight the peak position of WT 
decamer while the grey vertical lines highlight the position of WT monomer. All of these 
chromatograms display a major decamer peak and a minor monomer peak, suggesting that 
these mutants appear not to affect the protein stability. Fractions from the SEC peaks were 
subjected to 15% SDS-PAGE analysis. (B) E31A, (C) E34A, (D) W38G and (E) E31A-E34A-
W38G. The SDS-PAGE analysis of E31A and E34A mutants show at least two major bands, 
corresponding to monomer and dimer. The W38G and triple mutation E31A-E34A-W38G both 
display a major single band around monomer size. These results suggest that the single 
mutations E31A and E34A does not alter the protein assembly, while the W38G mutation 




4.2.3 Crystallisation results of Rru-EncFtnSH mutants 
All of the Rru-EncFtnSH mutants purified from LB medium were concentrated to 
around 10 mg/ml and were crystallised under similar conditions to the wild-type 
protein, with the exception of double mutation E32A-E62A and triple mutation E32A-
E62A-H65A, which crystallised from PEG 3350 with magnesium formate rather than 
calcium acetate (Table 4.2.1). Images of the crystals formed by these proteins are 
shown in Figure 4.2.4. X-ray data of all mutants have been collected without iron 
soaking except for E62D and E34A mutants. X-ray diffraction data from each of the 
crystals were collected at the 10–100 eV above the experimentally determined Fe-Kα 
edge, except the 3A mutant (E32A-E62A-H65A), which was collected at 1.5 Å. The 
structures of each of the mutants were determined, except for W38G and W38G-
E31A-E34A (WEE). The W38G crystal displayed poor quality of diffraction and thus 
was not refined. Although the WEE crystal diffracted up to 2.6 Å, the poor diffraction 
quality and crystal defects including twinning and multiple lattices have prevented the 
unambiguous assignment of the space group; hence this data were not refined further.  
 
Figure 4.2.4 Crystal images of Rru-EncFtnSH mutants. 















Crystallisation conditions Cryo-protectant 
Single mutation 
FOC 
E32A 2.74 Å P 1 21 1 
14% (w/v) PEG 3350 + 0.14 M 
CaAc 
14% (w/v) PEG 3350 + 0.14 M CaAc + 20% 
(v/v) PEG 200 
E62A 2.34 Å P 1 21 1 
15% (w/v) PEG 3350 + 0.13 M 
CaAc 
15% (w/v) PEG 3350 + 0.13 M CaAc + 20% 
(v/v) PEG 200 + 1 mM acidic FeSO4 
E32D 2.27 Å P 1 21 1 
14% (w/v) PEG 3350 + 0.14 M 
CaAc 
14% (w/v) PEG 3350 + 0.14 M CaAc + 20% 
(v/v) PEG 200 
E62D 2.50 Å P 1 21 1 
15% (w/v) PEG 3350 + 0.13 M 
CaAc 
15% (w/v) PEG 3350 + 0.13 M CaAc + 20% 
(v/v) PEG 200+ 1mM acidic FeSO4 
H65A 2.97 Å P 1 21 1 
15% (w/v) PEG 3350 + 0.15 M 
CaAc 
15% (w/v) PEG 3350 + 0.15 M CaAc + 20% 
(v/v) PEG 200 
Metal ion 
entry site 
E31A 2.75 Å P 1 21 1 
15% (w/v) PEG 3350 + 0.1 5M 
CaAc 
15% (w/v) PEG 3350 + 0.1 5M CaAc + 20% 
(v/v) PEG 200 
E34A 2.19 Å P 1 21 1 
15% (w/v) PEG 3350 + 0.14 M 
CaAc 
15% (w/v) PEG 3350 + 0.14 M CaAc + 20% 
(v/v) PEG 200 + 50 mM Tris-HCl (pH 8.5) + 1 
mM acidic FeSO4 
W38G 3.32 Å P 1 21 1 
15% (w/v) PEG 3350 + 0.13 M 
CaAc 
15% (w/v) PEG 3350 + 0.13 M CaAc + 20% 
(v/v) PEG 200 
Double 
mutation 
FOC E32A-E62A 2.10 Å C 1 2 1 
0.2 M Magnesium formate + 
18% (w/v) PEG 3350 
0.2 M Magnesium formate + 18% (w/v) PEG 
3350 + 17% (v/v) PEG 200 
Triple mutation 
FOC E32A-E62A-H65A 2.20 Å P 41 21 2 
0.2 M Magnesium formate + 
20% (w/v) PEG 3350 
0.2 M Magnesium formate + 20% (w/v) PEG 
3350 + 15% (v/v) PEG 200 
Metal ion 
entry site 
W38G-E31A-E34A 2.64 Å P 41 21 2 
13% (w/v) PEG 3350 + 0.14 M 
CaAc 
13% (w/v) PEG 3350 + 0.14 M CaAc + 20% 
(v/v) PEG 200 
Table 4.2.1 Crystallisation results of Rru-EncFtnSH mutants. 
The crystallisation related solutions are diluted from stock solutions, which includes 50% (w/v) PEG 3350, 100% (v/v) PEG 200, 1 M CaAc, 1 M magnesium 





 Assembly of FOC mutants 
4.3.1 FOC mutants purified from MM ± Fe(II) 
E32A, E62A, H65A and E32A-E62A-H65A (3A) were produced in E. coli cells grown 
in 1 litre minimal medium with or without Fe(II) and purified by IMAC and SEC. The 
size exclusion chromatograms are displayed in Figure 4.3.1. The E32A and E62A 
mutants eluted at a volume consistent with the decameric form of Rru-EncFtnSH, with 
a small proportion of monomer; the H65A mutant eluted at a volume consistent with 
the monomeric form of Rru-EncFtnSH. For the three single mutations of FOC studied, 
no change in oligomerisation states was observed upon addition of Fe(II) in the MM. 
These results suggest that the Fe(II)-dependent assembly of Rru-EncFtnSH was 
compromised by single mutations of FOC.  
Interestingly, triple mutation E32A-E62A-H65A purified from 1 litre of MM ± Fe(II) 
showed an enhanced quantity of protein when compared to the other mutants, as well 
as chromatogram shifts toward higher oligomers compared to other three single 
mutations. The addition of Fe(II) in the MM of E32A-E62A-H65A led to a broader 
chromatographic peak, which may indicate some higher-order oligomer formation; or 
the enhanced production of protein in these growth conditions may have led to peak 





Figure 4.3.1 Size exclusion chromatograms of Rru-EncFtnSH FOC mutants purified 
from MM ± Fe(II) using HiLoad 16/600 Superdex 200 pg column.  
Rru-EncFtnSH single mutations E32A, E62A, and H65A were produced from E. coli BL21(DE3) 
cells grown in MM or MM supplemented with Fe(II) were subjected to SEC. (A) 
Chromatograms of the E32A mutant purified from MM ± Fe(II) display a majority of the protein 
eluting as the decameric form of the protein and a small proportion of monomer. (B) Purified 
E62A mutant resulted in an elution profile with a major decameric peak. (C) Gel-filtration of 
the H65A mutant resulted in a single chromatographic peak corresponding to the monomer. 
(D) Gel-filtration of the triple mutation E32A-E62A-H65A (or 3A) purified from MM resulted in 
a major broad peak across several oligomeric states while the Fe(II) addition to the MM led to 




4.3.2 The assembly of FOC mutants determined by native mass 
spectrometry 
The major peak fractions of each mutant purified from MM were pooled and subjected 
to nESI-MS (or native mass spectrometry) analysis by Dr. David Clarke and Sam 
Huges (School of Chemistry, University of Edinburgh). The results were compared 
with the wild-type apo-Rru-EncFtnSH protein (Figure 4.3.2). According to our earlier 
results (Figure 3.4.8), the apo-Rru-EncFtnSH has a charge state distribution consistent 
with an unstructured monomer, and decamer formation is only initiated upon addition 
of ferrous iron. Both the E32A mutant and E62A mutant displayed charge state 
distributions consistent with decamers, even in the absence of Fe(II). This gas-phase 
observation is consistent with SEC measurements, which indicates both of these 
variants were also decamers in solution. Thus it appears that single mutation E32A or 
E62A allows the decamer assembly in the absence of iron in the FOC. In contrast to 
the glutamic acid mutants, MS analysis of the H65A mutant is similar to wild-type 
apo-Rru-EncFtnSH and is present as a monomer; interestingly a minor population of 
dimeric H65A was also observed. The triple mutation E32A-E62A-H65A, while 
showing primarily low-order assemblies in solution, displayed peaks consistent with 
decamer (10mer) and dodecamer (12mer) formation in the gas phase. The observation 
of the dodecamer has been reproducible, suggesting that instead of being an artefact 
the dodecamer of E32A-E62A-H65A could be a structural reassembly in gas phase or 
a random dimer attachment to the decamer ring structure. 
The observed differences in the oligomeric state of the E32A and E62A mutants 
compared to wild-type possibly arise from the changes in the electrostatic environment 
within the FOC. At neutral pH the glutamic acid residues are negatively charged, while 
the histidine residues are predominantly in their uncharged state. In the wild-type Rru-
EncFtnSH this leads to electrostatic repulsion between subunits in the absence of iron. 
Iron coordination in this site stabilises the dimer and reconstitutes the active FOC. The 
geometric arrangement of E32 and E62 in the FOC explains the behavior of the alanine 
substitution mutants in solution and the gas phase, where they both favor the formation 
of decamers due to the loss of a repulsive negative charge. The FOC in the H65A 
mutant is destabilised through the loss of this metal coordinating residue and potential 




still remains elusive why the dodecamer appeared in gas phase study of E32A-E62A-
H65A mutant. 
 
Figure 4.3.2 Native mass spectrometry of Rru-EncFtnSH WT and FOC mutants.  
All spectra were acquired in 100 mM ammonium acetate, pH 8.0 with a protein concentration 
of 50 µM by Dr. David Clarke and Sam Huges. (A) WT (Rru-EncFtnSH monomer fractions) in 
the absence of iron displays a charge state distribution consistent with a monomer (see also 
figure 8). (B) E32A displays a charge states consistent with a decamer (green circles), a minor 
species, consistent with the monomer of E32A is also observed (blue circles). (C) E62A 
displays a charge states consistent with a decamer (green circles). (D) H65A displays charge 
states consistent with both monomer (blue circles) and dimer (purple circles). (E) apo-E32A-
E62A-H65A displays two distinct charge states, consistent with a decamer (green circles) and 




 Structures of Rru-EncFtnSH mutants 
All Rru-EncFtnSH mutants purified from LB were subjected to crystallization trials. 
The X-ray crystal structures were determined in the similar way to the wild-type (WT) 
(Section 2.5), but using the monomeric or decameric WT structure as the search 
template in molecular replacement. The X-ray data collection and refinement statistics 
of all the mutants with structure solved are listed in Table 4.4.1 and Table 4.4.2.  
The crystal packing of all of the single mutation variants in the FOC of Rru-EncFtnSH 
in this study are essentially isomorphous to the WT structure, with three decamers in 
a P 1 21 1 space group. The E32A-E62A-H65A mutant displays a space group P 41 21 
2 while the E32A-E62A mutant has a space group C 1 2 1; in both cases only a decamer 
is shown in the ASU. All of the mutants display the same decameric arrangement in 
the crystals as the wild-type Rru-EncFtnSH structure, and the monomers superimpose 
with an average RMSDC of less than 0.3 Å (Figure 4.4.1). A close inspection of 
residues involved in the metal binding site of each mutant highlights their effects on 
metal coordination. 
 
Figure 4.4.1 Structural superposition of FOC mutants and wild-type Rru-EncFtnSH. 
(A) Aligned decamer structures of Rru-EncFtnSH wild-type (grey), mutants E32A (purple), 
E62A (green), H65A (cyan), 3A (orange), E32A-E62A-H65A (orange), E32A-E62A (brown), 
E62D (salmon), E31A (marine), E34A (forest) in cartoon mode with metal ion binding shown 
in spheres (iron-red, magnesium-green, calcium-grey). The positions of the N-termini and C-
termini of the structures are marked. (B) Aligned FOC dimer structures of mutants and wild-




 E32A E62A H65A E32A-E62A-H65A 
Data collection     
Beamline I04 I02 I02 I04 










Space group P 1 21 1 P 1 21 1 P 1 21 1 P 41 21 2 
Unit cell (Å)  a 97.78 98.09 98.03 92.10 
                    b 120.28 120.23 120.29 92.10 
                    c 140.53 140.36 140.43 217.11 
α = γ = 90°, ß = 95.41° 95.51° 95.39° 90° 
Total reflections 405,488 (36,186) 1,069,345 (95,716) 323,853 (32,120) 26,1388 (23,040) 
Unique reflections 100,067 (9,735) 162,379 (15,817) 66,658 (6,553) 44,951 (4,371) 
Multiplicity 4.1 (3.7) 6.6 (6.1) 4.9 (4.9) 5.8 (5.3) 
Completeness (%) 99 (97) 100 (97) 100 (99) 99 (99) 
Mean I/sigma(I) 8.46 (1.79) 13.74 (1.80) 8.09 (1.74) 11.79 (1.72) 
Wilson B-factor 40.1 33.97 52.01 34.6 
Rmerge 0.171 (0.792) 0.0979 (1.009) 0.177 (0.863) 0.112 (0.865) 
Rmeas 0.196 (0.923) 0.106 (1.107) 0.199 (0.966) 0.123 (0.961) 
CC1/2 0.985 (0.557) 0.998 (0.642) 0.989 (0.627) 0.997 (0.557) 
CC* 0.996 (0.846) 0.999 (0.884) 0.997 (0.878) 0.999 (0.846) 
Image DOI 10.7488/ds/1419  10.7488/ds/1420  10.7488/ds/1421 10.7488/ds/1422 
Refinement     
Rwork 0.185 (0.292) 0.165 (0.299) 0.186 (0.271) 0.179 (0.264) 
Rfree 0.219 (0.350) 0.216 (0.364) 0.237 (0.325) 0.241 (0.318) 
CC(work) 0.953 (0.796) 0.966 (0.751) 0.949 (0.816) 0.961 (0.782) 
CC(free) 0.941 (0.647) 0.947 (0.670) 0.918 (0.814) 0.916 (0.661) 
Number of non-
hydrogen atoms 
22362 22691 22145 7561 
  macromolecules 22005 21965 22066 7269 
  ligands 9 24 74 20 
Protein residues 2684 2675 2700 898 
RMS(bonds) (Å) 0.003 0.011 0.002 0.012 
RMS(angles) (°) 0.53 1.02 0.4 1.08 
Ramachandran 
favoured (%) 
99 100 99 100 
Ramachandran 
allowed (%) 
0.8 0.42 0.91 0.34 
Ramachandran 
outliers (%) 
0 0 0.038 0 
Rotamer outliers 
(%) 
1.3 1.2 1.2 0.92 
Clashscore 1.74 1.79 0.97 2.87 
Average B-factor 
(Å2) 
41.25 41.34 47.68 41.05 
  macromolecules 41.29 41.31 47.6 41.07 
  ligands 73.18 65.55 72.34 46.01 
  solvent 37.74 41.46 33.85 40.09 
Protein Data Bank 
code 
5L89 5L8B 5L8G 5L8F 
Table 4.4.1 X-ray data collection and refinement statistics of Rru-EncFtnSH mutants 




Statistics for the highest-resolution shell are shown in parentheses. Friedel mates were 




  E32A-E62A E62D E31A E34A 
Data collection     
Beamline I04 I04 I24 I02 










Space group C 1 2 1 P 1 21 1 P 1 21 1 P 1 21 1 
Unit cell (Å)  a 140.82 97.97 97.89 97.79 
                    b 66.43 120.27 120.16 120.14 
                    c 117.46 139.85 139.37 139.34 
α = γ = 90°, ß = 107.53 95.30 95.33 95.20 
Total reflections 382,224 (36,130) 623,209 (56,386) 31,0118 (30,187) 90,6650 (86,276) 
Unique reflections 58,549 (5,594) 111,676 (10,978) 9,0283 (8,770) 161,177 (15,444) 
Multiplicity 6.5 (6.5) 5.6 (5.1) 3.4 (3.4) 5.6 (5.6) 
Completeness (%) 0.96 (0.93) 1.00 (0.99) 0.97 (0.95) 0.97 (0.94) 
Mean I/sigma(I) 13.73 (2.18) 9.60 (1.88) 7.55 (1.93) 11.27 (2.00) 
Wilson B-factor 34.2 37.95 39.14 33.05 
Rmerge 0.0991 (0.794) 0.140 (0.737) 0.152 (0.700) 0.106 (0.761) 
Rmeas 0.108 (0.864) 0.155 (0.822) 0.181 (0.828) 0.117 (0.839) 
CC1/2 0.998 (0.707) 0.994 (0.667) 0.985 (0.641) 0.997 (0.717) 
CC* 0.999 (0.91) 0.999 (0.895) 0.996 (0.884) 0.999 (0.914) 
Image DOI     
Refinement     
Rwork 0.171 (0.243) 0.188 (0.283) 0.191 (0.296) 0.176 (0.277) 
Rfree 0.202 (0.273) 0.217 (0.304) 0.231 (0.316) 0.209 (0.313) 
CC(work) 0.964 (0.868) 0.958 (0.808) 0.953 (0.806) 0.964 (0.839) 
CC(free) 0.948 (0.786) 0.938 (0.786) 0.925 (0.768) 0.957 (0.760) 
Number of non-
hydrogen atoms 
7698 22389 22386 22775 
  macromolecules 7239 22031 21988 22082 
  ligands 15 153 65 48 
Protein residues 886 2668 2680 2698 
RMS(bonds) (Å) 0.003 0.002 0.002 0.005 
RMS(angles) (°) 0.48 0.46 0.44 0.62 
Ramachandran 
favoured (%) 
100 100 99 100 
Ramachandran 
allowed (%) 
0 0.46 0.8 0.45 
Ramachandran 
outliers (%) 
0 0 0 0.038 
Rotamer outliers 
(%) 
0.39 1.4 1.7 0.95 
Clashscore 0.49 0.97 0.81 1.5 
Average B-factor 
(Å2) 
37.95 44.21 41.07 39.69 
  macromolecules 37.7 44.21 41.13 39.69 
  ligands 47.27 47.77 53.51 45.77 
  solvent 41.76 42.05 34.94 39.35 
Protein Data Bank 
code 
        
Table 4.4.2 X-ray data collection and refinement statistics of Rru-EncFtnSH mutants 




Statistics for the highest-resolution shell are shown in parentheses. Friedel mates were 




4.4.1 E32A structure 
The FOC of the E32A mutant structure has no visible metal ions (Figure 4.4.2); the 
position of H65 is essentialy unchanged, while E62 moves closer towards where the 
di-iron centre would be in the wild-type structure (1.6–2.1 Å), so does Y39 (3.8–4.2 
Å). But the absence of the axial-metal coordinating ligand provided by the E32 side 
chain abrogates metal binding in this site. The E32A mutant has five coordinated 
calcium ions among the fifteen metal ion entry sites (E31 and E34) in the ASU. The 
chi3 of some E31 residues are rotated by 180°, weakening the metal coordination in 
this site. Although all the side chains of H57, E61 and E64 resemble their counterparts 





Figure 4.4.2 Comparison of metal binding sites in the E32A and WT Rru-EncFtnSH 
structures. 
The metal binding sites in dimers of the E32A and WT Rru-EncFtnSH structures are shown in 
stick mode with Cα coloured in purple and white, respectively. The 2mFo-DFc density map for 
the mutant structure is superimposed on metal binding sites of E32A mutant as a blue mesh 
and contoured at 1.5 σ. Residues from dimers are differentiated with a prime symbol in their 
labels. (A) Aligned FOCs with di-iron (red spheres) coordinated in the WT structure. (B) Top 
view of (A) with residues labelled. The E32A mutant does not bind any metal in its FOC. (C) 
Metal ion entry site comparison between E32A mutant and WT. A single calcium ion is bound 
by both E32A mutant and WT in purple and grey spheres, respectively. (D) Metal ion exit site 
comparison between E32A mutant and WT with two calcium ions bound in grey spheres. The 
E32A mutant does not bind any metal in the exit site. The distance between iron or calcium 
ions and coordinating residues from E32A mutant, or WT, is marked by dashed lines and 




4.4.2 E62A structure 
In E62A mutant the position of the side chains of the remaining iron coordinating 
residues in the FOC is essentially unchanged (Figure 4.4.3). Since one carboxylate 
oxygen of E62 coordinates two iron in the FOC of WT, the alanine mutation of E62 
abrogates metal binding in the FOC. The entry sites of E62A mutant in the ASU are 
all occupied with a calcium ion coordinated between residues E31 and E34. The metal 
ion exit site (H57, E61 and E64) coordinates zero to one calcium in the ASU. Among 
fifteen FOC dimers in the ASU of E62A structure, only two FOC dimers are occupied 
with a single calcium in the metal ion exit site. Both the metal ion entry site and exit 





Figure 4.4.3 Comparison of metal binding sites in the E62A and WT Rru-EncFtnSH 
structures.  
Metal binding sites in dimeric E62A and WT are shown in stick mode with Cα coloured in green 
and white, respectively. 2mFo-DFc density map is superimposed on metal binding sites of 
E62A mutant as a blue mesh and contoured at 1.5 σ. Residues from dimers are differentiated 
with a prime symbol in their labels. (A) Aligned FOCs with di-iron (red spheres) coordinated in 
WT. (B) Top view of (A) with residues labelled. E62A mutant does not bind any metal in its 
FOC. (C) Metal ion entry site comparison between E62A mutant and WT. Ca ion is bound by 
both E62A mutant and WT in green and grey spheres, respectively. (D) Metal ion exit site 
comparison between E62A mutant and WT with two Ca ions bound in grey spheres. E62A 
mutant displays only one Ca ion (green sphere) at the exit site. The distance between iron or 
calcium ions and coordinating residues from E62A mutant or WT is marked by dashed lines 




4.4.3 H65A structure 
H65A mutant coordinates two Ca(II) in the FOC, one Ca(II) in the entry site and two 
Ca(II) in the metal ion exit site (Figure 4.4.4). The H65A mutant diverges significantly 
from the wild-type in the position of the residues E32 and Y39 in the FOC. E32 appears 
in either the original orientation as the wild-type and coordinates Ca(II) in this position, 
or the chi3 is rotated by 104, moving away from the coordinated calcium ion in the 
FOC. Y39 moves closer to Ca(II) compared to the wild-type and coordinates the 
calcium ion. Therefore, in FOC of H65A mutant, each calcium was coordinated by 
monodentate E62 and Y39, leading to a wider distance 5.1 Å between two calcium 
ions in the FOC. A single calcium ion was present in the entry site of this mutant; 
however, E31 of one chain is rotated away from the metal ion and is not involved in 
coordination. It is worth noting that because of the resolution limitation (3.0 Å) it is 
likely the conformation of E31 stayed the same as the WT. The metal ion exit site of 





Figure 4.4.4 Comparison of metal binding sites in the H65A and WT Rru-EncFtnSH 
structures. 
Metal binding sites in dimeric H65A and WT are shown in stick mode with Cα coloured in cyan 
and white, respectively. 2mFo-DFc density map is superimposed on metal binding sites of 
H65A mutant as a blue mesh and contoured at 1.5 σ. Residues from dimers are differentiated 
with a prime symbol in their labels. (A) Aligned FOCs with di-iron (red spheres) bound in WT 
and di-calcium (grey spheres) coordinated in H65A mutant. (B) Top view of (A) with residues 
labelled. (C) Metal ion entry site comparison between H65A mutant and WT. Ca ion is bound 
by both H65A mutant and WT in cyan and grey spheres, respectively. (D) Metal ion exit site 
comparison between H65A mutant and WT with two cyan and two grey spheres as Ca ions, 
respectively. The distance between iron or calcium ions and coordinating residues from H65A 




4.4.4 E32A-E62A-H65A structure 
When triple alanine mutations (E32A-E62A-H65A) are introduced in the FOC of WT, 
the FOC in the E32A-E62A-H65A mutant is totally abolished except for that only Y39 
stays in the original conformation; and a triethylene glycol as the polyethylene glycol 
degradation product is coordinated in its original di-iron centre. No metal binds in the 
metal ion entry site of E32A-E62A-H65A mutant where E31 is not engaged in the 
metal coordination due to the rotation of E31 side chain. There are still two magnesium 
ions bound in the metal ion exit site, suggesting that the metal binding ability of metal 





Figure 4.4.5 Comparison of metal binding sites in the E32A-E62A-H65A and WT Rru-
EncFtnSH structures. 
Metal binding sites in dimeric E32A-E62A-H65A (3A) mutant and WT are shown in stick mode 
with Cα coloured in orange and white, respectively. 2mFo-DFc density map is superimposed 
on metal binding sites of 3A mutant as a blue mesh and contoured at 1.5 σ. Residues from 
dimers are differentiated with a prime symbol in their labels. (A) Aligned FOCs with di-iron (red 
spheres) bound in WT and triethylene glycol (PGE) coordinated in 3A mutant. (B) Top view of 
(A) with residues labelled. (C) Metal ion entry site comparison between 3A mutant and WT 
with Ca(II) in grey sphere. No metal is bound in the metal ion entry site of 3A mutant. (D) Metal 
ion exit site comparison between 3A mutant and WT. Two magnesium in green and two 
calcium ions in grey spheres are coordinated by 3A mutant and WT, respectively. The distance 
between iron, calcium or magnesium ions and coordinating residues from 3A mutant or WT is 




4.4.5 E32A-E62A structure 
The E32A-E62A mutant structure displays a FOC without metal binding (Figure 
4.4.6). Compared to the WT, the H65 conformation does not change; the Y39 moves 
from 4.7 Å to 4.0 Å towards the di-iron centre of the WT. No anomalous peaks were 
observed in this mutant structure although the diffraction datasets were collected at 
10–100 eV above the theoretical Fe-Kα edge, indicating the absence of iron binding in 
the E32A-E62A structure. Mg(II) instead of Ca(II) was modelled in the metal ion 
entry/exit sites of E32A-E62A mutant given that the crystallisation condition 
contained 0.2 M magnesium formate, which has been validated through the 
‘CheckMyMetal’ web server (see the appendices) (Zheng et al. 2014). The Mg(II) in 
the metal ion entry site is coordinated by six water molecules and keeps a distance 
with E34 as 4.7 Å in contrast to the 2.9 Å in WT. The chi3 angle of E31 flips away 
from the Mg(II) by 116° and keeps a distance with Mg(II) at 5.5 Å. It suggested that 
the metal ion entry site of E32A-E62A mutant did not bind Mg(II); instead it was 
hexacoordinated Mg(II) bound by water present in the metal ion moving channel. 
There are two Mg(II) ions coordinated in the metal ion exit sites, which is far from 
with each other at 7.4 Å instead of 4.0 Å of Ca(II)-Ca(II) in the WT. Compared to the 
Ca(II) position, Mg(II) in this site moves closer to H57 from 4.5 Å to 2.1 Å and further 
from E64 of the adjacent chain from 3.2 Å to 4.1 Å. The Mg(II) in the metal ion exit 
site is also surrounded by four water molecules. Collectively, the double mutation of 
E32A and E62A abolished the metal binding in the FOC and affect the metal binding 





Figure 4.4.6 Comparison of metal binding sites in the E32A-E62A and WT Rru-EncFtnSH 
structures. 
Metal binding sites in dimeric E32A-E62A mutant and WT are shown in stick mode with Cα 
coloured in brown and white, respectively. 2mFo-DFc density map is superimposed on metal 
binding sites of E32A-E62A mutant as a blue mesh and contoured at 1.5 σ. Residues from 
dimers are differentiated with a prime symbol in their labels. The distance between metal ions 
and coordinating residues is marked by dashed lines and labelled with numbers nearby and Å 
as the unit. (A) Aligned FOCs with di-iron (red spheres) bound in WT. (B) Top view of (A) with 
residues labelled. (C) Metal ion entry site comparison between E32A-E62A mutant and WT 
with Mg and Ca ions bound in brown and grey spheres, respectively. The Mg(II) is coordinated 
by six water molecules shown in red crosses. The distances between Mg(II) and E31/E34 of 
the E32A-E62A mutant are 5.5 Å/4.7 Å by contrast to the 2.4–2.9 Å of the counterparts of WT. 
(D) Metal ion exit site comparison between E32A-E62A mutant and WT. Two Mg(II) ions 
shown in brown spheres in the mutant are bound by four water molecules in red crosses. Mg(II) 
is also coordinated by H57 in 2.1 Å and E61 in 2.2 Å. The distance between E64’ and Mg(II) 
is 4.1 Å. Two Ca(II) ions shown in grey spheres in the WT are coordinated by H57, E61 and 




4.4.6 E62D structure 
The E62D crystal has been soaked in 1 mM acidic FeSO4 for 10–15 min prior to X-
ray diffraction data collection at 10–100 eV above the theoretical Fe K-edge (Figure 
4.4.7). The NCS-averaged anomalous peak height of 70 σ in the FOC confirmed the 
presence of di-iron ions. Apart from the E62D mutation, E32, H65 and Y39 kept the 
original conformation. The coordination of di-iron by the monodentate carboxylate 
oxygen was not affected by the E62D mutation. Above the di-iron ions a glycolic acid 
(GOA) was bound in the E62D in analogy to WT. In the metal ion entry site of E62D 
mutant statistically smaller NCS-averaged anomalous peaks were found at 40 σ and 
metal ion exit site at 25 σ, where Ca(II) ions were modelled. The metal ion entry site 
of E62D mutant consisted of a Ca(II) ion coordinated by E31 and E34 in slightly 
further distances than the WT, changing from 2.8 to 3.4 Å. The metal ion exit site of 
E62D mutant also consisted of two Ca(II) ions in a longer distance of 7.2 Å from each 
other. In contrast to the WT, the Ca(II) was bound by H57 in a shorter distance of 2.9 
Å and a longer distance of 4.3 Å to E64’. Taken together, the E62D mutation altered 





Figure 4.4.7 Comparison of metal binding sites in the E62D and WT Rru-EncFtnSH 
structures. 
Metal binding sites in dimeric E62D and WT are shown in stick mode with Cα coloured in 
salmon and white, respectively. 2mFo-DFc density map is superimposed on metal binding 
sites of E62A mutant as a blue mesh and contoured at 1.5 σ. An NCS-averaged anomalous 
map is superimposed on FOC of E62D mutant as an orange mesh and contoured at 20 σ. 
Residues from dimers are differentiated with a prime symbol in their labels. (A) Aligned FOCs 
with di-iron coordinated as red spheres in WT and orange spheres in E62D mutant. (B) Top 
view of (A) with residues labelled. (C) Metal ion entry site comparison between E62D mutant 
and WT. Ca ion is bound by both E62D mutant and WT in salmon and grey spheres, 
respectively. (D) Metal ion exit site comparison between E62D mutant and WT with two Ca(II) 
ions bound in salmon and grey spheres, respectively. The distance between two Ca(II) ions 
from E62A mutant is 7.2 Å by contrast to 4.0 Å in the WT. The Ca(II) in E62D mutants keeps 




4.4.7 E31A structure 
An NCS-averaged anomalous peak height of 43 σ has been detected in the FOC of 
E31A mutant at the 10–100 eV above the theoretical Fe-Kα edge, indicating the di-
iron binding of FOC in E31A mutant. The E31A structure displays a similar FOC with 
WT with the exception of the water molecule bridging the di-iron instead of the 
glycolic acid in the WT structure (Figure 4.4.8). The metal ion entry site of E31A 
mutant still coordinated a Ca(II) by E34 from two chains in a distance of 3.4 Å/3.8 Å. 
The Ca(II) in the entry site of E31A structure stays further away from the di-iron 
binding in the FOC. The metal ion exit site of E31A mutant bound two Ca(II) in a 
distance of 5.5 Å with each other. The conformations of Ca(II) residues E61, H57 and 
E64 from the next chain kept the minimal change in the E31A mutant. The second 
Ca(II) in the metal ion exit site of E31A mutant moves closer to H57 from 4.9 Å to 3.1 
Å and further to E64 of the adjacent chain from 3.1 Å to 3.8 Å. Overall, the E31A 





Figure 4.4.8 Comparison of metal binding sites in the E31A and WT Rru-EncFtnSH 
structures. 
Metal binding sites in dimeric E31A mutant and WT are shown in stick mode with Cα coloured 
in marine and white, respectively. 2mFo-DFc density map is superimposed on metal binding 
sites of E31A mutant as a blue mesh and contoured at 1.5 σ. An NCS-averaged anomalous 
map is superimposed on FOC of E31A mutant as an orange mesh and contoured at 20 σ. 
Residues from dimers are differentiated with a prime symbol in their labels. The distance 
between metal ions and coordinating residues is marked by dashed lines and labelled with 
numbers nearby and Å as the unit. (A) Aligned FOCs with di-iron bound as orange spheres in 
E31A mutant and red spheres in WT. A water molecule shown as a red cross is coordinated 
above the di-iron of E31A mutant. (B) Top view of (A) with residues labelled. (C) Metal ion 
entry site comparison between E31A mutant and WT with both Ca(II) bound in grey and brown 
spheres, respectively. In the E31A mutant the Ca(II) moves further from FOC and is 
coordinated by E34 from two chains in a distance of 3.4 Å/3.8 Å by contrast to the 2.8 Å/2.9 Å 
in the WT. (D) Metal ion exit site comparison between E31A mutant and WT, where two Ca(II) 
bound by both are shown in marine and grey spheres, respectively. One Ca(II) in E31A mutant 




4.4.8 E34A structure 
The crystal of E34A mutant was soaked in 1 mM FeSO4 for 10–15 min prior to X-ray 
diffraction data collection at 10–100 eV above the theoretical Fe-Kα edge. The 
structure of E34A mutant displayed a FOC with two NCS-averaged anomalous peaks 
at the height of 100 σ, indicating the di-iron ions binding in the FOC. All di-iron 
binding residues kept the minimal change compared the WT. No metal was observed 
in the metal ion entry site of E34A mutant, where the chi3 angle of E31 residue flipped 
away from the metal position because of the E34A mutation. The chi2 angle of W38 
from the next chain flipped by 38° towards the metal position. The metal ion exit site 
of E34A mutant, in analogous to the WT, possessed a single Ca(II) whereas the second 
Ca(II) binding site was occupied by a water molecule. Given that in the WT structure 
the metal ion exit site was also partially occupied, the comparison between WT and 
E34A regarding this site displayed the minimal difference. Overall, the E34A mutation 
diminished the metal binding in the metal ion entry site but did not affect the FOC and 





Figure 4.4.9 Comparison of metal binding sites in the E34A and WT Rru-EncFtnSH 
structures. 
Metal binding sites in dimeric E34A mutant and WT are shown in stick mode with Cα coloured 
in forest and white, respectively. 2mFo-DFc density map is superimposed on metal binding 
sites of E34A mutant as a blue mesh and contoured at 1.5 σ. An NCS-averaged anomalous 
map is superimposed on FOC of E34A mutant as an orange mesh and contoured at 20 σ. 
Residues from dimers are differentiated with a prime symbol in their labels. The distance 
between metal ions and coordinating residues is marked by dashed lines and labelled with 
numbers nearby and Å as the unit. (A) Aligned FOCs with di-iron ions bound as orange 
spheres in E34A mutant and red spheres in WT. (B) Top view of (A) with residues labelled. (C) 
Metal ion entry site comparison between E34A mutant and WT. No metal is coordinated in this 
site of E34A mutant while WT binds a Ca(II) shown in grey sphere. The E31 in E34A mutant 
moves away by 117° and keeps a distance of 6 Å to the Ca(II) of WT. The indole ring of W38 
rotates towards the central Ca(II) of WT by 38°. (D) Metal ion exit site comparison between 
E34A mutant and WT, where only one Ca(II) shown in forest sphere is bound by E34 while 
two Ca(II) in grey spheres are bound by the WT. The conformation of metal ion exit site does 





























FOC E32A Mainly 
10mer 
Ca(II)   None None 
E62A 10mer Ca(II) None 1 Ca(II) 
E62D Mainly 
10mer 
Ca(II) 2 Fe 
ions 
2 Ca(II) 



























None   PGE 2 Mg(II) 
Table 4.5.1 Summary of protein assembly and metal binding in Rru-EncFtnSH mutants. 
The oligomeric states of WT were determined using SEC-MALS. The oligomeric states of 
mutants E32A, E62A, H65A and E32A-E62A-H65A were estimated based on nESI-MS 
analysis. The oligomeric states of E62D and E32A-E62A were determined based on the 
calibration curve of the HiLoad 16/600 Superdex 200 pg column. In mutants E31A and E32A-
E62A metal ion observed near the metal ion entry site, but were not bound by E31 and E34 
residues in Ca/Mg coordination distance. In E32A-E62A-H65A mutant the FOC was occupied 
by triethylene glycol (PGE) instead of metal ions. 
Each of the Rru-EncFtnSH mutants listed in Table 4.5.1 crystallised into annular 
decamer structures in an analogous manner to the WT. The presence of additional Fe(II) 
in minimal medium did not alter the assembly of E32A, E62A, H65A and E32A-
E62A-H65A variants, indicating that the alanine mutations of the FOC abrogated their 
iron binding abilities. This was later confirmed by the crystal structure of E32A, E62A 
and H65A, where the FOC was not populated by iron. The E62D displaying a similar 
metal binding with the WT, indicating that the E62D mutation did not alter the metal 
binding environment in the FOC of Rru-EncFtnSH. The E32A-E62A and E32A-
E62A-H65A mutations both affected the metal binding in the metal ion entry site as 




of E31 and thus abolished the metal coordination in the metal ion entry site, which was 
supported by the absence of metal in the entry site of E31A mutant. The E34A mutant 
also did not bind any metal in the entry site. Both E31A and E34A mutations did not 
affect the metal binding in the FOC and metal ion exit site. 
To understand the function of Rru-EncFtnSH and the influence of the different metal 
coordination sites on the structure and activity of the protein, further biochemical 
analyses will be presented in Section 5.5. Since the E32D structure has not been finally 
determined, the structure together with the application in alternative metal 
coordination will be explored in future work. Besides, it is also very important to 
investigate the metal binding of metal ion exit site mutants regarding structures and 
biochemistry as it could possibly be related to the iron mineralisation. The second 
mutation site that should be taken into account is Y39, the well-conserved residue in 
the FOC in a far distance from the di-iron that has been demonstrated to facilitate the 
iron oxidation of classical ferritin as a single-electron molecular capacitor (Ebrahimi, 
Hagedoorn & Wilfred R Hagen 2013). It has been always intriguing to understand the 




5 Chapter 5 Iron storage in encapsulin 
nanocompartments 
 Introduction 
The encapsulin nanocompartment from R. rubrum consists of two proteins, a ferritin-
like protein (Rru-EncFtn or Rru-EncFtn) and the encapsulin shell protein Rru-Enc 
(Rru-Enc). The structure of the ferritin-like protein (EncFtn) of R. rubrum has been 
characterised as an annular decamer (Section 3.4), whereas the encapsulin structure is 
still unknown. The encapsulin family proteins are structurally related to HK97 virus 
capsid gp5 (Akita et al. 2007). Within the encapsulin family, Rru-Enc shares 33% 
protein sequence identity with the T. maritima encapsulin Tm-Enc (KEGG ID: 
Tmari_0786, PDB ID: 3DKT) (Sutter et al. 2008); 21% identity with the M. xanthus 
encapsulin Mx-Enc (KEGG ID: MXAN_3556, PDB ID: 4PT2) (McHugh et al. 2014); 
and 21% identity with P. furiosus encapsulin Pf-Enc (KEGG ID: PFC_05175, PDB 
ID: 2E0Z) (Akita et al. 2007). This chapter described the production of Rru-Enc in E. 
coli and purification via sucrose cushion/gradient ultracentrifugation. To understand 
the function of the encapsulin nanocompartment in its biochemical context, Rru-
EncFtn was coexpressed with Rru-Enc in E. coli; purified by sucrose cushion/gradient 
ultracentrifugation, and further compared with the encapsulin Rru-Enc itself regarding 
the size distribution using transmission electron microscopy. The iron oxidation and 
loading capacity were compared in Rru-EncFtn, Rru-Enc and Rru-EncFtn-Enc with 
apoferritin as a control. Based on assembly, structure and biochemistry data, an iron 
storage model of encapsulin nanocompartments is proposed. 
 Purification of untagged Rru-Enc and Rru-EncFtn-Enc 
Rru-Enc was overexpressed in E. coli BL21(DE3) using the pACYCDuet-1 vector. 
The co-expression of Rru-EncFtn and Rru-Enc was achieved by inserting the coding 
sequences for Rru-EncFtn and Rru-Enc into the two multiple cloning sites on 
pAYCDuet-1 vector. Coexpressed Rru-EncFtn and Rru-Enc (Rru-EncFtn-Enc) were 
purified from E. coli BL21(DE3) grown in LB, or SeMet medium for SeMet-labelled 
proteins. The SeMet-labelled proteins can be analysed by ICP-MS to determine the 




phasing method to determine the structure. The purification of the SeMet-labelled 
proteins is shown below. 
5.2.1 Sucrose cushion ultracentrifugation 
The Rru-EncFtn-Enc protein complex and Rru-Enc were both purified in GF buffer 
using 38% (w/v) sucrose cushion ultracentrifugation at 100,000 x g, 4°C for 21 hrs. 
The bottom 3 ml fractions including the pellet were analysed by 15% SDS-PAGE 
(Figure 5.2.1). 
 
Figure 5.2.1 18% SDS-PAGE analysis of SeMet-labelled encapsulin nanocompartments 
purified by sucrose cushion ultracentrifugation. 
The crude extracts of SeMet-labelled Rru-Enc (Rru-Enc-SeMet) and co-expressed Rru-
EncFtn and Rru-Enc (Rru-EncFtn-Enc-SeMet) were treated by 50 µg/ml RNase A for 2 hrs, 
followed by centrifugation at 48,300 x g and 4°C for 20 min; the supernatant of each protein 
was loaded into lanes 1 and 7 while the pellet was loaded into lanes 2 and 8, respectively. The 
supernatant of each protein was filtered through 0.45 µm Millipore Syringe Filter before loading 
to 38% sucrose cushion, followed by ultracentrifugation at 100,000 x g and 4°C for 21 hrs. The 
last 3 ml fractions from each ultracentrifugation tube were loaded to lanes 3–4 and 9–11, 
respectively. The bottom pellets were fully resuspended in GF buffer and centrifuged to 
separate the soluble proteins, which were loaded to lanes 5 and 12, respectively. The insoluble 
part of the bottom pellets was loaded into lanes 6 and 13, respectively. The SDS-PAGE 
displays a major band closed to 25 kDa, existing in both Rru-Enc-SeMet and Rru-EncFtn-Enc-
SeMet fractions, which was identified as Rru-Enc protein via PMF. There are another two 
major bands around 30 and 15 kDa in Rru-EncFtn-Enc-SeMet, consistent with the dimer and 
monomer sized Rru-EncFtn. They were subsequently identified as R. rubrum EncFtn. Two 
proteins in lanes 5 and 12 highlighted in red dashed rectangles, respectively, were further 





5.2.2 Sucrose gradient ultracentrifugation 
The pelleted fractions from the sucrose cushion were resuspended in GF buffer, 
followed by removing any insoluble material by centrifugation at 15,000 x g and 
filtering through a 0.22 µm Millipore Syringe Filter. The filtered supernatant was 
further purified in GF buffer using 10%–50% (w/v) sucrose gradient 
ultracentrifugation at 100,000 x g and 4°C for 17 hrs. Every 0.75 ml fraction was 
removed from top to bottom of the 38.5 ml centrifuge tubes and the A280 and A260 of 
each fraction was determined by using a NanoDrop 2000 spectrophotometer. Fractions 
of Rru-Enc from 24 ml to the bottom pellet were subjected to SDS-PAGE analysis. 
Fractions of Rru-EncFtn-Enc from 26 ml to the bottom pellet were analysed by SDS-
PAGE as well (Figure 5.2.2). The SDS-PAGE gels revealed a major band around 25 
kDa in both Rru-Enc and Rru-EncFtn-Enc proteins, corresponding to the monomer 
size of Rru-Enc. The other two major bands around 15 kDa and 35 kDa in the SDS-
PAGE of Rru-EncFtn-Enc correlated with the monomer and dimer sized Rru-EncFtn, 
suggesting that the coexpression of Rru-EncFtn and Rru-Enc allowed the 
encapsulation of Rru-EncFtn in the Rru-Enc nanocompartment.  
 
Figure 5.2.2 18% SDS-PAGE analysis of SeMet-labelled encapsulin nanocompartments 
purified via sucrose gradient ultracentrifugation. 
Proteins Rru-Enc and Rru-EncFtn-Enc with SeMet labelling were purified through a 10%–50% 
(w/v) sucrose gradient by ultracentrifugation. Fractions were removed from each centrifuge 
tube from top to the bottom. (A) The fractions from 24 ml to 38 ml of Rru-Enc-SeMet and (B) 
fractions of Rru-EncFtn-Enc-SeMet from 26 ml to 38 ml were subjected to 15% SDS-PAGE 
analysis. A single major band around 25 kDa shown on the SDS-PAGE of Rru-Enc-SeMet and 
Rru-EncFtn-Enc-SeMet indicates the monomer of Rru-Enc. Another two major bands around 
15 kDa and 35 kDa on the gel of Rru-EncFtn-Enc-SeMet correspond to the monomer and 





 TEM visualisation of encapsulin nanocompartments 
SeMet-labelled Rru-Enc and Rru-EncFtn-Enc proteins were purified as above and 
pooled before buffer exchange against 2 litres of GF buffer for two days to remove the 
sucrose. Proteins were diluted in GF buffer to 0.1 mg/ml prior to visualisation by 
negative-stain transmission electron microscopy (TEM) experiment (Figure 5.3.1). 
The TEM of negatively stained specimens confirmed that the purified Rru-Enc and 
Rru-EncFtn-Enc consisted of a population of sphere-like particles of around 24 nm in 
diameter, consistent with the size of the encapsulin (KEGG ID: Tmari_0786, PDB ID: 
3DKT) from T. maritima as a 60-mer encapsulin nanocompartment (Sutter et al. 2008). 
Micrographs of purified Rru-EncFtn-Enc revealed 24 nm nanocompartments with 
regions in the centre that excluded stain, consistent with the presence of the Rru-
EncFtn within the encapsulin shell. The size distribution of each protein complex was 
analysed in the software GraphPad Prism 6.0 by measuring the diameter of each 
nanoparticle in three different directions using ImageJ (Abramoff et al. 2004). The 
similar size of Rru-Enc and Rru-EncFtn-Enc indicated that the packaging of Rru-





Figure 5.3.1 TEM visualisation of R. rubrum encapsulin nanocompartments and their 
size distribution.  
Red arrows highlight the nanocompartments in TEM images of SeMet labelled (A) Rru-Enc 
and (B) Rru-EncFtn-Enc stained by 2% uranyl acetate. All samples were imaged at 143,000 x 
magnification; the scale bar corresponds to 50 nm. (C) 15% SDS-PAGE analysis of Rru-Enc 
and Rru-EncFtn-Enc. (D) Histogram of size distribution of Rru-Enc and Rru-EncFtn-Enc 
particles. A Gaussian curve was fitted to the data by non-linear least squares regression to 
obtain a mean diameter of 24.6 nm with a standard deviation of 2.0 nm for Rru-Enc (grey) and 
a mean value of 23.9 nm with a standard deviation of 2.2 nm for Rru-EncFtn-Enc (black). 
 Crystallisation of Rru-Enc 
Both native and SeMet labelled Rru-Enc at 10 mg/ml was subjected to crystallisation 
trials using MRC 96 well crystallisation plates and the sitting drop vapour diffusion 
technique. An Art Robbins Gryphon crystallisation robot was used with commercial 
screen kits including PEG/Ion HT from Hampton Research, JCSG-plus HT-96 and 




Rru-Enc has grown in a bi-pyramidal morphology in a number of different 
crystallisations conditions. Figure 5.4.2 A–B shows a number of representative 
crystals of Rru-Enc. Crystals of both the native and SeMet labelled Rru-Enc did not 
diffract with a dmax better than 10 Å. The poor diffraction quality may be a result of 
impurities carried over from the sucrose cushion/gradient ultracentrifugation. 
Therefore, a pET-28a(+) based Rru-Enc construct with a C-terminal his-tag (Rru-Enc-
his) was overexpressed in E. coli for structural determination. This protein was purified 
through IMAC and SEC (Figure 5.4.1). However, Rru-Enc-his readily precipitated 
during dialysis or concentration by centrifugal ultrafiltration. Although much purer 
protein was obtained using this construct it did not improve the diffraction resolution 
(Figure 5.4.2 C). 
 
Figure 5.4.1 Size exclusion chromatography purification of Rru-Enc-his using a HiLoad 
16/600 Superdex 200 pg column. 
(A) The chromatogram of SEC purification of Rru-Enc-his shows a major peak (fractions G10–
G14) with a retention volume of 46 ml, which is close to the void volume of the column. Two 
small peaks are shown at 68 ml (fractions H3–H4) and 88 ml (fractions H10–H11). (B) 
Fractions labelled in (A) were subjected to 15% SDS-PAGE. There is a major band around 30 
kDa and some contaminant bands around 85 kDa. The major band correlating with the size of 






Figure 5.4.2 Images of crystals of Rru-Enc, Rru-Enc-SeMet and Rru-Enc-his. 
(A) Rru-Enc purified from LB medium by sucrose cushion/gradient ultracentrifugation 
crystallised in the E11 condition of the PEG/Ion kit containing 4% (v/v) tacsimate pH 5.0 and 
12% (w/v) PEG 3350. (B) The SeMet-labelled Rru-Enc purified from SeMet medium using 
sucrose cushion/gradient ultracentrifugation crystallised in the condition containing 0.25 M 
KNO3 and 20% (w/v) PEG 3350. (C) The Rru-Enc with C-terminal his-tag (Rru-Enc-his) purified 
through IMAC and SEC was grown into bi-pyramidal crystals in the A10 position of the MIDAS 
screen kit, which contains 24% (w/v) polyvinyl pyrrolidone K15 and 0.1 M sodium sulphate. 
The scale bar indicates 200 µm in each image. 
 Ferroxidase assay of EncFtn and encapsulin 
It is generally accepted that iron storage in ferritin cages involves Fe(II) oxidation to 
Fe(III) and the subsequent formation of iron oxide-hydroxide and iron phosphate 
minerals. These reactions are catalysed by the ferroxidase centre of the ferritin 
structure. In light of the identification of an iron-loaded FOC in the crystal structure 
of EncFtn and the native mass spectrometry data, peroxidase and ferroxidase assays 
were performed to demonstrate the catalytic activity of this protein. In addition, equine 
apoferritin, an example of a classical ferritin enzyme, was also assayed as a positive 
control. Unlike the DPS family of ferritin-like proteins, EncFtn showed no peroxidase 
activity when assayed with the substrate ortho-phenylenediamine (Pesek et al. 2011). 
5.5.1 Iron oxidation by encapsulin nanocompartments 
To measure the ferroxidase activity of Rru-EncFtnSH, Fe(II) was added to the protein 
in GF buffer at 25°C and progress curves for the formation of Fe(III) minerals were 
recorded for 1800 s at 315 nm. Fe(II) was added to the reactions at 20 and 100 µM 
final concentration (2 and 10 times molar ratio of Fe(II)/FOC). The concentration of 
Rru-EncFtnSH was determined using a BCA microplate assay prior to the Fe(II) 
loading. Each solution used in these assays was prepared anaerobically including fresh 
Fe(NH4)2(SO4)2 in 0.1% (v/v) HCl, GF buffer and diluted protein samples. Decamer 




effects from protein assembly in the presence of Fe(II). Since Rru-EncFtn is 
encapsulated in Rru-Enc in the native bacterium, R. rubrum, the ferroxidase activity 
of both recombinant Rru-Enc and coexpressed Rru-EncFtn and Rru-Enc (Rru-EncFtn-
7374) was also measured. As the Rru-Enc structure was not available and it 
presumably resembles the T. maritima encapsulin, Tmari_0786, based on the TEM 
observation as well, the recombinant Rru-Enc was very likely to be a 60-meric T=1 
icosahedron with 12 pentamers. Therefore, the Rru-Enc nanocompartment can 
sequester no more than twelve decameric Rru-EncFtn, leading to a maximum molar 
ratio 2:1 of Rru-EncFtn: Rru-Enc. The ribosome binding site (RBS) calculation of the 
mRNA sequence of pACYCDuet-1-Rru-EncFtn-Rru-Enc estimated that the ‘ATG’ 
translation rate of recombinant Rru-EncFtn was twice as high as the counterpart of 
Rru-Enc, suggesting a 2:1 molar ratio of Rru-EncFtn: Rru-Enc in the co-expression 
system in E. coli BL21(DE3) (Espah Borujeni et al. 2014; Salis et al. 2009). Therefore, 
10 µM Rru-EncFtn-Enc was used in this ferroxidase assay based on the estimation that 
the recombinant Rru-Enc was fully occupied by Rru-EncFtn (Figure 5.7.4). It is worth 
mentioning that the RBS calculation was based on a biophysical model developed by 
Salis lab that predicts translation initiation rate for each start codon in an mRNA 
sequence. Thus it is likely that the RBS calculation might be inaccurate to some extent. 
In this case, obitrap mass spectrometry can be very instrumental in solving the 
stoichiometry of encapsulin nanocompartment proteins (Snijder et al. 2014). 
To explore if Rru-Enc contributed enzymatic activity towards iron storage in 
encapsulin nanocompartments, Fe(II) was also added to Rru-Enc at a proportional 
protein concentration to the Rru-EncFtn-Enc complex. Horse spleen apo-ferritin (apo-
HsFtn) purchased from Sigma, prepared as iron-free sample was also used in this 
ferroxidase assay to demonstrate the validity of this method and as a positive control 
for ferroxidase activity. Since the mammalian ferritin monomer has a single 
ferroxidase centre (FOC) in each of the four-helix bundle monomers, a monomer of 
apo-HsFtn has an equivalent number of FOCs to a dimer of Rru-EncFtnSH. Therefore, 
the concentration of apo-HsFtn used in these experiments was half of the concentration 
of Rru-EncFtnSH. Finally, iron background oxidation was monitored by mixing Fe(II) 




performed on different days, iron background oxidation was also measured on each 
day to reduce the variation of the assays. 
 
Figure 5.5.1 Progress curve of Fe(II) oxidation catalysed by encapsulin 
nanocompartments. 
(A) 20 µM Rru-EncFtnSH decamer fraction (73sH-10mer, 10 µM FOC) or 10 µM horse spleen 
apo-ferritin (apo-HsFtn, 10 µM FOC) was incubated with 20 or 100 µM Fe(II) in GF buffer (pH 
8) at 25°C for 1800 s with absorbance at 315 nm (A315) monitored. Fe background oxidation 
was detected by mixing 100 or 20 µM Fe(II) with GF buffer. (B). 10 µM encapsulin 
nanocompartment with co-expressed Rru-EncFtn and Rru-Enc (7374) or encapsulin Rru-Enc 
(0974) was mixed with 20 or 100 µM Fe(II) in GF buffer. The results are averaged from three 
technical repeats with error bars indicating the standard deviation from the mean shown. 
The ferroxidase assay demonstrated that Rru-EncFtnSH was catalytically active to 
oxidise Fe(II) to Fe(III). When compared to apoferritin, Rru-EncFtnSH oxidised Fe(II) 
at a slower rate and the reaction did not appear to run to completion over the 1800 
seconds of the experiment. Addition of higher quantities of iron resulted in the 
formation of a yellow/brown precipitate at the end of the reaction, which could be the 
insoluble iron minerals formed on the surface of Rru-EncFtnSH, and subsequent 
precipitation of the Rru-EncFtnSH. The Rru-Enc encapsulin protein did not show iron 
oxidation ability above the background Fe(II) oxidation. The ferroxidase activity of 
Rru-EncFtnSH is retained and enhanced when encapsulated by Rru-Enc as a co-




oxidation rate than Rru-EncFtnSH on its own and a comparable ferroxidase activity 
with apo-HsFtn (10 Fe(II) / 2 FOC). 
5.5.2 Iron oxidation by Rru-EncFtnSH FOC mutants 
To investigate the biochemical role played by the metal binding residues in the FOC 
of Rru-EncFtnSH, the ferroxidase activity for a number of FOC mutants was 
investigated, including E32A, E62A and H65A (Figure 5.5.2). Compared to the wild-
type, all mutants demonstrated substantially reduced ferroxidase activities, of which 
the E62A mutant almost diminished all Fe(II) oxidation capability. These data, 
coupled with the mutant structures (Section 4.4), confirmed the central role of 
ferroxidase centre in achieving the ferroxidase activity of the EncFtn protein. 
 
Figure 5.5.2 Spectroscopic evidence for Fe(II) oxidation by FOC mutants of Rru-
EncFtnSH. 
FOC mutants of Rru-EncFtnSH including E32A, E62A and H65A at 20 µM were mixed with 
100 µM or 20 µM Fe(II) in GF buffer (pH 8) at 25°C and the progress curve at A315 was 
monitored for each sample for 1800 seconds. A negative control of Fe(II) background oxidation, 
and positive control of wild-type decameric Rru-EncFtnSH (73sH-10mer) catalysis are both 
shown for reference. The experiments were performed as three technical repeats with the 
error bars indicating the standard deviation of the mean for each sample. (A) E32A vs wild-
type Rru-EncFtnSH; (B) E62A vs H65A. (C) The relative ferroxidase activity of mutants is 
plotted as a proportion of the activity of the wild-type protein using the endpoint measurement 
of A315. The error bars represent the calculated standard deviations of three technical repeats. 
The FOC mutants showed reduced ferroxidase activity to varied extents, with the E62A mutant 




 Iron storage capacity of encapsulin nanocompartments 
Since the iron oxidation catalysed by Rru-EncFtnSH did not fully finish in the 1800 
seconds recorded for the progress curves, the final iron loading capacity of each protein 
was determined after 3-hour-incubation of protein with different amounts of Fe(II). 
Before iron determination by ferrozine assay, the free iron ions in samples were be 
removed by desalting with a pre-equilibrated Zeba™ spin desalting column (7K 
MWCO, Thermo Scientific). 
5.6.1 Standard curve of ferrozine assay 
FeCl3 was used in the ferrozine assay as the iron standard. The ferrozine assay involves 
three steps: iron release from proteins using a mixture of 0.7 M HCl and 2.25% (w/v) 
KMnO4 at 60°C for 2 hrs; iron chelation by a mixture of 6.5 mM ferrozine, 6.5 mM 
neocuproine, 2.5 M buffer (ammonium acetate) and reducing agent (1 M ascorbic acid) 
in room temperature for 30 min; and detection by measuring the absorbance at 562 nm 
for the detection of the -ferrozine complex (Riemer et al. 2004). The standard curve 
for the ferrozine assay was plotted using Fe(III) concentration (µM) as the X-axis and 
A562nm as the Y-axis (Figure 5.6.1). The iron content in proteins was detected in the 
same procedure, with the standard curve used to estimate the iron content of the sample. 
 
Figure 5.6.1 Ferrozine standard 
curve. 
FeCl3 standards of concentrations 
(black sold circles) ranging from 0 to 
120 µM are applied in the ferrozine 
assay. The corresponding A562 is 
recorded to plot against each FeCl3 
concentration and fitted with a red 
linear regression line with the 
equation and R-squared correlation 
shown. This experiment has three 
technical repeats with the error bars 
indicated by standard deviation. 
 




















5.6.2 Standard curve of BCA microplate assay 
The concentration of proteins used in these assays was determined using the Pierce™ 
BCA Protein Assay Kit based on the manufacturer’s instructions (Thermo Fisher 
Scientific). The bovine serum albumin (BSA) standard was used in the BCA 
microplate assay and a standard curve was plotted using BSA concentration as the X-
axis and absorbance at 562 nm as the Y-axis. 
 
Figure 5.6.2 Standard curve of BCA microplate assay.  
25 µl BSA in GF buffer at 25, 50, 100, 150, 250, 500, 750 and 1000 µg/ml concentrations were 
mixed with 200 µl of freshly prepared working solution in a 96-well plate with three technical 
repeats. The absorbance at 562 nm was measured after incubation at 37°C for 30 min. Each 
BSA standard at different concentrations (black solid circles) is fitted with a red linear 
regression line with the equation and R-squared correlation shown.  
 
5.6.3 Iron loading capacity of encapsulin nanocompartments vs EncFtn 
Protein samples at 8.5 µM were mixed with various concentrations of acidic Fe(II) at 
room temperature for three hours before removal of protein and mineral precipitation 
by centrifugation and desalting with a centrifugal desalting column. The iron content 
and protein concentration were determined on each desalted sample by the ferrozine 
assay and BCA microplate assay, respectively (Figure 5.6.3 A–D).  





















Figure 5.6.3 Comparison of iron loading capacities of EncFtn, encapsulin and ferritin.  
Fe(II) at various concentrations were mixed with 8.5 µM (A) decameric Rru-EncFtnSH (73sH), 
(B) Rru-Enc (0974), (C) and co-expressed Rru-EncFtn and Rru-Enc (7374), or (D) horse 
spleen apo-ferritin (apo-HsFtn) and incubated at room temperature for three hours before 
desalting. Iron content (black solid squares) and protein concentration (black empty circles) 
are plotted for each sample. (E) The maximum iron loading capacity of each protein as a 
biological assembly was calculated based on the protein-iron sample (highlighted by red 
ellipses) with the highest iron concentration and the least protein loss. Error bars indicate the 
standard deviation from the mean of three technical repeats. The data were statistically 
compared by one-way ANOVA analysis (GraphPad Prism 6.0 software). Asterisks indicate 
significant differences between pairs of proteins regarding the maximum Fe loading capacity. 
Four asterisks mean extremely significant with p < 0.0001; while one asterisk indicates the 




Protein samples displayed a limited iron storage capacity to different degrees since 
yellow/brown precipitate started to form when too much Fe(II) was loaded. The 
precipitate could arise from background iron oxidation by air when the ferroxidase was 
saturated; or the denatured protein when it was overloaded by iron. Rru-EncFtnSH-Fe 
mixture started to precipitate when more than 150 µM Fe(II) was present. Both Rru-
Enc and Rru-EncFtn-Enc became instable in the presence of over 1 mM Fe(II); but 
Rru-Enc concentration reduced more sharply than the coexpressed protein complex. 
Apoferritin showed a certain stability when less than 700 µM Fe(II) was loaded. 
Therefore, the protein stability in terms of the Fe(II) tolerance was shown in an order: 
Rru-EncFtn-Enc > Rru-Enc > apo-HsFtn > Rru-EncFtnSH. The iron loading of the 
protein samples with significant precipitation has not been taken into account, since it 
was not possible to directly measure the distribution of iron and protein in both the 
supernatant and precipitation. Therefore, the maximum iron concentration with the 
least protein loss was used to derive the maximum iron loading capacity of the samples 
in this experiment.  
The maximum iron loading capacity of the protein samples was calculated as the 
quantity of iron per biological assembly, which corresponded to ten subunits of Rru-
EncFtnSH, 60 subunits of Rru-Enc, 60 subunits of Rru-EncFtn-Enc (2:1 of Rru-EncFtn: 
Rru-Enc) and 24 subunits of apo-HsFtn. Therefore, the Rru-EncFtnSH decamer bound 
a maximum of around 47 iron ions before excess iron induced the protein precipitation. 
The encapsulin protein Rru-Enc could sequester about 2,199 iron ions before 
significant protein loss occurred, and the Rru-EncFtn-Enc sequestered about 4,137 
iron ions. This latter result was significantly more than the apoferritin binding ability 
determined in this assay, which housed approximately 570 iron ions (Figure 5.6.3 E). 
The Rru-EncFtnSH could bind iron ions at the FOC, metal ion entry/exit sites as well 
as the surface acidic residues, which are likely to contribute to the 47 iron ions detected 
in this experiment. While the isolated encapsulin Rru-Enc did not display any 
ferroxidase activity, it bound around 2,000 iron ions in this assay. This implies that the 
encapsulin nanocompartment shell could bind a significant amount of iron ions on its 
outer and inner surfaces. The Rru-EncFtn-Enc complex was able to bind seven times 




highlight the different roles that Rru-EncFtn and Rru-Enc play in the oxidation and 
storage of iron ions in encapsulin nanocompartments: Fe(II) is oxidised by Rru-EncFtn 
into Fe(III) and its mineralisation product is then stored in the cavity of Rru-Enc. It did 
not escape our notice that apoferritin in this experiment did not display comparable 
iron loading ability to the literature, which cited an iron binding capacity of between 
1,000 and 4,000 iron ions (Le Brun et al. 2010). This is likely a consequence of the 
iron loading method used in this experiment; other experimental approaches used a 
step-wise addition of iron to load ferritin, which might allow an increased loading 
capacity to be measured, due to lower levels of protein damage and loss through 
precipitation. This also implies that the bacterial naoncompartments might have not 
been fully occupied by iron. With experimental optimisation and progressive iron 
loading, it may be possible to record higher levels of iron storage for these complexes.  
5.6.4 Visualisation of iron-loaded proteins by TEM 
Rru-EncFtnSH was too small to be visualised under the TEM. To visualise the 
products of iron loading in the samples and to determine whether the EncFtn and 
encapsulin form amorphous iron precipitates, or ordered iron nanoparticles, the four 
protein samples including Rru-EncFtnSH, Rru-Enc, Rru-EncFtn-Enc, and horse spleen 
apoferritin were loaded with  based on the maximum  loading ratio (Figure 5.6.3) for 
1 hour at room temperature before subjecting them to transmission electron 
microscopy (TEM) analysis with or without stain by uranyl acetate (Figure 5.6.4). The 
Rru-EncFtnSH-Fe mixture showed the formation of large, irregular electron-dense 
precipitates (Figure 5.6.4 A). A similar distribution of particles was observed after 
addition of Fe(II) to the encapsulin protein (Figure 5.6.4 B). In contrast, addition of 
Fe(II) to the Rru-EncFtn-Enc nanocompartment resulted in small, highly regular, 
electron dense particles of approximately 5 nm in diameter (Figure 5.6.4 C); this was 
interpreted as controlled mineralisation of iron within the nanocompartment. Addition 
of Fe(II) to apoferritin resulted in a mixture of large particles and small (~2 nm) 
particles consistent with partial mineralisation by the ferritin and some background 
oxidation of the iron (Figure 5.6.4 D). Negative stain TEM of these samples revealed 
that upon addition of iron, the Rru-EncFtnSH protein showed significant aggregation 




present as distinct nanocompartments without significant protein aggregation (Figure 





Figure 5.6.4 TEM visualisation of iron-loaded EncFtn, encapsulin, and ferritin protein samples.  
Decameric Rru-EncFtnSH (73sH), encapsulin Rru-Enc (0974), co-expressed Rru-EncFtn and Rru-Enc (7374), and horse spleen apoferritin (apo-HsFtn), 
at 8.5 µM, were mixed with 147 µM, 1 mM, 1 mM and 215 µM acidic Fe(NH4)2(SO4)2 respectively. Protein mixtures were incubated at room temperature 
for 1 hour prior to TEM analysis with or without uranyl acetate stain. (A-D) Unstained 73sH, 0974, 7374, apo-HsFtn loaded with Fe(II), respectively, with 
35,000 x magnification and scale bars indicating 100 nm. (E) Protein-free sample as a control. (F-I) Uranyl acetate stained 73sH, 0974, 7374, apo-HsFtn 
loaded with Fe(II), respectively, with 140,000 x magnification and scale bars indicating 25 nm. The insets are bigger views corresponding to the small red 




 The iron storage in encapsulin nanocompartments 
5.7.1 Comparison of encapsulins 
As EncFtn is natively enclosed inside an encapsulin nanocompartment, the surface 
pores in encapsulin are therefore of great importance for the movement of substrates 
for the EncFtn across the nanocompartment shell. Herein, the structures of three 
encapsulins including Tm-Enc from T. maritima (KEGG ID: Tmari_0786, PDB ID: 
3DKT, resolution: 3.1 Å) (Sutter et al. 2008), Pf-Enc from P. furious (KEGG ID: 
PFC_05175, PDB ID: 2E0Z, resolution: 3.6 Å) (Akita et al. 2007) and Mx-Enc from 
M. xanthus (KEGG ID: MXAN_3556, PDB ID: 4PT2, resolution: 4.6 Å) (McHugh et 
al. 2014) were analysed for the possibility of molecule trafficking through their surface 
pores.  
Tm-Enc is a 60-meric icosahedron with 12 pentamers assembling in T = 1 symmetry. 
Both Pf-Enc and Mx-Enc form a 180-meric icosahedron, with 12 pentamers and 20 
copies of hexamers assembled in T = 3 symmetry. The R. rubrum encapsulin Rr-Enc 
(KEGG ID: Rru-Enc) shares 33% amino acid sequence identity with Tm-Enc (Sutter 
et al. 2008), and 21% identity with Pf-Enc (Akita et al. 2007) and Mx-Enc (McHugh 
et al. 2014) (Figure 5.7.1). Among the three encapsulin structures reported, only Tm-
Enc shows a similar size to Rru-Enc as determined by TEM (Figure 5.3.1), indicating 
that Rru-Enc is very likely to be a 60-meric T = 1 icosahedron assembled as 12 
pentamers. The multiple sequence alignment of these encapsulin proteins highlights 
the 5-fold or quasi-6-fold symmetry pore, which may act as the entry and exit sites of 






Figure 5.7.1 Multiple sequence alignment of encapsulin proteins. 
Encapsulin protein sequences were aligned using Clustal Omega (Sievers et al. 2011) 
including T. maritima encapsulin Tm-Enc (PDB ID: 3DKT) (Sutter et al. 2008), P. furiosus 
encapsulin Pf-Enc (PDB ID: 2E0Z) (Akita et al. 2007), 4PT2 (PDB ID) from M. xanthus 
encapsulin Mx-Enc (PDB ID: 4PT2) (McHugh et al. 2014) as well as the R. rubrum encapsulin 
Rr-Enc (KEGG ID: Rru-Enc). The alignment was presented using Espript 3.0 (Robert & Gouet 
2014). The secondary structure of Tm-Enc is shown on top of the alignment. Consensus 
sequence over 70% identity is displayed at the bottom of the alignment. Dots indicate gaps in 
the alignment. Protein residues around the 5-fold symmetry pore of encapsulin pentamers are 
highlighted in green. Residues highlighted in yellow are on encapsulin 6-fold symmetry, or 






Figure 5.7.2 Encapsulin 
residues of the 5-fold or 6-
fold symmetry pore. 
Encapsulins from (A/B) T. 
maritima (Tm-Enc), (C–F) P. 
furiosus (Pf-Enc) and (G–J) M. 
xanthus (Mx-Enc) are shown in 
their pentamer and/or hexamer 
assembly, which are presented 
in cartoon mode and coloured 
by chain. The central pore of 
the encapsulin pentamer or 
hexamer is labelled with the 
diameter (Å). (B/D/F/H/J) a cut-
away view of the encapsulin 5-
fold or 6-fold symmetry 
channels are shown in 
electrostatic potential surface 
mode with pore residues 
highlighted as sticks. (A/B) The 
5-fold symmetry channel of 
Tm-Enc pentamer is 6 Å wide 
and contains residues H190, 
Y191 and K195. (C/D) The 5-
fold symmetry channel of Pf-
Enc pentamer is 10 Å wide and 
contains residues I262 and 
E272. (E/F) The 6-fold 
symmetry channel of Pf-Enc 
hexamer is 7.6 Å wide and 
includes residues K265 and 
S266. (G/H) The 5-fold 
symmetry channel of Mx-Enc 
pentamer is 5.2 Å wide and 
contains residues T200, G201, 
V202 and E206. (I/J) The 6-fold 
symmetry channel of Mx-Enc is 
4.8 Å wide and consists of 




The Mx-Enc has a pore size of around 5 Å in the pentamer and hexamer central 
channels; this contrasts with the 6 Å pore of the of Tm-Enc pentamer and 7.6 Å of the 
Pf-Enc hexamer (Figure 5.7.2 A/E/G/I). All of the other surface pores have a diameter 
of around 5–6 Å at the narrowest region. Notably, residues 263–270 ‘YEKSGKML’ 
of Pf-Enc are not shown in the 5-fold symmetry channel due to the missing density in 
the structure, which suggests that the 10 Å pore size may be an overestimation (Figure 
5.7.2 C/D). This observation also indicates the greater levels of flexibility in the 5-fold 
symmetry pore than the 6-fold symmetry pore in the Pf-Enc structure. It is possible 
that the central channels of pentamer and hexamer of encapsulins may display 
substrate specificity and transfer molecules at different rates according to the need for 
iron storage or mobilisation.  
The 5-fold symmetry channel of encapsulins appears like an upside-down funnel, in 
which the residues are relatively less conserved between the different encapsulin 
proteins. The 5-fold and 6-fold symmetry pores of 180-meric encapsulins are very 
likely to share the same residues, as suggested by T200 and G201 in the symmetry 
pores of Mx-Enc pentamer and hexamer (Figure 5.7.2 H/J). However, the T200 
carboxylate oxygen points towards the central channel of Mx-Enc pentamer while the 
T200 side chain methyl group points towards the hexamer central channel. This 
suggests that the 180-meric encapsulin proteins utilise different orientations of the 
pentamer and hexamer central pore residues to allow the entry/exit of various 
molecules (Figure 5.7.2 C–J). The K265 in the Pf-Enc hexamer central channel 
suggests that the 6-fold symmetry pore may transport other molecules such as water, 
or phosphate ions instead of iron (Figure 5.7.2 F). The methyl side chain of T200 and 
G201 of the Mx-Enc hexamer central channel are also unlikely to coordinate iron. 
According to the sequence alignment of the encapsulin proteins, the 5-fold symmetry 
pore of Rr-Enc consists of the residues ‘TTPGGYPVLQ’ (Figure 5.7.1), in which the 
underscored GY---Q correspond to the HY---K labelled in Tm-Enc, the GV---E of Pf-
Enc, and GK---E of Mx-Enc (Figure 5.7.2 B). In the Tm-Enc 5-fold symmetry pore, 
the negatively-charged outer surface arises from the backbone carbonyl oxygen of 




interior surface (Figure 5.7.2 A/B); this electrostatic gradient would allow the entry 
of iron into the T. maritima encapsulin, but not its release by this route.  
Taken together, the 5-fold symmetry pore is very likely to be the main Fe(II) entry site 
in both the 60-meric and 180-meric encapsulins. The 6-fold symmetry pore of 180-
meric encapsulins could transport other molecules. The presence of other encapsulin 
surface pores does not rule out the possibility that they could also be involved in 
molecule trafficking across the encapsulin shell. Future experiment will focus on 
understanding the structure of Rr-Enc and the role that the residues identified in these 




5.7.2 Iron storage model of 60-meric encapsulin nanocompartments 
Since Rru-Enc crystals failed to diffract to higher than 10 Å resolution, the protein 
structure remains elusive. To understand how iron storage can occur in encapsulin 
nanocompartments, Rru-EncFtnSH as a representative of the EncFtn family was 
docked inside the Tm-Enc crystal structure, and a model for iron metabolism by the 
nanocompartment is proposed based on this analysis (Figure 5.7.3). Given that the 
decameric EncFtn associates with the inner shell of the encapsulin through its C-
terminal localisation sequence, EncFtn decamer is most likely to dock into the 
pentameric vertex of the shell rather than hexamer due to the arrangement of EncFtn 
structure. It is possible that the FOC dimer of EncFtn, or even monomer, may exist 
inside the encapsulin as iron nucleation sites (McHugh et al. 2014).  
 Although the C-terminal localisation sequence was missing in the truncated Rru-
EncFtnSH structure, the positions of the C-termini of the monomers in the Rru-
EncFtnSH structure and the localisation sequences found in Tm-Enc structure are 
spatially consistent. Thus, it appears that the EncFtn decamer is the physiological state 
of this protein. Docking the decamer in a consistent position with the localisation 
sequences in the Tm-Enc, places the central ring of EncFtn directly above the pore at 
the five-fold symmetry axis of the encapsulin shell and highlights a potential route for 
the entry of iron into the encapsulin and towards the active site of EncFtn (Figure 
5.7.3). In this bacterial compartment model, Fe(II) can enter the encapsulin shell 
through the surface pore and moves along the well-aligned central channel of EncFtn 
before accessing the metal ion entry site.  is then stripped of it hydration shell and 
translocated to the FOC where it is and oxidised. The Fe(III) is subsequently released 
to the outer surface (exit site) of the EncFtn. Fe(III) is then mineralised within the 
lumen of the encapsulin cage (Figure 5.7.3 B). This iron storage model suggests that 
iron moves from the putative entry site to the exit site of the EncFtn. To validate this 
hypothesis, the iron oxidation and storage of entry/exit site mutants of Rru-EncFtnSH 





Figure 5.7.3 The Iron storage model of 60-meric encapsulin nanocompartment. 
(A) Model of EncFtn (Rru-EncFtnSH, PDB ID: 5DA5) docked into the encapsulin shell. A single pentamer of the icosahedral T. maritima encapsulin 
structure (PDB ID: 3DKT) (Sutter et al. 2008) is shown as a blue surface with the encapsulin localisation sequence of EncFtn shown as a red surface. 
The C-terminal regions of the EncFtn subunits correspond to the position of the localisation sequences seen in 3DKT. Alignment of EncFtn with 3DKT 
positions the central channel directly above the pore in the 3DKT pentamer axis (shown as a grey pentagon). (B) Iron metabolic route in encapsulin 
nanocompartments. As EncFtn is unable to mineralise iron on its surface directly, Fe(II) must pass through the encapsulin shell to access the first metal 
binding site within the central channel of EncFtn (entry site) prior to oxidation within the FOC and release as Fe(III) to the outer surface of the protein, 
where it can be mineralised within the lumen of the encapsulin cage. (C) Surface view of EncFtn within the encapsulin nanocompartment (grey and blue 
respectively). The lumen of the encapsulin nanocompartment is considerably larger than the interior of ferritin (shown in orange behind the encapsulin for 
reference) and thus allows the storage of significantly more iron. The proposed pathway for iron movement through the encapsulin shell and EncFtn FOC 







Figure 5.7.4 Interior space comparison of fully occupied encapsulin nanocompartment 
and E. coli bacterioferritin. 
Twelve copies of R. rubrum EncFtn (Rru-EncFtnSH) coloured in grey surface mode were 
manually docked into the T. maritima encapsulin structure (PDB ID: 3DKT) (Sutter et al. 2008) 
(blue surface) to produce a model of a fully occupied encapsulin nanocompartment. This 
arrangement has an interior cavity with around 8.4 nm diameter. E. coli bacterioferritin (EcBfr, 
PDB ID: 1BFR) (Dautant et al. 1998) is a 12 nm octahedron with an 8 nm diameter cavity. 
 
A comparison of the encapsulin nanocompartment and the ferritin nanocage highlights 
the size differential between the two complexes (Figure 5.7.3 C), highlighting the 
observation that encapsulin nanocompartments can physically allow more iron to be 
stored within their cavities. However, this model assumes that the 60-meric encapsulin 
houses only one decamer of EncFtn. When the encapsulin is fully occupied by twelve 
EncFtn decamers, the inner cavity of the encapsulin nanocompartment is similar to the 
classical ferritin cage (Figure 5.7.4). This manual docking process has been described 
in Section 2.11, and can be validated by an alternative program ‘HADDOCK’ (Van 
Zundert et al. 2016). The docking results can also be evaluated using PDBePISA server 
to analyse the EncFtn-Enc interaction or EncFtn-EncFtn interaction (Krissinel & 
Henrick 2007). An estimation of the encapsulin nanocompartment interior volume 




C); a fully occupied 60-meric encapsulin nanocompartment possesses about 270 nm3 
interior space, which is analogous to 24-meric classical ferritins (Figure 5.7.4).  
When R. rubrum EncFtn and encapsulin were coexpressed in E. coli, it was very likely 
that the recombinant encapsulin was fully occupied as discussed in Section 5.5.1. 
Therefore, the presence of sixty FOCs in twelve EncFtn decamers means that they 
could potentially achieve a higher rate of iron mineralisation across the entire 
nanocompartment than the ferritin cage with 24 FOCs. This has been confirmed by 
seven-fold difference in iron loading of EncFtn-Enc in our biochemical assays than the 
horse spleen apoferritin in the same time period (Figure 5.6.3).  As the iron storage 
ability depends on iron oxidation rate and the mineralisation cavity, the practical 
maximum iron loading capacity of encapsulin nanocompartments is still unknown due 
to the uncertain stoichiometry of EncFtn and encapsulin in native bacteria. When the 
encapsulin is fully occupied by EncFtn, or the monomer ratio of EncFtn: Enc is 2:1 (as 
in our model), the iron oxidation rate would reach the maximum, while the iron storage 
space was limited to minimum (Figure 5.7.4). If the encapsulin contains only one 
decameric EncFtn (EncFtn: Enc = 1:6), the iron oxidation rate is limited by the number 
of FOCs, while the mineralisation space is maximised (Figure 5.7.3 C). It is 
anticipated that the theoretical maximum iron loading capacity can be achieved by 
optimising the expression ratio of EncFtn and encapsulin. Whether the ratio of EncFtn 
and encapsulin is regulated in the native system is not known, but it could be readily 
achieved in recombinant systems using customised ribosome binding sites, or tunable 




 Conclusions and discussion 
The recombinant R. rubrum EncFtn (Rru-EncFtn) is an active ferroxidase; and its iron 
oxidation ability was retained when co-expressed with the encapsulin protein Rru-Enc 
or Rr-Enc. Mutation of the putative ferroxidase centre of Rru-EncFtn reduces the 
ferroxidase activity of this enzyme, highlighting the essential role of the ferroxidase 
centre (FOC) in achieving the iron oxidation. Rru-EncFtn is able to bind only 48 iron 
ions due to its open structure; and while the encapsulin shell is not active to oxidise 
iron, it is able to bind up to 2,200 Fe atoms. The coexpressed EncFtn and encapsulin 
(Rru-EncFtn-Enc) is able to bind around 4,150 iron ions in our experimental system, 
which is significantly more than the calculated combined maximum iron binding 
(2,776 ± 63) of Rru-EncFtnSH and Rru-Enc as two separate proteins. These results 
suggest that the Rru-Enc encapsulin protein plays an essential supporting role as the 
iron storage vessel for the EncFtn protein.  
Comparison of the quaternary structure of EncFtn and classical ferritins shows an 
everted FOC and highlights the importance of a closed-compartment for iron 
mineralisation. With its open ‘ring-doughnut’ structure, EncFtn requires localisation 
within an encapsulin nanocompartment to function as a competent iron store. 
Collectively, a metabolic model for the storage of iron in encapsulated ferritin 
nanocompartments is proposed: Fe(II) moves inside encapsulin shell through surface 
pores to access the EncFtn, followed by translocation from the entry site to the FOC 
where Fe(II) is oxidised into Fe(III), which is subsequently released into encapsulin 
cavity and forms iron minerals.  
There are a number of open questions that remain to be answered regarding iron 
storage within encapsulin nanocompartments:  
1. The proposed iron storage model should be confirmed through mutagenesis 
of residues along the proposed oxidation and storage route in the encapsulated ferritin 
and encapsulin protein.  
2. The biochemistry and kinetics of iron oxidation catalysed by Rru-EncFtn 
remains unclear with respect to the stoichiometry of iron ions, oxidant, and electron 




methods including O2 or peroxide uptake measured by electrode oximetry and 
stopped-flow kinetic measurement (Bou-Abdallah et al. 2004; Bou-Abdallah et al. 
2005; Pfaffen et al. 2013). The transferrin-A460 method can be an alternative to the 
direct measurement of ΔA315 regarding ferroxidase activity (Bakkers & Boyerg 1986).  
3. What is the iron mineral produced by the encapsulin nanocompartments? 
Energy Dispersive X-Ray Analysis (EDX) can be applied to identify the composition 
of iron minerals in encapsulin nanocompartments (Yoshimura 2006). Optimised ICP-
MS could be used to determine the stoichiometry of iron to phosphate if it is in the 
minerals, as has been suggested for the Myxococcus xanthus encapsulin 
nanocompartment (McHugh et al. 2014). 
4. Understanding the Rru-Enc structure will give insights into the details of the 
iron storage model of encapsulin nanocompartments. Although Rru-Enc crystal trials 
failed to generate high-quality diffraction data, X-ray data collection at room 
temperature has not yet been attempted to assess the effect of cryoprotection on the 
crystals. Furthermore, optimised purification methods may yield better diffracting 
crystals. Besides, single-particle cryo-electron microscopy, as an alternative approach, 
can be employed to determine the encapsulin Rru-Enc structure and a preliminary 
dataset has been collected on samples of this protein.  
5. The native stoichiometry of Rru-EncFtn and Rru-Enc can be explored by 
orbitrap mass spectrometry (Snijder et al. 2014). Through promoter optimisation, the 
influence of the stoichiometry of EncFtn and encapsulin on iron oxidation and storage 




6 Chapter 6 Structural characterisation of EncFtn 
homologues 
 Introduction 
Encapsulin nanocompartments with encapsulated ferritin-like proteins (EncFtn) are 
widely distributed in eubacteria and archaea (Giessen & Silver 2016); and there is no 
clear environmental or lifestyle niche connecting the species with these 
nanocompartments. The organisation of the encapsulin nanocompartment operon is 
well conserved with the gene encoding EncFtn upstream of the encapsulin gene. This 
is the case for the encapsulin nanocompartment operon in eubacteria R. rubrum, T. 
maritima and H. ochraceum (Figure 6.1.1).  
 
Figure 6.1.1 Genomic context of encapsulin nanocompartments. 
Encapsulin nanocompartments including proteins EncFtn and encapsulin are encoded by two 
neighbouring genes with EncFtn locating upstream of encapsulin in eubacteria, of which the 
linker sequence between genes EncFtn and encapsulin differs in lengths. The arrows indicate 
the promoter of each gene expression. The EncFtn and encapsulin proteins are encoded by 
genes Rru_A0973 and Rru_A0974 in R. rubrum, Hoch_3836 and Hoch_3837 in H. ochraceum, 
Tmari_0787 and Tmari_0786 in T. maritima, respectively. The encapsulin nanocompartments 
in archaea are represented by P. furiosus, in which a single gene PFC_05175 encodes a 
polypeptide that contains EncFtn and encapsulin domains. 
T. maritima is an anaerobic thermophilic eubacterium and grows optimally at 80°C 
(Huber et al. 1986). The structure of the encapsulin protein from the encapsulin 
nanocompartment of T. maritima was determined in 2008 as a 60-meric icosahedron 
with T = 1 (PDB ID: 3DKT) (Sutter et al. 2008). H. ochraceum is an aerobic, obligate 
halophile which grows in 0.5–6% NaCl (optimally in 1–3% NaCl) and at 20–40°C 
(Fudou et al. 2002). The DNA sequence between EncFtn and encapsulin genes varies 




rubrum a promoter was predicted in the linker sequence (87 bp) between Rru_A0973 
and Rru_A0974 by using an online program BPROM (Solovyev & Salamov 2011). 
There are only two bases between Hoch_3836 and Hoch_3837 while between 
Tmari_0787 and Tmari_0786 there are 14 bp; in either case no promoter of encapsulin 
protein was predicted. 
In contrast to this conserved genomic architecture the encapsulin nanocompartment in 
P. furiosus is encoded by a single gene PFC_05175 (Figure 6.1.1). P. furiosus is an 
anaerobic hyperthermophilic archaeon and grows optimally at about 100°C and pH 7 
(Namba et al. 2005). The crystal structure of the encapsulin nanocompartment isolated 
from P. furiosus displayed a 30–32 nm icosahedron with electron density observed 
only for the encapsulin shell from residues 110 to 345 of the mature protein (Akita et 
al. 2007). This ‘one gene encoding an encapsulin nanocompartment’ has been found 
in about 10% archaeal species according to the orthologue search of protein 
PFC_05175 in KEGG database (Ogata et al. 1999). 
Given the different environmental niches that these microorganisms live it is 
interesting to know if they possess different structural and functional features of 
EncFtn related to their lifestyles. In this chapter, truncated EncFtn from H. ochraceum, 
T. maritima and P. furiosus was overexpressed in E. coli and purified through IMAC 
and SEC. The structures of these recombinant proteins were determined using X-ray 
crystallography. The structural features of EncFtn homologues will be further 
discussed related to the ecological niches of their microbes. As T. maritima EncFtn 
failed to grow any protein crystals, the protein was not analysed further.   
 Protein purification 
Rru-EncFtn shares 55% amino acid sequence identity with Hoch-EncFtn (Hoch_3836) 
and 29% identity with the EncFtn domain of PFC_05175 (Pfc-EncFtn). A multiple 
sequence alignment of EncFtn homologues reveals the highly conserved ferroxidase 
centre including E32, E62, H65 and Y39 of Rru-EncFtnSH. While the metal ion entry 
site (E31 and E34 of Rru-EncFtnSH) and exit site (H57, E61 and E64 of Rru-
EncFtnSH) are well conserved in Hoch-EncFtn, but poorly conserved in the Pfc-




by EncFtn family is missing in PFC_05175 (Figure 6.2.1). Based on the alignment, 
constructs for the heterologous expression of Hoch-EncFtn and Pfc-EncFtn were 
designed for crystallisation as truncated proteins with 1–98 residues (Hoch-EncFtnS) 
and 1–99 residues (Pfc-EncFtnS), respectively (Figure 6.2.1).  
 
Figure 6.2.1 Protein sequence alignment of EncFtn proteins. 
EncFtn proteins in different constructs including Rru-EncFtn (Rru_A0973), Rru-EncFtnSH, 
Hoch-EncFtn (Hoch_3836), Hoch-EncFtnS, Pfc-EncFtnS and Pfc-EncFtn-Enc (PFC_05175) 
were aligned using Clustal Omega (Sievers et al. 2011; McWilliam et al. 2013; Li et al. 2015), 
and the alignment picture was generated by Espript 3.0 (Robert & Gouet 2014). Dots indicate 
gaps in the alignment. Secondary structure information of Rru-EncFtnSH (PDB ID: 5DA5) and 
PFC_05175 (PDB ID: 2E0Z) is highlighted on top and in the bottom of the alignment, 
respectively. The C-terminal localisation sequences of EncFtn are highlighted with yellow 
rectangles. Residues in the FOC of Rru-EncFtnSH are highlighted with solid red triangles. 
Residues in the metal ion entry site are pointed by solid red spheres. Residues in the metal 




6.2.1 Pfc-EncFtnS purification 
The Pfc-EncFtnS protein construct was calculated to have a molecular weight of 
11.304 kDa and pI value of 4.49. It was purified from E. coli Tuner(DE3) cells grown 
in LB medium using Q sepharose AEC (Figure 6.2.2), followed by SEC (Figure 6.2.3). 
Unlike the size-exclusion chromatogram of Rru-EncFtnSH, Pfc-EncFtnS only 
displayed a single A280 peak and an A315 peak at around 72 ml retention volume, 
suggesting the presence of a single oligomeric state with iron bound. The SDS-PAGE 
analysis revealed a major band at decamer size (around 110 kDa), which was later 
identified as PFC_05175 protein through PMF. It suggested a stronger interaction in 
the decamer assembly of Pfc-EncFtnS. 
 
Figure 6.2.2 Anion exchange chromatography purification of Pfc-EncFtnS using a Q 
sepharose column. 
(A) Q-sepharose purification chromatogram of Pfc-EncFtnS. Fractions FT indicate the flow-
through. Proteins were eluted by a linear gradient of 0 - 1 M NaCl over 20 column volumes as 
fractions from A9 to G12. (B) Fractions from (A) were analysed by 15% SDS-PAGE in which 






Figure 6.2.3 Size-exclusion chromatography purification of Pfc-EncFtnS using HiLoad 
Superdex 16/600 200 pg column.  
(A) Size exclusion chromatogram of Pfc-EncFtnS purified from E. coli Tuner(DE3). Proteins 
were eluted by GF buffer as fractions B3-B9. (B) Fractions from (A) were analysed by 18% 
SDS-PAGE as a minor monomer-sized band (11.3 kDa) and a major decamer-sized band 
(113 kDa). 
6.2.2 Hoch-EncFtnS purification 
Hoch-EncFtnS protein was calculated to have a molecular weight of 11.572 kDa and 
pI of 4.76 by ExPASy ProtParam tool (Gasteiger et al. 2005). It was purified from E. 
coli BL21(DE3) grown in LB medium by Q sepharose AEC (Figure 6.2.4), followed 
by SEC (Figure 6.2.5). The gel-filtration chromatogram of Hoch-EncFtnS displayed 
a number of A280 and A315 peaks at around 47, 60, 69, 78 and 88 ml retention volume. 
The SDS-PAGE analysis revealed more than two bands of monomer and dimer masses, 
suggesting the presence of multiple oligomeric states of Hoch-EncFtnS in solution. It 
was very interesting to observe that the A315 curve showed a similar profile with A280, 
which is in contrast to the observation that monomeric Rru-EncFtnSH has no 
absorbance at 315 nm due to the lack of iron binding. However, since the A315 had the 
highest peak at 110 ml, of which no protein was detected, the solution might have 






Figure 6.2.4 Anion exchange chromatography purification of Hoch-EncFtnS using Q 
sepharose column.  
(A) Q sepharose purification chromatogram of Hoch-EncFtnS. Fractions FT indicates the flow-
through. Proteins were eluted by a NaCl gradient from 0–1 M over 20 column volumes. (B) 
Fractions 17-34 collected from (A) were analysed by 18% SDS-PAGE in which only fractions 
17-20 show two major bands around 12 and 25 kDa, correlating with the estimated monomer 





Figure 6.2.5 Size exclusion chromatography purification of Hoch-EncFtnS using HiLoad 
Superdex 16/600 200 pg column. 
(A) Size-exclusion chromatogram of Hoch-EncFtnS purified from E. coli BL21(DE3). Proteins 
were eluted by GF buffer as fractions D3-G3. (B) 15% SDS-PAGE analysis of S200-purified 




 Crystallisation and structure determination of Hoch-EncFtnS 
and Pfc-EncFtnS 
The major size-exclusion chromatographic peak fractions of Pfc-EncFtnS and Hoch-
EncFtnS were pooled separately and concentrated to around 10 mg/ml before being 
subjected to crystallisation trials. The Pfc-EncFtnS fractions crystallised easily in 
many conditions from JCSG plus (Molecular Dimensions) (Newman et al. 2005) and 
PEG/Ion (Hampton Research) screening kits using sitting-drop vapour diffusion 
method. The best diffraction data were collected from a crystal grown in 0.2 M lithium 
sulphate monohydrate and 20% (w/v) PEG 3350 (Figure 6.3.1). Cryo-protectant 
solution including 0.2 M lithium chloride, 20% (w/v) PEG 3350 and 15% (v/v) PEG 
200 was used when flash cooling the crystal prior to the data collection at 100 K at the 
Diamond Light Source (Didcot, UK). Hoch-EncFtnS crystallised in 0.2 M sodium 
chloride, 0.1 M Bis-Tris (pH 5.5) and 20% (w/v) PEG 3350 using the hanging-drop 
vapour diffusion method (Figure 6.3.1). 15% (v/v) PEG 200 was supplemented into 
the mother liquor as the cryo-protectant solution. 
 
Figure 6.3.1 Crystal images of Pfc-
EncFtnS and Hoch-EncFtnS. 
The horizontal and vertical scale bars 
indicate the crystal size. 
 
 
Both diffraction datasets were collected at 10–100 eV above the theoretical Fe-K edge, 
integrated and scaled using XDS , and merged with Aimless (Evans & Murshudov 
2013). Structures were phased by molecular replacement using a modified Rru-
EncFtnSH monomer or decamer structure as the search model in Phaser (McCoy et al. 
2007). The structures were then built using Coot (Emsley et al. 2010) and refined with 
Refmac5 (Pannu et al. 1998; Steiner et al. 2003), followed by Phenix.refine (Adams et 




  Hoch-EncFtnS Pfc-EncFtnS 
Data collection   
Beamline I04 I04 
Wavelength (Å) 1.72 1.74 
Resolution range 47.82–2.06 (2.13–2.06) 47.19–2.03 (2.10–2.03) 
Space group C 1 2 1 P 1 21 1 
Unit cell (Å)  a 91.63 99.85 
                    b 92.65 110.06 
                    c 119.29 136.27 
α = γ = 90°, ß = 106.93 91.22 
Total reflections 112,239 (10,771) 371,374 (36,434) 
Unique reflections 57,293 (5,570) 190,563 (18,927) 
Multiplicity 2.0 (1.9) 1.9 (1.9) 
Completeness (%) 96 (94) 100 (99) 
Mean I/sigma(I) 9.50 (2.48) 13.87 (5.76) 
Wilson B-factor 31.67 22.84 
Rmerge 0.0403 (0.283) 0.0396 (0.158) 
Rmeas 0.0571 (0.401) 0.0560 (0.224) 
CC1/2 0.997 (0.914) 0.996 (0.95) 
CC* 0.999 (0.977) 0.999 (0.987) 
Image DOI   
Refinement   
Rwork 0.199 (0.285) 0.174 (0.223) 
Rfree 0.244 (0.334) 0.202 (0.245) 
CC(work) 0.965 (0.930) 0.967 (0.931) 
CC(free) 0.936 (0.855) 0.953 (0.914) 
Number of non-hydrogen atoms 7,819 25,735 
  macromolecules 7,650 23,691 
  ligands 1 30 
Protein residues 916 2,922 
RMS(bonds) (Å) 0.003 0.002 
RMS(angles) (°) 0.46 0.44 
Ramachandran favoured (%) 99 100 
Ramachandran allowed (%) 1.2 0.1 
Ramachandran outliers (%) 0 0 
Rotamer outliers (%) 0.84 0.35 
Clashscore 1.2 1.21 
Average B-factor (Å2) 44.57 28.97 
  macromolecules 44.59 28.32 
  ligands 34.68 19.73 
  solvent 43.7 36.74 
Protein Data Bank code     
Table 6.3.1 Data collection and refinement statistics of Hoch-EncFtnS and Pfc-EncFtnS. 
Statistics for the highest-resolution shell are shown in parentheses. Friedel mates were 




 Structural analysis of Hoch-EncFtnS and Pfc-EncFtnS 
The Hoch-EncFtnS (Hoch) structure was determined to 2.05 Å resolution in space 
group C 1 2 1; with ten monomers in an annular decamer in the ASU. The structure of 
Pfc-EncFtnS (Pfc) was determined to 2.02 Å resolution in space group P 1 21 1, with 
three decamers in the ASU. The RMSDCα of Rru-EncFtnSH (Rru) in 16–76 residues 
(α1-α2) are 0.333 Å with counterparts of Hoch-EncFtnS and 0.461 Å of Pfc-EncFtnS 
(Figure 6.4.1 and Figure 6.4.2). A closer inspection of the structural alignment 
revealed three main differences among Hoch, Pfc and Rru structures: the N-terminus, 
the C-terminal helix and metal binding sites.  
 
Figure 6.4.1 Decameric structure alignment of EncFtn homologues.  
Decamer structures of Rru-EncFtnSH (purple), Pfc-EncFtnS (cyan) and Hoch-EncFtnS (yellow) 
were aligned by secondary structure matching and are shown in cartoon mode with 






The N- and C-termini of the Hoch-EncFtnS structure displayed high similarity with 
Rru-EncFtnSH structure. The crystal structure of the Pfc-EncFtnS construct had an 
ordered N-terminus, which is in contrast to the disordered N-termini of the Rru-
EncFtnSH and Hoch-EncFtnS structures (Figure 6.4.2). This observation implied that 
the N-terminal region of the EncFtn homologues had a varying degree of flexibility in 
the different species. Since the N-terminus of the protein was found within the central 
channel of decameric EncFtn that connected the 5-fold symmetry pore of encapsulin 
and the metal ion entry site of Rru-EncFtn as a potential Fe(II) moving route in 
encapsulin nanocompartments (Figure 5.7.3), the flexibility of the N-terminus might 
affect the Fe(II) access to the metal ion entry site and thus the catalytic activity of the 
EncFtn. The C-terminus of Pfc-EncFtnS was longer and more structured than the 
equivalent parts of Rru-EncFtnSH and Hoch-EncFtnS. The contribution of the C-
terminus to the structural stability will be further explored in the Figure 6.5.3. 
 
 
Figure 6.4.2 Structural alignment of FOC dimers of EncFtn homologues.  
The aligned FOC dimer structures of Rru-EncFtnSH (Rru, purple), Pfc-EncFtnS (Pfc, cyan) 
and Hoch-EncFtnS (Hoch, yellow) are shown in cartoon mode with glycolic acid (GOA), iron 
ions (purple and cyan balls) and calcium ions (white balls) coordinated. GOA, Ca(II) and Fe 
ions in purple belong to Rru-EncFtnSH structure while iron ions in cyan spheres belong to the 
Pfc-EncFtnS structure. The N-termini and C-termini of proteins are highlighted in 




6.4.1 Putative metal binding sites in the Hoch-EncFtnS structure 
 
Figure 6.4.3 Wall-eyed stereo view of the equivalent metal binding residues of Rru-
EncFtnSH in Hoch-EncFtnS dimer interface. 
Protein residues are shown as sticks with yellow and orange carbons for the different chains 
of Hoch-EncFtnS, green and blue carbons for the different chains of Pfc-EncFtnS structure. 
2mFo-DFc density map is superimposed on the structure and contoured at 1.3 σ. (A) The 
equivalent metal ion entry site of Rru-EncFtnSH in the Hoch-EncFtnS structure consists of 
E30 and E33 from two chains. (B) The equivalent FOC of Hoch-EncFtnS consists of E31, E61, 
H64 and Y38 of two adjacent chains. (C) The equivalent metal ion exit site in Hoch-EncFtnS 
is composed of H56, E60 and E63 of two chains. 
Although the metal binding residues of Rru-EncFtnSH are conserved in the Hoch-
EncFtnS protein sequence (Figure 6.2.1), no metal ions were observed in the 
equivalent FOC or metal entry/exit sites of Hoch-EncFtnS structure (Figure 6.4.3). 




and E33, equivalent to the E31 and E34 of Rru-EncFtnSH structure (Figure 6.4.7 A). 
There was no metal binding in the metal ion entry site of Hoch-EncFtnS structure. The 
metal ion exit site consisted of H56, E60 and E63 of two chains, equivalent to the H57, 
E61 and E64 of Rru_A073sH (Figure 6.4.7 B). However, the metal ion exit site of 
Hoch-EncFtnS did not bind any metal in the structure. 
The absence of metal in the FOC of the Hoch-EncFtnS structure could be ascribed to 
two possibilities. The first hypothesis was that Hoch-EncFtnS was not a real 
ferroxidase and thus could not bind iron. In the FOC of Hoch-EncFtnS structure, two 
of three main di-iron coordinating residues moved beyond the iron binding distance 
(Harding et al. 2010). The chi3 angle of E31 in the Hoch-EncFtnS structure is flipped 
100° away from the aligned counterparts, and keeps a 4 Å distance with the iron ions 
of Pfc-EncFtnS and Rru-EncFtnSH structures (Figure 6.4.7 A). Besides, the E61 side 
chain of Hoch moved closer to the iron ions of Pfc-EncFtnS and Rru-EncFtnSH as 1.6 
Å. The coordination symmetry also broke in E61 and E61’ from Hoch-EncFtnS FOC 
dimer (Figure 6.4.6 B). This hypothesis would be readily validated by ferroxidase 
assays.  
The second hypothesis was that due to the low pH of the Hoch-EncFtnS crystallisation 
buffer (Bis-Tris, pH 5.5), in which the side chain nitrogen of H64 would possibly be 
protonated, leading to an inability to coordinate iron and the possibility of hydrogen 
bonding (3.5 Å) between H64 and E61’, thus precluding metal binding completely. To 
further assess if basic pH of crystallisation conditions combined with iron soaking of 
crystals will facilitate the iron binding in Hoch-EncFtnS structure, the protein was 
crystallised in 0.2 M (NH4)2SO4, 0.1 M Tris-HCl, pH 8.0, 23% (w/v) PEG 3350 and 
then soaked in a cryo-protectant solution containing the mother liquor and 12% (v/v) 
PEG 200 as well as 1 mM acidic Fe(NH4)2(SO4)2 for 1–30 minutes; or crystals grown 
in similar conditions with 0.1 M Bis-Tris (pH 5.5) instead of Tris-HCl were soaked in 
the 1 mM acidic Fe(NH4)2(SO4)2 for 1-45 minutes. To reduce the radiation damage 
caused by free iron ions in crystals, some iron-soaked crystals were also back-soaked 
swiftly in cryo-protectant without iron. However, none of these crystals displayed di-




6.4.2 Putative metal binding sites in Pfc-EncFtnS 
 
Figure 6.4.4 Putative metal binding sites in Pfc-EncFtnS FOC dimer interface. 
(A) Putative metal/ligand binding sites of Pfc-EncFtnS consist of E32, E62, H65 and Y39 of 
two adjacent chains, which are shown as sticks and coloured in green and cyan. The 2mFo-
DFc electron density is shown in blue mesh and contoured at 1.3 σ. The mFo-DFc difference 
map is shown in green mesh and contoured at 3.5 σ. (B) The top view of (A). Two peaks of 
the difference map, with each surrounded by monodentate E62, Y39 and bidentate E32’, H65’ 
of the adjacent chain, correspond to the two metal ions. There are another two small peaks on 
top of di-metal, corresponding to water molecules. 
The electron density map of the initial model of Pfc-EncFtnS displayed two significant 
positive peaks in the mFo-DFC map at the centre of FOC with a difference peak height 
around 3 σ (Figure 6.4.4). The diffraction data were collected at the experimentally 
determined Fe-K edge, and an anomalous difference Fourier map was calculated with 
the data (Figure 6.4.5 B). Despite the Pfc-EncFtnS being produced with no additional 
iron and the absence of additional iron in the crystallisation mother liquor, the FOC 
was still occupied by two iron ions. Furthermore, compared to the glycolic acid (GOA) 
coordinated above the di-iron in Rru-EncFtnSH, two water molecules were 
coordinated above the di-iron centre in Pfc-EncFtnS (Figure 6.4.6). The metal ion 
entry and exit sites in the Pfc-EncFtnS structure are not well conserved with the Rru-
EncFtn and Hoch-EncFtn proteins and did not display any metal binding in the crystal 
structure (Figure 6.4.5 A/C and Figure 6.4.7). The entry site in Pfc-EncFtnS 




two homologues. In the absence of suitable coordinating residues, it is perhaps not 
surprising that no metal is seen in this site in the Pfc-EncFtnS structure. The lack of 
the conserved secondary metal-binding sites in the Pfc-EncFtnS structure suggests its 
biochemistry may have different kinetics, or even activity compared to the Rru-
EncFtnSH, which is worth exploring in future studies.  
 
Figure 6.4.5 Wall-eyed stereo view of the equivalent metal binding residues of 
Rru_0973sH in Pfc-EncFtnS dimer interface. 
Protein residues are shown as sticks with green and blue carbons for the different chains of 
the Pfc-EncFtnS structure. 2mFo-DFc density map is superimposed on the structure and 
contoured at 1.3 σ. (A) The equivalent metal ion entry site in Pfc-EncFtnS structure consists 
of A31 and D34 from two chains. (B) The equivalent FOC of Pfc-EncFtnS consists of E32, E62, 
H65 and Y39 of two adjacent chains, which coordinate di-iron ions (cyan spheres) with two 
water molecules (red crosses) bound above. The anomalous difference Fourier map obtained 
from data collected at the Fe-K edge is superimposed as an orange mesh and contoured at 5 
σ. (C) The equivalent metal ion exit site in Pfc-EncFtnS is composed of D57, E61 and A64 of 





Figure 6.4.6 FOC of Pfc-EncFtnS and the superimposed FOC of EncFtn homologues. 
(A) Symmetrical FOC of Pfc-EncFtnS with distance between iron ions and coordinating residues shown in Ångstroms. Protein residues are shown as 
sticks with green and blue carbons for the different chains of Pfc-EncFtnS structure in the dimer. (B) Aligned FOC of Rru-EncFtnSH (purple), Hoch-
EncFtnS (yellow) and Pfc-EncFtnS (cyan) are shown in stick mode. The positions of di-iron ions of Rru-EncFtnSH and Pfc-EncFtnS are well aligned and 
shown as purple and cyan spheres, respectively. The two water molecules above the cyan di-iron ions of Pfc-EncFtnS are shown in red crosses. Glycolic 
acid bound by the purple di-iron ions of Rru-EncFtnSH are shown in purple lines. Labels of residues from each protein were in the same colour following 
by protein anonyms (Rru: Rru-EncFtnSH, Pfc: Pfc-EncFtnS, Hoch: Hoch-EncFtnS). Labels of residues from dimers were differentiated with a prime symbol. 
Among aligned residues, Hoch differs from Pfc and Rru in E31 and E61 residues, with the chi3 angle of E31 residue flipping away from the centre and 





Figure 6.4.7 Superimposed metal ion entry and exit sites of EncFtn homologues. 
Aligned metal ion entry sites (A) and exit sites (B) of Rru-EncFtnSH (Rru, purple), Pfc-EncFtnS (Pfc, cyan) and Hoch-EncFtnS (Hoch, yellow) are shown 
in sticks. Ca(II) ions shown in white spheres are coordinated by Rru-EncFtnSH. Distance between Ca(II) and neighbouring residues labelled by dashed 
lines of different colours with Å as the unit. The geometry of entry sites in Hoch-EncFtnS and Pfc-EncFtnS suggests that they do not bind metal ions. The 




6.4.3 Surface characteristics of EncFtn homologue structures 
To analyse the surface characteristics of the EncFtn homologues, molecular surfaces 
with mapped electrostatic potentials were calculated using the APBS plugin (Baker et 
al. 2001) in PyMOL (Schrodinger 2015). The three EncFtn homologues display 
distinct charge distributions on the decamer surface (Figure 6.4.8 A–F). It is very clear 
to see that the size of five-fold symmetry channel varies among Rru, Pfc and Hoch, 
although this is dependent on the completeness of the crystallographic model in the N-
terminal regions as mentioned above. The five-fold symmetry channel of EncFtn in 
the native encapsulin in vivo is proposed to be the route of entry of Fe(II) from the 
five-fold channel of the encapsulin towards the metal ion entry site of EncFtn (Figure 
5.7.3). Notably, the large size of the five-fold symmetry channel seen in Rru-
EncFtnSH and Hoch-EncFtnS structures was likely an artefact of the crystallographic 
models and did not imply greater level of iron access through the complex (Figure 
6.4.8 A/C), as it was surrounded by the N-terminus of the protein in the EncFtn 
homologue structures. 
The negatively-charged patch in the metal ion entry site of Rru-EncFtnSH was 
consistent with the structural observation of E31 and E34 residues (Figure 6.4.8 G). 
The metal entry site of Pfc-EncFtnS was blocked by the N-terminus of the protein, 
which was shown as a positively-charged patch contributed by the backbone nitrogens 
of residues in this region (Figure 6.4.8 H). The red patch of negative charge in the 
metal ion entry site of Hoch (Figure 6.4.8 I) supported the wider space measured in 
Figure 6.4.7 A. The surface comparison of metal ion exit sites of Rru-EncFtnSH and 
Hoch-EncFtnS revealed a similar negatively-charged region (Figure 6.4.8 J/L), while 
the narrower red patch in Pfc-EncFtnS metal exit site (Figure 6.4.8 K) was consistent 





Figure 6.4.8 Electrostatic surfaces of EncFtn homologues. 
The solvent accessible surface of EncFtn homologues are shown, coloured by electrostatic 
potential as calculated in PyMOL(Schrodinger 2015). Negatively charged regions are coloured 
red and positively charged regions in blue, neutrally charged regions in grey. (A, B, C) Top 
view of decameric Rru-EncFtnSH, Pfc-EncFtnS and Hoch-EncFtnS. (D, E, F) Side cross-
section view of (A, B, C). (G, H, I) Side view of monomeric Rru-EncFtnSH, Pfc-EncFtnS and 
Hoch-EncFtnS with metal ion entry site highlighted by green circles. (J, K, L) Side view of 
monomeric Rru-EncFtnSH, Pfc-EncFtnS and Hoch-EncFtnS with metal ion exit site 
highlighted by yellow circles. Ca(II) as white spheres bound by metal exit site of Rru-EncFtnSH 




 The dimer interface comparison of EncFtn homologues 
With a conserved quaternary architecture, both Pfc-EncFtnS and Hoch-EncFtnS have 
dimer interfaces that correspond to the those seen in the Rru-EncFtnSH structure, with 
the main difference seen in the metal coordination within the FOC interface (Figure 
6.5.1). There are no disulphide bridges present in either of these interfaces.  
 
Figure 6.5.1 Dimer interfaces of EncFtn homologues. 
The two distinct dimer interfaces of the EncFtn homologues are shown with one chain shown 
as a secondary structure cartoon and the other chain as a surface representation with mapped 
electrostatic potential calculated in PyMOL (Schrodinger 2015). On the surface red areas 
indicate negatively-charge, blue positive charge, and white showing neutral regions. (A) The 
FOC dimer interface of Rru-EncFtnSH is shown with iron ions bound as magenta spheres and 
calcium ions as white spheres. (B) The FOC dimer interface of Pfc-EncFtnS is shown with di-
iron ions shown in cyan spheres. (C) The FOC dimer interface of Hoch-EncFtnS is shown. 
Non-FOC dimer interfaces of (D) Rru-EncFtnSH, (E) Pfc-EncFtnS and (F) Hoch-EncFtnS are 




6.5.1 Structural adaptation of Pfc-EncFtnS to hyperthermophilic 
conditions 
Pfc-EncFtnS buried 45% surface area in the FOC dimer interface, which was stabilised 
by 14 hydrogen bonds and 5 salt bridges (Table 6.5.1 and Figure 6.5.2). Here the 
contribution of iron binding to the interface interaction was not counted by PDBePISA 
server (Krissinel & Henrick 2007). The non-FOC dimer interface of Pfc-EncFtnS 
comprised around 47% of the buried surface area, which was stabilised by 19 hydrogen 
bonds and 24 salt bridges (Figure 6.5.3 B/E and Table 6.5.1). Notably, the more 
structured C-terminal α3 helix and longer N-terminus of Pfc-EncFtnS allowed it to 
interact not only with the adjacent chain, but also with the chain next to the 
neighbouring chain (Figure 6.5.3 B/E), which is likely to enhance the structural 
stability of the decamer. Most thermophilic proteins are generally characterised by 
large hydrophobic core, increased disulphide bonds, high number of salt-bridges and 
surface charges compared to the mesophilic counterparts (Reed et al. 2013). In the case 
of hyperthermophilic Pfc-EncFtnS, more interface residues and hydrogen bonding 
involved in the FOC dimer interface as well as the higher number of salt bridges in the 
non-FOC dimer interface than the mesophilic Rru-EncFtnSH counterpart, supporting 
the notion that thermophiles maintain the structural stability under high temperature 
via structural adaptation such as increased ionic interactions (Reed et al. 2013). 
Proteins 



















Rru-EncFtnSH 34%–36% 8 6 60% 21 15 
Pfc-EncFtnS 45% 14 5 47% 19 24 
Hoch-EncFtnS 34% 5 15 58% 17 4 
Table 6.5.1 Dimer interface comparison of EncFtn homologues analysed by PDBePISA. 
The FOC dimer and non-FOC dimer of Rru-EncFtnSH, Pfc-EncFtnS and Hoch-EncFtnS were 
analysed by PDBePISA to determine the residues and bonds formed in the interfaces  




6.5.2 Structural adaptation of Hoch-EncFtnS to halophilic conditions 
Hoch-EncFtnS resembled Rru-EncFtnSH regarding the residues forming the dimer 
interfaces (Table 6.5.1). The FOC dimer interface contained 5 hydrogen bonds and 15 
salt bridges (Figure 6.5.2 C/F). The non-FOC dimer interface was stabilised by 17 
hydrogen bonds and 4 salt bridges (Figure 6.5.3 C/F). Halophilic proteins that are able 
to stay active in hypersaline environment are characterised by increased negative 
surface charge due to increased acidic residues (Siglioccolo et al. 2011), reduced 
numbers of hydrophobic residues as well as the salt-dependent assembly (Reed et al. 
2013). In the case of halophilic Hoch-EncFtn, both the full length protein and the short 
construct contained the same amount of acidic amino acid residues with the 
counterparts of Rru-EncFtn. The Hoch-EncFtn full length protein consisted of 59 non-
polar residues by contrast to the 70 of Rru-EncFtn according to the estimation by 
EMBOSS Pepstats (Rice et al. 2000). Since EncFtn is natively enclosed in its 
encapsulin protein, the structural adaptation of encapsulated proteins may be different 





Figure 6.5.2 Polar 
contacts in the FOC 
dimer interfaces of 
EncFtn homologues. 
(A/B/C) FOC dimers of 
Rru-EncFtnSH (pink and 
purple), Pfc-EncFtnS 
(cyan and green), Hoch-
EncFtnS (yellow and 
orange) are shown as 
cartoon representations. 
(C/ D/E) Residues 
involved in the polar 
contacts between FOC 
dimers of (A/B/C) are 
shown as sticks. The 
polar contacts are 
displayed as red dashed 
lines between the 
interacting residues of 





Figure 6.5.3 Polar contacts in the non-FOC dimer interface of EncFtn homologues. 
The Non-FOC dimers of (A) Rru-EncFtnSH (purple and light teal), (B) three chains of Pfc-EncFtnS (green, cyan and wheat) and (C) non-FOC dimers of 
Hoch-EncFtnS (forest and yellow) are shown as cartoon representations. (C/D/E) Residues involved in the polar contacts between non-FOC dimers of 
(A/B/C) are shown in sticks and labelled with different colours representing 2–3 chains of each protein. The polar contacts are displayed as red dashed 
lines between the interacting residues of two chains. (B/E) In the Pfc-EncFtnS structure, the long C-terminal α3-helix and the N-terminal loop of the wheat 
chain are both interacting with the green and cyan chains. The red circles highlight the interacting residues between the C-terminus of the wheat chain 




 The putative assembly of P. furiosus encapsulin 
nanocompartment 
The structure of the P. furiosus encapsulin nanocompartment (KEGG ID: PFC_05175) 
was determined in the year 2007 and was initially thought to be a virus-like particle 
(PDB ID: 2E0Z). The native encapsulin purified from P. furiosus formed an 
icosahedron with T = 3 symmetry and 180 copies of the 38.8 kDa protein present in 
the capsid (Akita et al. 2007). The P. furiosus encapsulin was made up of 12 pentamers 
and 20 hexamers. In this article, it was proposed as a single gene with fused EncFtn 
and encapsulin encoding a single polypeptide, or EncFtn: Enc = 1:1, which meant that 
there were 180 subunits of encapsulin and 180 subunits of EncFtn in P. furiosus 
encapsulin nanocompartment. Since the Pfc-EncFtnS was determined as a ring-like 
decamer structure, the question was how the 12 pentamers and 20 hexamers of 
encapsulin accommodated 18 copies of decameric EncFtn. The Pfc-EncFtnS decamer 
structure could only be docked within the pentameric encapsulin structure in analogous 
to the R. rubrum encapsulin nanocompartment model, which remained 20 hexameric 
encapsulin and 60 subunits of EncFtn. This contradicted with the 1:1 molar ratio of 
EncFtn and encapsulin in P. furiosus encapsulin nanocompartment.  
There was no doubt that it was a single gene encoding two fused proteins EncFtn and 
encapsulin. Firstly, the sequencing of PFC_05175 gene amplified using P. furious 
DSM 3638 genome as the template confirmed it was a single gene. Secondly, the 
PFC_05175 protein sequence did not show the C-terminal localisation sequence 
shared by EncFtn family proteins, indicating that the C-terminus of EncFtn and N-
terminus of encapsulin were fused. However, our expression test of PFC_05175 with 
optimised codon (pET-28a(+)-optPFC_05175) in E. coli BL21(DE3) revealed two 
major bands around 26 kDa and 38 kDa, which survived 100°C treatment, consistent 
with the encapsulin protein and the full length of PFC_05175 (Figure 6.6.1). The 
inspection of the RBS of PFC_05175 mRNA sequence revealed that when expressed 
in native archaeon P. furiosus the first ATG was evaluated as translation rate 4278 au 
while the GTG at position 327 had the highest translation rate 13540 au, suggesting 
that an extra translation could have initiated from the GTG (Espah Borujeni et al. 2014; 
Salis et al. 2009). Interestingly, the sequence translated from GTGGAATATTTTGAG 




encapsulin structure, indicating that an extra encapsulin protein could be expressed on 
top of the full-length EncFtn-Enc translated from the first ATG. The deduction, 
however, was inconsistent with the single band (38 kDa) on SDS-PAGE gel of the 
encapsulin nanocompartment purified from P. furiosus (Namba et al. 2005). When 
PFC_05175 was overexpressed in E. coli without codon optimisation, the first ATG 
was assessed as the highest translation rate, indicating that only a single fused EncFtn-
encapsulin was produced; theoretically, the encapsulin nanocompartment could not be 
assembled functionally with 1:1 of EncFtn to encapsulin. 
 
Figure 6.6.1 Expression test of pET-28a(+)-optPFC_05175 in E. coli BL21(DE)3 on 15% 
SDS-PAGE. 
E. coli BL21(DE3) harbouring the plasmid pET-28a(+)-optPFC_05175 was expressed in 5 ml 
LB medium with the induction of 1 mM IPTG under the conditions of 37°C, 4 hrs or 18°C, 22 
hrs. Protein marker was loaded in lane M. 1 ml uninduced cells were pelleted by centrifugation 
at 15,000 g for 1 min and loaded into lane 1 as a control. 4 ml induced cells were centrifuged 
and the pellet was resuspended in 1 ml GF buffer, followed by sonication for 20 s and 
centrifuged at 15,000 g for 1 min. The lysate supernatants were loaded into lanes 2 and 7. 
The pellet or insoluble proteins were loaded into lanes 3 and 8. The lysate supernatants were 
heated at 80°C for 10 min, followed by centrifugation; the resulting supernatants were loaded 
into lanes 4 and 9. The lysate supernatants were heated at 80°C for 10 min and another 100°C 
for 10 min, followed by centrifugation; the resulting supernatants were loaded into lanes 5 and 
10 while the pellets were loaded into lanes 6 and 11. All samples were mixed with 1 x SDS 
loading buffer, boiled at 100°C for 10 min and centrifuged at 15,000 x g for 1 min before loading 
to each lane. There are two major bands at about 26 kDa and 38 kDa (pointed by black and 
red arrows) in both supernatant and pellet of the lysate. Both bands are shown in the 
supernatants of the samples with 80°C or 100°C heat treatment (lanes 4/5 and 9/11), indicating 
their thermostable property. The 26 kDa band corresponds to the encapsulin protein of 
PFC_05175 while the 38 kDa band corresponds to the size of PFC_05175. 
Taken together, we hypothesised that mRNA sequence of PFC_05175 was translated 




extra encapsulin protein of PFC_05175 that formed pentamers (Figure 6.6.2). 
Decameric EncFtn was docked on top of pentameric encapsulin along the 5-fold 
symmetry axis but not in analogous to the 60-meric encapsulin nanocompartment as 
mentioned in Figure 5.7.3. Instead, the C-termini of EncFtn appeared to connect with 
the N-termini of hexameric encapsulin nearby. Therefore, it was likely in P. furiosus 
120 subunits of fused EncFtn-Enc and extra 60 subunits of encapsulin were expressed; 
EncFtn formed 12 decamers that docked to 12 pentameric encapsulin formed due to 
the extra translation; and the connecting 120 subunits of encapsulin assembled into 20 
hexamers. 
 
Figure 6.6.2 Hypothesis of P. furiosus encapsulin nanocompartment assembly. 
(A) P. furiosus encapsulin with twelve pentamers in pink lines and twenty hexamers in 
green/blue lines is fully occupied by twelve decameric EncFtns (cyan cartoons). Each 
decameric EncFtn is docked on top of a pentameric encapsulin along the 5-fold symmetry axis. 
(B) Big view of the docking complex highlighted by a black square in (A). The C-termini of 
EncFtn are shown in blue spheres. The N-termini of pentameric encapsulin are shown in red 
spheres while the N-termini of hexameric encapsulin are shown in yellow spheres. Five 
dashed circles highlight the potential connection between the two C-termini of EncFtn with 
adjacent two N-termini of hexameric encapsulin, correlating with the equivalent expression of 
EncFtn and encapsulin as a full-length protein. It also suggests that the extra expression of 




When each pentamer of the P. furiosus encapsulin nanocompartment were fully 
occupied by EncFtn (Pfc-EncFtnS), the inner cavity had a diameter of 20–30 Å, which 
was much larger than the 8 Å inner diameter of the T. maritima encapsulin when it 
was fully occupied by 12 copies of EncFtn of R. rubrum. The larger encapsulin cavity 
was consistent with the potential for much greater storage and correlating with 
observations of the M. xanthus encapsulin (PDB ID: 4PT2) with 180 subunits, which 
has been estimated to be able to carry around 30000 iron ions based on the scanning 
transmission electron microscopy analysis of the dense core inside the encapsulin 
(McHugh et al. 2014). 
 
Figure 6.6.3 Interior space comparison of 180-meric and 60-meric encapsulin 
nanocompartments. 
P. furiosus (PFC) encapsulin (the outer circle in lines, PDB ID: 2E0Z) fully occupied with 12 
copies of Pfc-EncFtnS (cyan cartoon with iron as yellow spheres) is compared with T. maritima 
encapsulin (TM, inner circle in green lines, PDB ID: 3DKT) fully occupied with 12 copies of 
decameric Rru-EncFtnSH (RRU, purple lines with iron as yellow spheres) while decameric 
Pfc-EncFtnS and Rru-EncFtnSH are well aligned. The diameter of the inner space of fully 
occupied PFC encapsulin nanocompartment is 20–30 Å whereas the inner diameter of fully 
occupied TM-RRU encapsulin nanocompartment (T. maritima-encapsulin docked with R. 




 Conclusions and discussion 
In this chapter the structures of EncFtn from the halophilic bacterium H. ochraceum 
and the thermophilic archaeon P. furiosus were determined and analysed. The two 
EncFtn homologues (Hoch-EncFtnS and Pfc-EncFtnS) display a similar annular 
decamer structure to R. rubrum EncFtn (Rru-EncFtnSH).  
The Hoch-EncFtnS sequence possessed all same metal binding residues with Rru-
EncFtnSH, but no metal was bound in the structure. The metal entry site in Hoch-
EncFtnS had a wider space and thus did not coordinate any metal. The metal exit site 
of Hoch-EncFtnS displayed a similar conformation with Rru-EncFtnSH. Future work 
involving assay of the ferroxidase activity of Hoch-EncFtnS is necessary to determine 
whether the protein is indeed active to oxidise Fe(II). Since Hoch-EncFtn was 
originally from a halobacterium, it is worth exploring if the salt concentration will 
influence its enzymatic activity. As it was not possible to obtain an iron-bound Hoch-
EncFtnS structure, native MS can be conducted to study the behaviour of Hoch-
EncFtnS under different pH values with respect to metal binding. ICP-MS can also be 
applied to explore the metal binding of Hoch-EncFtnS. Further to analysis of the 
ferroxidase assay of this enzyme, other ferritin-related functions such as peroxidase 
activity is worth exploring in Hoch-EncFtnS. The assembly and disassembly of Hoch-
EncFtnS in the presence of different metal ions and salt concentrations are also worth 
exploring. 
The P. furiosus encapsulin nanocompartment (Pfc-EncFtn-Enc, KEGG ID: 
PFC_05175) was encoded by a single gene with the EncFtn and encapsulin domains 
produced as a single polypeptide as suggested in the article (Namba et al. 2005), thus 
the C-terminal localisation sequence shared by EncFtn family proteins was not seen in 
the EncFtn domain. The Pfc-EncFtnS structure displays a conserved FOC with di-iron 
coordinated. By contrast, the metal entry site and exit site are not conserved in Pfc-
EncFtnS, suggesting a different mechanism for iron movement in the P. furiosus 
encapsulin nanocompartment. Because of the annular decamer assembly of the P. 
furiosus EncFtn, there was no way for 180 subunits of encapsulin to accommodate 180 
subunits or EncFtn or 18 decameric EncFtns. Therefore, an assembly model of P. 




nanocompartment assembly that decameric EncFtn was docked to pentameric 
encapsulin through the C-terminal extension, the PFC_05175 mRNA was translated 
into two proteins: a full length protein with 120 subunits of fused EncFtn and 
encapsulin forming 20 hexameric encapsulins and 12 decameric EncFtns, and an extra 
translation of 60 subunits of encapsulin protein assembling into 12 pentamers. The 12 
decamers of EncFtn were docked on top of 12 pentameric encapsulins while the C-
termini of EncFtn were still connecting with the N-termini of hexameric encapsulin 
nearby the pentameric encapsulin. To validate this hypothesis, PFC_05175 will be 
purified and subjected to the native mass spectrometry. Alternatively, the co-
expression of Pfc-EncFtn and Pfc-Enc can be performed in E. coli using the two 
multiple cloning sites of pAYCDuet-1 vector, followed by nanocompartments 
production and analysis by TEM. The size comparison of encapsulin 
nanocompartments from P. furiosus and T. maritima revealed that more space in 180-
meric encapsulin nanocompartment would allow higher iron storage, and thus could 
be explored pertaining to the application of iron-loaded encapsulin nanocompartments 




7 Chapter 7 Conclusion and outlook 
 Conclusion 
Encapsulin-associated ferritin-like proteins (EncFtn) represent a unique family class 
in the ferritin superfamily and are possible to be in the early stage of ferritin evolution. 
This study provides the first evidence of looking into EncFtn families and 
understanding the protein assembly, structure and biochemistry of R. rubrum EncFtn. 
The wide distribution of EncFtn in different bacteria or archaea has also been 
investigated by structural characterisation of EncFtn homologues in H. ochraceum and 
P. furiosus.   
The recombinant R. rubrum EncFtn overexpressed in E. coli displays two oligomeric 
states in solution: monomer and decamer. The ICP-MS result reveals that the monomer 
contains no detectable iron, while the decamer fractions have a significant amount of 
iron. The in vitro metal titration results reveal that in the gas phase EncFtn decamerises 
completely in the presence of a five-fold excess of Fe(II). Subsequent analytical gel-
filtration and native PAGE results confirm that EncFtn oligomerises in the presence of 
molar equivalents of Fe(II), Zn(II) or Co(II). Furthermore, Fe(III) does not alter the 
EncFtn assembly, suggesting the complex has a preference for ferrous iron over ferric 
iron. Both monomer and decamer fractions are able to crystallise into a ring-doughnut-
like decamer structure (5 x 7 x 7 nm) with a central 5-fold symmetry channel at1.6 nm 
wide, which consists of a pentamer of dimers. The monomer of EncFtn contains two 
main alpha-helices (α1-α2) and a C-terminal short α3; two monomers arrange in an 
anti-parallel manner to form two types of dimer, with or without metal associated, 
named as FOC and non-FOC dimers, respectively. There are three metal binding sites 
in the FOC dimer interface: metal ion entry site, consisting of E31 and E34 from two 
chains that coordinate a hydrated calcium ion in the crystal structure; ferroxidase 
centre (FOC), composed of E32, E62, H65 and Y39 from two chains, which binds di-
iron ions; metal ion exit site, comprising H57, E61 and E64 from two chains, which 
coordinate two calcium ions with partial occupancy in the structure. The single alanine 
mutations of residues in the FOC abolish the iron binding but do not change the 




presence of 15 iron ions in EncFtn, suggesting that metal ion entry/exit site in the 
structure can be alternative iron binding sites. The alignment of dimeric EncFtn with 
monomeric bacterial ferritin highlights a common four-helix bundle architecture 
around the FOC and suggests that classical ferritins may have evolved from EncFtn 
through gene duplication. Superimposing decameric EncFtn with the 24-meric 
bacterial ferritin suggests that the two proteins differ in their iron-storage behaviour. 
In the classical ferritins iron is proposed to move from the outer surface to the FOC 
where it is oxidised prior to mineralisation in the ferritin nanocage; however, the 
orientation of the FOC in EncFtn is flipped, suggesting that iron moves from the 
central channel towards the outer surface of EncFtn. These structural observations lead 
to major questions: Does EncFtn act as a ferroxidase enzyme? How is iron stored by 
EncFtn in the absence of an enclosed nanocage structure? 
The subsequent ferroxidase assay and end-point ferrozine assay confirm that EncFtn 
is able to oxidise Fe(II) to Fe(III) and can bind a maximum of 47 iron ions. The 
ferroxidase activity conferred by the FOC of EncFtn is supported by the diminished 
iron oxidation of FOC single mutants. The EncFtn gene in R. rubrum is in a locus 
upstream of a gene encoding an encapsulin protein. The recombinantly expressed R. 
rubrum encapsulin protein (Rr-Enc) forms a 24-nm spherical structure with the highest 
sequence identity to the T. maritima encapsulin (Sutter et al. 2008). R. rubrum Enc 
does not possess iron oxidation ability; instead, it binds a maximum of 2200 iron ions, 
possibly due to a negatively-charged interior surface as seen in the structures of other 
members of the encapsulin family. The co-expressed Rru-EncFtn and Rru-Enc (Rru-
EncFtn-Enc) nanocompartment displays a similar size to Rru-Enc, with an estimated 
12 copies of the EncFtn decamer targeted to the interior surface of the pentameric 
vertices of the encapsulin through the C-terminal location sequence of EncFtn. The 
EncFtn-Enc complex shows a comparable ferroxidase activity with horse spleen 
apoferritin. Its maximal iron loading capacity in the assay conditions tested is about 
4200 iron ions, which is 7–8 times higher than the iron incorporation in apoferritin in 
the experiment. Although fully occupied encapsulin nanocompartment shares a similar 
sized inner cavity with 24-meric apoferritin, at 8 nm diameter, the higher iron loading 




due to the 60 FOCs present in the twelve EncFtn decamers in the encapsulin in contrast 
to the 24 FOCs of classical ferritins. 
Based on the protein structure, assembly and biochemical data a model for iron storage 
can be proposed for the 60-meric encapsulin nanocompartment (EncFtn-Enc). Fe(II) 
traverses the encapsulin shell through the 5-fold symmetry surface pore, moves along 
the well-aligned 5-fold central channel of EncFtn, followed by the coordination at the 
metal ion entry site and translocation to the FOC where Fe(II) is oxidised to Fe(III). 
Subsequent to oxidation, Fe(III) translocates to the metal ion exit site and is 
mineralised within the encapsulin cage. The EncFtn-Enc nanocompartment is 
reminiscent of 24-meric classical ferritins with multiple di-iron centres that may 
increase the iron oxidation; and the presence of encapsulin is critical for iron 
mineralisation. Therefore, compared to classical ferritins, the iron oxidation and 
mineralisation occur in two proteins, with EncFtn oxidising Fe(II) and encapsulin 
providing the space for the formation of Fe(III) minerals.  
The structure and overall arrangement of the EncFtn decamer is conserved across 
homologues from a halophilic bacterium H. ochraceum (Hoch) and a thermophilic 
archaeon P. furiosus (Pfc). There is no metal binding in the Hoch-EncFtn structure, 
although all metal binding sites are the same as the Rru-EncFtn. Pfc-EncFtn displays 
more structured N-/C-termini than the other two homologues; this may be related to 
the fact that the native protein is from a thermophile, which requires stable proteins at 
high temperatures. The FOC of Pfc-EncFtn is highly conserved, while the metal 
binding entry/exit sites possess more variable residues without metal association, 
suggesting differences in the iron oxidation chemistry.  
 Outlook 
To validate the iron storage model of EncFtn-Enc, it will be necessary to obtain the 
structure of the Rru-Enc protein. The purification methods used in this work—RNase 
treatment plus sucrose cushion/gradient ultracentrifugation, produces reasonably pure 
encapsulin proteins; however, the crystals grown from this protein did not diffract to 
better than 10 Å. It is possible that the impurities in Rru-Enc have affected the crystal 




diffraction data at room temperature; alternatively, cryo-protectants can be optimised 
when collecting diffraction data at 100 K. Besides, different truncated constructs of 
Rru-Enc can be designed based on cross-linking information, and subjected to 
crystallisation. Although His-tagged Rru-Enc is easier to purify and gives protein of a 
much higher purity, it appears to be unstable during dialysis or buffer exchange and 
precipitates eventually. Other tags such as strep tag can be used to label Rru-Enc, 
which may help to obtain purer proteins for crystallisation. Alternatively, cryo-EM can 
also be helpful in determining the Rru-Enc structure.  
To understand the transport of Fe(II) ions across the encapsulin shell, molecular 
dynamic simulations can be performed on models of Rru-Enc to estimate the iron 
movement across encapsulin shell (Laghaei et al. 2014). Alternatively, 
hydrogen/deuterium exchange mass spectrometry can be carried out to determine the 
conformational dynamics of the encapsulin protein (Konermann et al. 2011). Based on 
these data, surface pore residues of Rru-Enc can be mutated to block the putative entry 
site and detect if iron oxidation and mineralisation will be affected.  
To explore the role of the metal ion entry and exit sites of the Rru-EncFtn in iron 
oxidation, ferroxidase assays can be performed on metal ion entry/exit mutants. The 
maximum iron loading capacity can be explored on the corresponding mutations of 
Rru-EncFtn when enclosed in the encapsulin (Rru-EncFtn-Enc). The conserved 
tyrosine39, which is proposed to facilitate the iron oxidation as a single electron 
molecular capacitor in classical ferritins (Ebrahimi, Hagedoorn & Wilfred R Hagen 
2013), can be mutated to determine how it affects the iron oxidation of Rru-EncFtn 
and Rru-EncFtn-Enc.  
It is not clear if Hoch-EncFtn and Pfc-EncFtn have iron oxidation ability. It is possible 
that salt concentration in buffers may affect the assembly and ferroxidase activity of 
Hoch-EncFtn. Thus ferroxidase assays should be performed on the EncFtn 
homologues in the future. 
The self-assembly of encapsulin nanocompartments as well as the potential for 
carrying cargos make encapsulins very appealing for biotechnological applications, 
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99 11304.01 4.49 4470 0.395 
Table 7.2.1 Protein information. 
Pfc-EncFtnS does not contain any Trp residues, which could result in more than 10% error in the computed extinction coefficient. The extinction coefficient 

















Figure 7.2.1 Multiple protein sequence alignment of ferritin family proteins. 
Protein names were adapted from either UniprotKB (UniProt Consortium 2014), KEGG (Ogata 
et al. 1999) database or common name with PDB entry code (Berman et al. 2000). Sequences 
were sorted in an order corresponding to the clades in phylogenetic tree (Figure 1.4.9). The 
alignment was performed progressively by EBI alignment tools as described above and edited 
by Espript 3.0 web server (Robert & Gouet 2014). The secondary structure of Brucella 
melitensis BFR (BmBfr, PDB ID: 3FVB) is shown on top of the alignment. Rru-EncFtn 
(Rru_A0973), as a representative of EncFtn proteins, is highlighted in yellow. The metal 
binding sites of P. furiosus bacterial ferritin (PfFtn_2JD7) (highlighted in blue) consist of FeA 
site (E17, E50, H53 and Q127, highlighted as solid blue triangles), FeB site (E50, E94, E130, 
Q127, labelled with solid blue circles) and FeC site (E49, E126, E129 and E130, solid blue 
squares). The FOC of Rru_A0973 was labelled with empty red triangles including E32, E62, 
H65 and Y39; and the metal entry site was marked with empty red circles including E31 and 
E34.The metal exit site was marked with empty red squares including H57, E61 and E64. The 
C-terminal localisation sequences shared by the encapsulin associated ferritins (EncFtn) were 





Table 7.2.2 Interaction summary of dimer interfaces of EncFtn homologues analysed by 
PDBePISA server. 
 interface 138 18.50% 142 19.20% 179 23.00% 178 22.90% 132 17.20% 127 16.70%
 surface 558 74.80% 555 74.90% 567 72.90% 574 73.80% 564 73.40% 548 72.20%
 total 746 100.00% 741 100.00% 778 100.00% 778 100.00% 768 100.00% 759 100.00%
 interface 33 36.30% 31 34.40% 44 45.40% 44 45.40% 31 33.70% 31 34.10%
 surface 91 100.00% 90 100.00% 97 100.00% 97 100.00% 91 98.90% 89 97.80%
 total 91 100.00% 90 100.00% 97 100.00% 97 100.00% 92 100.00% 91 100.00%
 interface 1240.7 17.00% 1243.3 16.90% 1796.1 22.50% 1797.1 21.90% 1208.8 16.60% 1224.9 16.90%
 total 7304.3 100.00% 7352.3 100.00% 7977.7 100.00% 8197.5 100.00% 7302.1 100.00% 7266.3 100.00%
 isolated structure -56.4 100.00% -53.9 100.00% -65.3 100.00% -64.7 100.00% -66.5 100.00% -64.6 100.00%
 gain on complex 
formation
-5.8 10.30% -5.6 10.40% -12.7 19.50% -12.7 19.70% -5 7.60% -3.8 5.90%
 aver ge gain -6.1 10.70% -6.6 12.30% -10.6 16.20% -10.6 16.40% -6 8.90% -6.4 9.90%
 P-value 0.554 0.623 0.34 0.351 0.601 0.751
 interface 268 35.90% 262 35.10% 195 25.10% 194 24.80% 241 31.40% 240 31.20%
 surface 556 74.50% 549 73.60% 561 72.10% 573 73.20% 552 71.90% 560 72.90%
 total 746 100.00% 746 100.00% 778 100.00% 783 100.00% 768 100.00% 768 100.00%
 interface 55 60.40% 55 60.40% 46 47.40% 46 46.90% 54 58.70% 53 57.60%
 surface 91 100.00% 91 100.00% 97 100.00% 98 100.00% 91 98.90% 89 96.70%
 total 91 100.00% 91 100.00% 97 100.00% 98 100.00% 92 100.00% 92 100.00%
 interface 2457.5 33.80% 2468.3 33.80% 1816 22.80% 1806.7 22.50% 2326.9 31.90% 2342.4 32.30%
 total 7281 100.00% 7307.7 100.00% 7954.7 100.00% 8026.8 100.00% 7296.6 100.00% 7245.3 100.00%
 isolated structure -55.3 100.00% -56.2 100.00% -62.1 100.00% -67 100.00% -66.7 100.00% -65.3 100.00%
 gain on complex 
formation
-15.1 27.30% -15.6 27.70% -7 11.30% -6.5 9.70% -17.2 25.80% -16.5 25.30%
 average gain -12.3 22.30% -11.8 21.00% -12.7 20.50% -11.2 16.70% -11 16.60% -11.6 17.70%
 P-value 0.314 0.254 0.875 0.831 0.124 0.173
Number of atoms
Number of residues
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Table 7.2.3 Hydrogen bonds and salt bridges of FOC dimer interface of EncFtn 
homologues analysed by PDBePISA. 
 
No. Chain D  Dist. [Å] Chain E No. Chain a  Dist. [Å] Chain c 
 1  D:TYR  39[ HH ]  1.82  E:GLU  32[ OE2]  1  a:LEU   3[ H  ]  2.04  c:ASP  34[ OD2] 
 2  D:THR  47[ H  ]  2.38  E:ASN  21[ OD1]  2  a:SER   4[ H  ]  2.09  c:ASP  34[ OD1] 
 3  D:HIS  65[ ND1]  3.66  E:GLU  62[ OE2]  3  a:ILE   5[ H  ]  2.19  c:GLN  41[ OE1] 
 4  D:THR  47[ OG1]  2.02  E:ASN  21[HD21]  4  a:TYR  16[ H  ]  1.94  c:TYR  45[ O  ] 
 5  D:GLU  32[ OE2]  1.76  E:TYR  39[ HH ]  5  a:TYR  39[ HH ]  1.90  c:GLU  32[ OE2] 
 6  D:ASN  21[ OD1]  3.88  E:SER  46[ OG ]  6  a:GLN  41[HE22]  1.96  c:ILE   5[ O  ] 
 7  D:ASN  21[ OD1]  2.34  E:THR  47[ H  ]  7  a:TYR  45[ HH ]  2.14  c:ARG  12[ O  ] 
 8  D:GLU  62[ OE2]  3.49  E:HIS  65[ ND1]  8  a:ASP  34[ OD2]  2.04  c:LEU   3[ H  ] 
 9  a:ASP  34[ OD1]  2.19  c:SER   4[ H  ] 
No. Chain E  Dist. [Å] Chain I   10  a:GLN  41[ OE1]  2.22  c:ILE   5[ H  ] 
 1  E:TYR  38[ HH ]  2.16  I:GLU  31[ OE2]  11  a:TYR  45[ O  ]  1.91  c:TYR  16[ H  ] 
 2  E:ARG  41[HH12]  1.96  I:GLU  30[ OE1]  12  a:GLU  32[ OE2]  1.86  c:TYR  39[ HH ] 
 3  E:ARG  41[HH22]  1.69  I:GLU  30[ OE2]  13  a:ILE   5[ O  ]  1.90  c:GLN  41[HE22] 
 4  E:GLU  30[ OE1]  1.78  I:ARG  41[HH22]  14  a:ARG  12[ O  ]  2.06  c:TYR  45[ HH ] 
 5  E:GLU  47[ OE2]  2.20  I:ARG  75[HH21]
No. Chain D  Dist. [Å] Chain E No. Chain E  Dist. [Å] Chain I  
 1  D:HIS  65[ ND1]  3.85  E:GLU  62[ OE1]  1  E:ARG  41[ NH1]  2.81  I:GLU  30[ OE1] 
 2  D:HIS  65[ ND1]  3.66  E:GLU  62[ OE2]  2  E:ARG  41[ NH1]  2.88  I:GLU  30[ OE2] 
 3  D:HIS  65[ NE2]  2.76  E:GLU  61[ OE1]  3  E:ARG  41[ NH2]  3.85  I:GLU  30[ OE1] 
 4  D:GLU  62[ OE2]  3.49  E:HIS  65[ ND1]  4  E:ARG  41[ NH2]  2.45  I:GLU  30[ OE2] 
 5  D:GLU  62[ OE1]  3.71  E:HIS  65[ ND1]  5  E:HIS  64[ ND1]  3.77  I:GLU  61[ OE2] 
 6  D:GLU  61[ OE1]  2.50  E:HIS  65[ NE2]  6  E:HIS  64[ NE2]  2.77  I:GLU  60[ OE1] 
 7  E:ARG  75[ NE ]  3.98  I:GLU  47[ OE1] 
 8  E:GLU  30[ OE1]  2.51  I:ARG  41[ NH2] 
 9  E:GLU  30[ OE1]  3.92  I:ARG  41[ NH1] 
No. Chain a  Dist. [Å] Chain c  10  E:GLU  30[ OE2]  3.62  I:ARG  41[ NH2] 
 1  a:HIS  65[ ND1]  4.00  c:GLU  62[ OE1]  11  E:GLU  30[ OE2]  3.65  I:ARG  41[ NH1] 
 2  a:HIS  65[ ND1]  3.36  c:GLU  62[ OE2]  12  E:GLU  47[ OE1]  3.71  I:ARG  75[ NH2] 
 3  a:HIS  65[ NE2]  3.00  c:GLU  61[ OE1]  13  E:GLU  47[ OE2]  3.96  I:ARG  75[ NE ] 
 4  a:HIS  65[ NE2]  3.53  c:GLU  61[ OE2]  14  E:GLU  47[ OE2]  2.98  I:ARG  75[ NH2] 
 5  a:GLU  62[ OE2]  3.34  c:HIS  65[ ND1]  15  E:GLU  60[ OE1]  2.99  I:HIS  64[ NE2] 
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Table 7.2.4 Salt bridges in Non-FOC dimer interface of EncFtn homologues analysed by 
PDBePISA. 
 
No. Chain A  Dist. [Å] Chain B No. Chain O  Dist. [Å] Chain Z
 1  A:HIS  23[ ND1]  3.46  B:ASP  37[ OD1]  1  O:ARG  26[ NH1]  3.87  Z:GLU  40[ OE1] 
 2  A:HIS  23[ ND1]  2.59  B:ASP  37[ OD2]  2  O:ARG  26[ NH1]  2.88  Z:GLU  40[ OE2] 
 3  A:ARG  22[ NH2]  3.77  B:ASP  40[ OD1]  3  O:ARG  26[ NH2]  3.16  Z:GLU  40[ OE1] 
 4  A:ARG  22[ NH2]  2.66  B:ASP  40[ OD2]  4  O:ARG  26[ NH2]  3.57  Z:GLU  40[ OE2] 
 5  A:ARG  22[ NE ]  3.26  B:ASP  40[ OD2]  5  O:ARG  44[ NH1]  2.86  Z:GLU  19[ OE1] 
 6  A:LYS  63[ NZ ]  2.99  B:ASP  77[ OD1]  6  O:ARG  44[ NH1]  3.32  Z:GLU  23[ OE2] 
 7  A:LYS  63[ NZ ]  3.24  B:ASP  77[ OD2]  7  O:ARG  44[ NH2]  3.05  Z:GLU  23[ OE1] 
 8  A:ASP  37[ OD1]  3.55  B:HIS  23[ ND1]  8  O:ARG  44[ NH2]  3.26  Z:GLU  23[ OE2] 
 9  A:ASP  37[ OD2]  2.59  B:HIS  23[ ND1]  9  O:ARG  60[ NH1]  3.34  Z:GLU  83[ OE2] 
 10  A:ASP  40[ OD1]  3.88  B:ARG  22[ NH2]  10  O:ARG  60[ NH1]  3.85  Z:GLU  83[ OE1] 
 11  A:ASP  40[ OD2]  3.41  B:ARG  22[ NE ]  11  O:LYS  63[ NZ ]  3.01  Z:ASP  77[ OD1] 
 12  A:ASP  40[ OD2]  2.82  B:ARG  22[ NH2]  12  O:LYS  63[ NZ ]  2.97  Z:ASP  77[ OD2] 
 13  A:ASP  44[ OD1]  3.40  B:LYS  16[ NZ ]  13  O:LYS  63[ NZ ]  3.02  Z:GLU  79[ OE1] 
 14  A:ASP  77[ OD1]  2.91  B:LYS  63[ NZ ]  14  O:GLU  40[ OE1]  3.91  Z:ARG  26[ NH1] 
 15  A:ASP  77[ OD2]  3.14  B:LYS  63[ NZ ]  15  O:GLU  40[ OE2]  2.90  Z:ARG  26[ NH1] 
 16  O:GLU  40[ OE1]  3.16  Z:ARG  26[ NH2] 
 18  O:GLU  20[ OE2]  2.70  Z:ARG  44[ NH1] 
 19  O:GLU  20[ OE2]  3.45  Z:ARG  44[ NH2] 
No. Chain E  Dist. [Å] Chain G  20  O:GLU  83[ OE1]  3.85  Z:ARG  60[ NH1] 
 1  E:HIS  22[ ND1]  3.35  G:ASP  36[ OD1]  21  O:GLU  83[ OE2]  3.68  Z:ARG  60[ NH1] 
 2  E:HIS  22[ ND1]  2.46  G:ASP  36[ OD2]  22  O:ASP  77[ OD1]  3.24  Z:LYS  63[ NZ ] 
 3  E:ASP  36[ OD1]  3.44  G:HIS  22[ ND1]  23  O:ASP  77[ OD2]  3.20  Z:LYS  63[ NZ ] 
 4  E:ASP  36[ OD2]  2.55  G:HIS  22[ ND1]  24  O:GLU  79[ OE1]  2.91  Z:LYS  63[ NZ ]
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Table 7.2.5 Hydrogen bonds in non-FOC dimer interface of EncFtn homologues analysed by PDBePISA. 
No. Chain A  Dist. [Å] Chain B No. Chain O  Dist. [Å] Chain Z No. Chain E  Dist. [Å] Chain G
 1  A:ARG  22[HH21]  1.84  B:ASP  40[ OD2]  1  O:ARG  26[HH12]  2.10  Z:GLU  40[ OE2]  1  E:HIS   8[ H  ]  2.02  G:GLN  40[ OE1] 
 2  A:HIS   9[ H  ]  1.99  B:GLN  41[ OE1]  2  O:ARG  26[HH21]  2.10  Z:ASN  37[ OD1]  2  E:SER  15[ H  ]  2.37  G:ASP  43[ OD2] 
 3  A:HIS   9[ ND1]  3.74  B:GLN  41[ OE1]  3  O:ARG  26[HH22]  2.32  Z:GLU  40[ OE1]  3  E:TYR  86[ HH ]  1.84  G:GLU  63[ OE2] 
 4  A:LYS  16[ H  ]  2.28  B:ASP  44[ OD2]  4  O:ASN  37[HD21]  2.17  Z:GLU  23[ O  ]  4  E:PHE  88[ H  ]  2.21  G:GLU  70[ OE1] 
 5  A:TYR  87[ HH ]  1.71  B:GLU  64[ OE2]  5  O:GLN  41[HE21]  2.41  Z:GLU  23[ OE1]  5  E:THR  89[ H  ]  2.36  G:GLU  70[ OE2] 
 6  A:PHE  89[ H  ]  2.26  B:GLU  71[ OE1]  6  O:ARG  44[HH11]  2.28  Z:GLU  19[ OE1]  6  E:ARG  74[HH21]  1.89  G:THR  89[ OG1] 
 7  A:THR  90[ H  ]  2.44  B:GLU  71[ OE2]  7  O:ARG  44[HH22]  2.27  Z:GLU  23[ OE1]  7  E:ARG  74[HH12]  2.27  G:ARG  91[ O  ] 
 8  A:LYS  63[ HZ3]  2.11  B:ASP  77[ OD1]  8  O:ARG  60[HH11]  2.49  Z:GLU  83[ OE2]  8  E:ARG  74[HH22]  2.05  G:ARG  91[ O  ] 
 9  A:ARG  75[HH21]  2.01  B:THR  90[ OG1]  9  O:LYS  63[ HZ3]  2.16  Z:ASP  77[ OD1]  9  E:GLN  40[ OE1]  1.93  G:HIS   8[ H  ] 
 10  A:ARG  75[HH12]  2.10  B:GLY  92[ O  ]  10  O:LYS  63[ HZ2]  2.16  Z:GLU  79[ OE1]  10  E:ASP  43[ OD2]  2.49  G:SER  15[ H  ] 
 11  A:ARG  75[HH22]  2.38  B:GLY  92[ O  ]  11  O:GLU  40[ OE2]  2.14  Z:ARG  26[HH12]  11  E:ASP  43[ OD2]  3.59  G:SER  15[ OG ] 
 12  A:ASP  40[ OD2]  2.00  B:ARG  22[HH21]  12  O:ASN  37[ OD1]  2.04  Z:ARG  26[HH21]  12  E:GLU  63[ OE2]  1.70  G:TYR  86[ HH ] 
 13  A:GLN  41[ OE1]  1.87  B:HIS   9[ H  ]  13  O:GLU  40[ OE1]  2.31  Z:ARG  26[HH22]  13  E:GLU  70[ OE1]  2.21  G:PHE  88[ H  ] 
 14  A:ASP  44[ OD2]  2.09  B:LYS  16[ H  ]  14  O:GLU  23[ O  ]  2.22  Z:ASN  37[HD21]  14  E:GLU  70[ OE2]  2.28  G:THR  89[ H  ] 
 15  A:GLU  64[ OE2]  1.84  B:TYR  87[ HH ]  15  O:GLU  23[ OE1]  2.11  Z:GLN  41[HE21]  15  E:THR  89[ OG1]  2.05  G:ARG  74[HH21] 
 16  A:GLU  71[ OE1]  2.29  B:PHE  89[ H  ]  16  O:GLU  20[ OE2]  1.98  Z:ARG  44[HH12]  16  E:ARG  91[ O  ]  2.32  G:ARG  74[HH12] 
 17  A:GLU  71[ OE2]  2.38  B:THR  90[ H  ]  17  O:ASP  77[ OD1]  2.39  Z:LYS  63[ HZ3]  17  E:ARG  91[ O  ]  2.20  G:ARG  74[HH22] 
 18  A:ASP  77[ OD1]  2.04  B:LYS  63[ HZ3]  18  O:ASP  77[ OD2]  2.43  Z:LYS  63[ HZ3] 
 19  A:THR  90[ OG1]  2.17  B:ARG  75[HH21]  19  O:GLU  79[ OE1]  2.03  Z:LYS  63[ HZ2] 
 20  A:GLY  92[ O  ]  2.33  B:ARG  75[HH22] 
 21  A:GLY  92[ O  ]  2.04  B:ARG  75[HH12] 
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